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Abstract 
Oestrogenic chemicals have become increasingly associated with health effects 
in wildlife populations and humans.  Transgenic animal models have been 
developed to understand the mechanisms by which these oestrogenic 
chemicals alter hormonal signalling pathways and how these alterations can 
lead to chronic health effects. The use of highly informative transgenic animal 
models will also result in better use and potential reduction of intact animals 
used in animal testing in line with the principles of the 3Rs. In this thesis work, 
two novel oestrogen responsive transgenic zebrafish models have been 
generated to investigate the effects of oestrogenic chemicals, identify their 
tissue targets and better understand the temporal dynamics of these responses. 
Both models express the pigment-free ‘Casper’ (a mutant line lacking skin 
pigment) phenotype, which facilitate identification of responding target tissues in 
the whole fish in all fish life stages (embryos to adults).  
The oestrogen response element green fluorescent (ERE-GFP)-Casper model 
was generated by crossing an established ERE-GFP line with the skin pigment 
free Casper line. The model generated is highly sensitive to oestrogenic 
chemicals, detecting responses to environmentally relevant concentrations of 
EE2, bisphenol A (BPA), genistein and nonylphenol.  Use of the ERE-GFP-
Casper model shows chemical type and concentration dependence for green 
fluorescent protein (GFP) induction and both spatial and temporal responses for 
different environmental oestrogens tested. A semi-automated (ArrayScan) 
imaging and image analysis system was also developed to quantify whole body 
fluorescence responses for a range of different oestrogenic chemicals in the 
new transgenic zebrafish model. The zebrafish model developed provides a 
sensitive and highly integrative system for identifying oestrogenic chemicals, 
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their target tissues and effect concentrations for exposures in real time and 
across different life stages. It thus has application for chemical screening to 
better direct health effects analysis of environmental oestrogens and for 
investigating the functional roles of oestrogens in vertebrates.    
The second model generated was an ERE-Kaede-Casper line developed via 
crossing of the ERE-GFP-Casper line and a UAS-Kaede line and screening 
subsequent generations for a desired genotype and homozygous expression of 
the transgenes. Kaede is a photoconvertible fluorescent protein that initially 
fluoresces green in colour and can be permanently converted to red 
fluorescence upon short exposure to UV light. The model has a silenced skin 
pigmentation and high sensitivity to oestrogenic chemicals comparable with the 
previously developed ERE-GFP-Casper model. Use of this model has identified 
windows of tissue-specific sensitivity to ethinyloestradiol (EE2) for exposure 
during early-life (0-48hpf) and illustrated that exposure to oestrogen (EE2) 
during early life (0-48hpf) can enhance responsiveness (sensitivity) to different 
environmental oestrogens (EE2, genistein and bisphenol A) for subsequent 
exposures during development. These findings illustrate the importance of 
oestrogen exposure history in effects assessments and they have wider 
implications for the possible adverse effects associated with oestrogen 
exposure.     
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Information 
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Chapter 1 
General Introduction 
1.1 Endocrine System 
The endocrine system is an information signalling system that regulates and 
controls reproduction, growth, development, behaviour and metabolism. The 
major components of the endocrine system are reproductive tissues, the 
pancreas, hypothalamus, gastrointestinal tract and the pineal, pituitary, thyroid, 
and adrenal glands. Endocrine cells secrete hormones, usually at very low 
concentrations, that are then transported throughout the body via the circulatory 
system; eliciting responses in target cells, through nuclear and membrane 
bound receptor systems. The endocrine system conducts information and elicits 
responses at a slower rate compared with the nervous system, but the effects 
are often much longer lasting. In vertebrates there are two main classes of 
hormones: non-steroidal and steroids, the latter for which oestrogens are one 
example.1 Steroid hormones are lipid based formed from cholesterol and they 
travel in the circulation around the body bound via attachment to carrier 
proteins, such as steroid-binding proteins. They then bind specifically to target 
receptor sites on the cell membrane or internal to the cell in the cytoplasm or to 
nuclear protein receptors and induce physiological changes through the release 
or inhibition of biochemicals, or regulation of genes. Nuclear hormone receptors 
are ligand-activated regulators effecting transcription of genes by interacting 
with specific DNA sequences upstream of their target genes.2  
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Oestrogens are primarily seen as female sex steroids due to their roles in the 
development and regulation of the female reproductive system and in 
secondary sex characteristics. However, the expression of oestrogen is not 
exclusive to females, nor is the role of oestrogen exclusive to the regulation of 
the female reproductive system.3 Oestrogens are fundamental in the growth 
and development of both the female and male gonads and are now known to 
play roles in male fertility and testicular function.4-6 Oestrogen has been shown 
to regulate growth and differentiation during development. In zebrafish (Danio 
rerio) in particular, endogenous oestrogen signalling plays a number of 
important roles in early stage development, including in the regulation of 
metabolism, transcription, tissue development and protein folding and 
trafficking.7 Oestrogens have important sites of action in the central nervous 
system (in the pituitary, hypothalamus, and other specific brain regions) and is 
subsequently linked to changes in behaviour.3 Oestrogens also exert crucial 
maintenance actions in bone,8 liver,9 immune system10 and cardiovascular 
system.11   
1.2 Oestrogen signalling 
Oestrogen signalling occurs via oestrogen binding to oestrogen receptors (ERs) 
in the nucleus, which then dimerise and bind to oestrogen response elements 
(EREs) located in promoters of target genes.12 Upon binding of the oestrogenic 
chemical ligand, a conformational change within the ER binding domain allows 
recruitment of coactivator proteins.13 There are two receptor sub types in 
mammals, esr1 and esr2,14 and three in zebrafish, esr1, esr2a and esr2b.15-17 
esr1 and esr2 subtypes in humans and zebrafish are corresponding orthologs 
with high amino acid sequence similarity for their respective ligand binding 
domains of 64% and 71% respectively.18  
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The expression of these subtypes in organs and tissues can change during 
development up to adolescence and the affinity of ligands for these subtypes 
varies for different oestrogenic chemicals. These differences influence the 
physiological targets and subsequent downstream effects.19, 20 As an example, 
in zebrafish, expression levels of esr1, esr2a and esr2b differ and vary 
significantly during the first 120 hours of development.19 Expression of esr1 and 
esr2b increases during the first 120 hours. At this time esr1 expression is 
comparatively higher. Esr2a expression remains relatively low during this 
period. Zebrafish ER sub-types also show tissue-specific expression; liver, brain 
and heart express all three ERs at relatively high levels compared with other 
somatic tissues at sexual maturity.19 However, there remains insufficient 
information on this in comparison to human tissue-specific subtype expression, 
which is well characterised.21, 22  
There is evidence that ERs can also regulate gene expression via different 
mechanisms. A third of genes regulated by ERs in humans do not contain ERE-
like sequences,23 and these appear to be modulated by other transcription 
factors.24 Oestrogen-related receptors (ERRs) are an example of a small group 
of orphan nuclear receptors that appear to share some target genes with 
ERs.25-28 Membrane ERs (mERs) also occur, and although features such as 
weight, mobility and affinity for oestradiol appear to be similar to nuclear ERs, 
their roles and mechanism(s) of action are still unclear.29-31 Nevertheless, 
oestrogens such as 17β-oestradiol (E2) have been shown induce a rapid rise in 
the intracellular free Ca2+concentration through membrane oestrogen receptors, 
thus affecting calcium-dependent cell signalling.32-34   
Certain oestrogens have been shown to bind ERs with different affinities and 
the expression levels of these receptors within different tissues may be linked to 
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their tissue-specific effects.35, 36 However, this is likely to be an 
oversimplification for explaining differences in tissue responses to oestrogens. 
An important aspect of the oestrogen-signalling pathway is the variable 
interactions of ERs with EREs and importantly the recruitment of co-regulators 
at the DNA-binding site. ESR1 and ESR2 differ in their abilities to recruit co-
activators and different xeno-oestrogen ligands can induce distinct 
conformations in the receptor co-activator-binding pockets, leading to 
differential co-regulator recruitment.37-39 The response-elements themselves 
have also been shown to influence receptor conformation and thus the 
subsequent recruitment of co-regulators.39 In summary, mechanisms behind 
ligand-specific effects may include receptor affinity, receptor expression levels, 
co-regulator expression (and recruitment) and promoter site availability via 
chromatin remodelling; all varying across different tissues and their stages of 
development during growth.  
1.3 EDCs and Oestrogenic Chemicals 
An increasing ecological and human health concern is the prevalence of 
endocrine disrupting chemicals (EDCs). These chemicals interfere with 
hormone signalling and have been linked to a number of chronic health issues 
in humans, and with effects in various wildlife populations.40, 41 Organisms 
endocrine systems may be affected by EDCs mimicking or antagonizing 
endogenous hormones or by disrupting their synthesis and metabolism.42-44 
One group of EDCs that have gained a lot of attention is oestrogenic chemicals, 
due to their widespread presence in both the environment and evidence for 
effects in both humans and wildlife. Exposure to xeno-oestrogens includes both 
natural (phyto- and mycoestrogens) and synthetic oestrogens and they include 
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various pesticides, pharmaceuticals and industrial chemicals.45 The main 
pathways of oestrogens into the environment arise through wastewater effluent 
discharges from municipal treatment plants, hospital effluent and livestock 
activities.46 To date, over 1000 chemicals have been highlighted as being 
potentially endocrine active and over 200 of those have been identified as 
oestrogenic.47 Key examples, and those used in this thesis work are 17α-
ethinylestradiol (EE2) found in the contraceptive pill, the plasticizer bisphenol A 
(BPA), the surfactant breakdown product 4-nonylphenol (mixture of linear and 
branched forms) and the phytoestrogen genistein.48-51  
Oestrogenic chemicals such as these are of particular interest due to their 
apparent potency and widespread accumulation in freshwater and marine 
environments. Oestrogenic chemicals have strong associations with adverse 
reproductive health effects in individual fish,52, 53 for example feminization of 
males52 and alteration of sexual behaviour,54 as well as recorded population 
effects such as altered sexual maturation, increased incidence of intersex and 
overall population decline.55-57 These adverse effects in fish populations are 
compounded by the multiple number of routes of chemical uptake that can 
occur in fish, including via skin and gills, via the diet, or via maternal transfer of 
EDCs that have accumulated in lipid reserves during ovarian development.58  
Fish have been a major focus for research into the effects of oestrogenic 
chemicals, but other wildlife species have also been shown to be affected by 
exposure, including links to eggshell thinning, teratogenesis and feminisation in 
in wild birds,59-62 demasculinisation of panthers (Felis concolor coryi) and 
alligators (Alligator mississippiensis) in Florida63, 64 and significant declines in 
amphibian populations.65 In humans too there are increasing links with 
exposure to environmental oestrogens and decreased semen quality/sperm 
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count and increased incidences of breast cancer and testicular germ cell 
cancer, urogenital tract malformation, heart disease and diabetes66-69. The 
effect of oestrogenic chemicals on the reproductive system and offspring 
development first gained major attention after the use of diethylstilbestrol (DES), 
a synthetic oestrogen, prescribed to many women to prevent miscarriages in 
the 1950s and 1960s. Adverse effects of this drug included defects in the uterus 
and ovaries and immune suppression in the offspring. Boys showed genital 
tract abnormalities and un-descended testes and girls had an unusual form of 
vaginal cancer.70 A large number of studies have since focused on the effect of 
EDCs on the development of both humans and wildlife at early-life stages.71, 72 
1.3.1 Early Life Exposure 
Due to the important role endogenous oestrogen signalling plays in early life 
stage development, an increasing number of studies have investigated adverse 
effects linked to oestrogenic chemical exposure at this life stage. In mice, BPA 
exposure caused disruptions in puberty onset, regularity of oestrous cyclicity,73 
and development of polycystic ovaries.74 Affects on sex differentiation and 
resultant sex ratios have been observed in zebrafish after early-life exposure to 
EE2.75 As mentioned above, BPA has been consistently linked to increased 
risks of breast cancer and more recent findings from rodent testing have 
suggested that exposure in the womb may lead to altered mammary gland 
development and a predisposition to breast cancer.76 A relatively recent area of 
study has been the role of oestrogens in brain development. Oestrogen 
sensitive genes such as cyp19a1b, which encodes for a brain form of 
aromatase (an oestrogen synthesising enzyme), have been identified in radial 
glial cells (RGC) that act as neuronal progenitors in both developing and adult 
fish.77 This may be linked to studies that have shown that phytoestrogens, such 
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as genistein exposure during specific life stages, can affect zebrafish brain 
development.78 These results indicate that early life exposure to oestrogenic 
chemicals may have significant effects on organism development and increased 
susceptibility to xeno-oestrogen related diseases but there requires further 
investigation of exposure effects during this period of life. In addition, little is 
known about the effect of early life exposure on organism sensitivity to repeated 
oestrogenic chemical exposures in later life.  
 
In the next sections, information is included on the sources, distribution, 
estimated environmental concentrations, potency and ER subtype affinity of the 
four oestrogenic chemicals used extensively in the work reported in this thesis, 
which are 17α-ethinylestradiol (EE2), bisphenol A (BPA), 4-nonylphenol mix 
(NP), and genistein. These chemicals were chosen for use because of their 
well-documented oestrogenic potencies, prevalence in the environment and the 
fact that they are on prioritised chemical lists for international EDC screening 
programmes.  
1.3.2 EE2 
Ethinylestradiol (EE2) is a derivative from the natural oestrogen estradiol (E2) 
and is a component found in the majority of female contraceptive pill 
formulations. Globally, the female contraceptive pill is one of the most 
commonly used medications. Excretion of EE2 into water systems, mainly via 
human urine, has lead to pressure on water companies to remove EE2 from 
effluent in wastewater treatment plants (WWTP) before its release into the 
environment.79 Concentrations of EE2 found in surface water can vary 
significantly depending on the site of sampling, but a review of almost twenty 
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different sources showed typical ranges fall within 0.2-25 ng/L range.80 In 
WWTP effluent, typical measured concentrations often fall within 0.5 to 10 ng/L 
range but can extend higher depending on seasons or treatment techniques.80-
82 Therefore concentrations in surface waters and WWTP effluent can be much 
higher than the predictive non-effect concentration (PNEC) of 0.002 ng/L.80, 83 
Using in vivo testing, EE2 has shown to be around 30-40 times more potent 
than E2 whereas in vitro assessments had suggested only a 1.25-1.6 fold 
increase in potency.48, 54, 84 Other in vivo studies have suggested that EE2’s 
binding affinity for ER is much higher in living organisms and its rate of 
metabolism much lower than E2, perhaps explaining the 30-fold difference of 
potency in comparison to in vitro tests.85, 86 EE2 has been found to have a high 
affinity for all major ER subtypes in both humans and zebrafish.87, 88  
1.3.3. BPA 
Bisphenol A (BPA) is a chemical of high-importance worldwide due to its 
application in the production of polycarbonate plastic, epoxy resins (used to line 
metal food and drink cans), and polyester resins. These materials are produced 
in vast quantities and widely distributed throughout the world. BPA, and more 
recently other bisphenolic chemicals, have become of environmental concern 
because they exhibit oestrogenic characteristics. In comparison to EE2, BPA is 
considered a weak environmental oestrogen. Nevertheless, a number of 
adverse effects have been associated with BPA exposure and this has resulted 
in the chemical being prioritised on national and international EDC screening 
lists. This is evidence of the importance of utilising both predictive potency data 
and data from in vivo adverse effects studies for prioritising oestrogenic 
chemicals for screening purposes. Notable health issues linked with BPA 
exposure include breast cancer, heart disease, diabetes and abnormal liver 
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enzymes.69, 89 Due to their presence in a wide range of food and drinks 
containers, human exposure to BPA is primarily through ingestion. BPA is 
rapidly metabolised into water soluble compounds within the body.90 These 
compounds are typically oestrogen inactive, however, recent research suggests 
that a particular metabolite, named MBP (4-methyl-2,4-bis(p-
hydroxyphenyl)pent-1-ene) displays much higher oestrogenic potency 
compared with the parent compound BPA.91 Studies using zebrafish models 
have identified that BPA has a particularly high specificity for inducing 
responses in heart valves in developing larvae.49, 92 This targeted response is 
likely due to BPA showing a higher binding affinity for ESR1 which is believed to 
be highly expressed in heart valves in zebrafish larvae.87, 92  
1.3.4 Nonylphenol 
Nonylphenol (NP) as a polyethoxylate is an alkylphenol used mainly in the 
production of cleaning products, such as detergents (surfactants), but also in 
many other products such as pesticides. Surfactants have been used for over 
40 years in the manufacture of plastics, elastomers, agricultural chemicals, 
pulping and industrial detergent formulations. NP in the environment is often 
found in matrices such as sewage sludge, effluents from sewage treatment 
works, river water and sediments, soil and groundwater. The impacts of 
nonylphenol in the environment include feminisation of aquatic organisms and 
decreased male fertility, effects that are induced in fish at concentrations as low 
as 8.2 μg/L.93 NP has now been banned for use in a number of countries and 
the concentrations in the environment has shown as associated decrease. 
However it is still found at concentrations of 4.1 μg/l in river waters and 1 mg/kg 
in sediments.93 As mentioned previously, potency measurements of EDC can 
widely vary between in vitro and in vivo tests and results from assessments of 
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NP potency are no exception. This is complicated by the 20 or so different 
isomers of NP. The linear form of NP (4n-NP) is often used as a reference for 
concentration and potency assessment. NP is mainly used in industry as a 
mixture of the isomers, most of which are branched and thus oestrogenic 
potency of these products can vary widely.94 In transgenic zebrafish, short-term 
exposures at concentrations as low as 1 μg/L have induced reporter gene 
responses through the oestrogen signalling pathway.49 According to the World 
Health Organisation (WHO), the estimated predicted environmental 
concentration (PEC) for surface water (0.6 µg/l) exceeds the aquatic PNEC of 
0.33 µg/l (http://www.who.int/ipcs/methods/Nonylphenol.pdf).  
1.3.5 Genistein 
Genistein is a phytoestrogen found in soy products and coffee and is an 
oestrogenic chemical of concern. Despite this relatively few studies have 
focused on possible adverse effects of genistein and other phytoestrogens. 
Furthermore studies on the oestrogenic potency of phytoestrogens have shown 
varying results in different species.95 Genistein has gained recent attention as a 
potential prophylaxis and therapeutic agent for cancer, obesity and diabetes as 
well as other chronic diseases.96-98 The difficulties surrounding the analysis of 
effects linked to genistein seemingly arise from its ability to disrupt a number of 
different signalling pathways in both ER and ER-independent manners.78 
Hence, the risks or benefits of genistein exposure are currently unclear. It 
nevertheless remains an environmental oestrogenic chemical of concern due to 
its high affinity binding to oestrogen receptors (ERs). Furthermore, isoflavone 
compounds, including genistein, are discharged in water effluents and are 
present in agricultural runoff as a result from intensive livestock management. 
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Concentrations of genistein in effluents are generally in the range 7-22 ng/L and 
in the range of 3-7 ng/L in surface waters.99, 100 
1.3.6 Testing Chemicals for Oestrogenic Activity 
Concern over environmental oestrogens has continued to gather momentum 
with increasing concern about potential adverse effects from exposure to them 
and a desire to better understand their target tissues and the mechanisms by 
which these effects may take place.  This concern has contributed to the 
establishment of national and international screening and testing programmes 
for EDCs. These regulatory frameworks include the European Union and 
Organisation for Economic Cooperation and Development’s  (OECD) Endocrine 
Disrupters Testing and Assessment (EDTA)101 programme, the US 
Environmental Protection Agency’s (US-EPA) Endocrine Disrupter Screening 
Program (EDSP)102 and the Strategic Programmes on Endocrine Disruptors 
(SPEED) at the Japanese Ministry of the Environment (MOE).103 These 
programs include data derived from a series of in vitro and in vivo assays that 
collectively attempt to make robust assessments on the chemical hazard. In 
vitro assays typically focus on a specific mechanism of oestrogen signalling 
demonstrated in human, rat or fish cell lines, for example oestrogen receptor 
binding and/or activation by a chemical ligand. In vivo assays are mainly 
focused on measuring consequent effects on reproductive development, 
function or output. Oestrogen’s role in the development of reproductive organs 
in particular is well established and unsurprisingly the majority of in vivo 
oestrogenic chemical assessments have focused on potential adverse effects in 
these tissues. For example, based on the strong proliferative effect that 
oestrogens have in the rodent female genital tract, uterotrophic tests have 
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become commonly used by researchers for oestrogenic chemical evaluation104, 
105 and validated by international screening programmes.106 
In vitro assays can be categorised into receptor binding assays, cell culture 
assays and reporter gene assays.107 To assess the ER subtype specificity of 
chemicals, cell lines used for in vitro assays can be generated to specifically 
express certain oestrogen receptor subtypes. Screens have been run with fish 
ER receptor subtypes using both in vitro and in vivo assays to validate 
selectivity and further to this more recent studies have then compared 
oestrogenic chemical selectivity for zebrafish and human receptor subtypes. 
Typically, these studies show that overall potency rankings of oestrogenic 
chemicals are very similar across the different vertebrate phyla but that affinities 
and activation of the different ER subtypes can differ.35, 36, 108, 109 These results 
show therefore that risk of endocrine disruption cannot necessarily be predicted 
for all wildlife based on simply examining receptor activation from a few 
selected test species. 
Examples of the most adopted in vitro techniques for oestrogen screening are 
the E-Screen assay,110 YES assay111 and more recently the ERLUX screen.112 
These screens mainly focus on reporter gene activation via ER subtype binding, 
but when compared employing the same ER they can report different 
sensitivities to oestrogenic chemicals.113, 114 As reported above, potency values 
of oestrogenic chemicals (such as EE2) using these in vitro techniques can also 
vary significantly in comparison to results from in vivo studies.48, 54, 84 The 
variation between in vitro and in vivo results demonstrate the limitations of using 
in vitro techniques to predict potency in living organisms, as they do not account 
for differences in uptake, bioaccumulation or metabolic properties of 
oestrogenic chemicals such as EE2 that may play a crucial role during in vivo 
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exposures.  In vitro systems are also much less able at detect pro-oestrogenic 
compounds due to the fact that most cells used in these systems are limited in 
their capacities for chemical metabolism.115 However, there is a current lack of 
in vivo screening tools for EDCs that can rival the high-throughput speed, cost 
effectiveness and ethical advantages of in vitro screens to improve adverse 
effect prediction. 
Screening protocols typically consist of single chemical exposures and yet 
exposures in the natural environment for EDCs, including for oestrogens, occur 
predominantly as mixtures and studies both in vitro116-118 with reporter gene 
assays and in vivo in fish48 and mammals119, 120 have illustrated the capacity for 
additive (and more than additive) effects. Furthermore, it has been shown that 
other EDCs, such as anti-androgens, can modulate the responses for 
oestrogenic chemicals when as mixture.121 Studies on chemical mixtures have 
also suggested increased tissue-specific adverse effects may occur, for 
example as seen for responses to EDC mixtures in mammary gland 
development in male and female rats.119, 120 Effects analysis for exposures 
representative of real world scenarios is thus extremely difficult. 
 1.4 Transgenic Biosensors 
Whole-animal systems are essential tools for biological research, including their 
application within toxicological/safety screening studies. The development of 
transgenesis techniques has provided the opportunity to custom tailor whole-
animal systems to answer specific biological questions, and has resulted in a 
vast array of highly informative transgenic animal models. Transgenic animals 
carry deliberately inserted foreign DNA derived from an exogenous source to 
express or accentuate a specific trait or feature. Transgenic animals have been 
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created since the early 1980s and range from mammals, birds, amphibians, fish 
to invertebrates.122-131 Transgenic technology has been used in biological and 
medical research to find cures for cancers, diabetes, Huntington’s disease and 
cardiovascular diseases and has contributed significantly to agriculture 
including for improved milk production, and both increased growth rate and 
disease resistance in farmed animals. 122, 123, 127, 132-136 Transgenic research 
applied to mammals was initiated in the 1980s and for fish somewhat after this 
in the late 1990s. Subsequently, there has been a rapid increase in the use of 
transgenic animals in research, illustrated by the number of academic papers 
published, increasing from around 280 in 1988 to almost 16000 in 2014 (using 
the search term transgenic animal- PubMed, Figure 1) and in fish from 8 in 
1990 to around 300 in 2012 (using the search term fish + transgenic- PubMed, 
Figure 1). Interestingly the number of academic papers published per year 
using these terms has decreased slightly between 2013 and 2015 (the most 
recent available data). It may be that the rate of generation of novel transgenic 
animals has slowed or may perhaps be linked to laboratories recently moving 
towards and becoming accustomed to next generation transgenesis techniques 
such as CRISPR.   
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Figure 1. Number of publications between the years 1967 and 2015 that 
include ‘transgenic animals’ (1A) or transgenic (TG) fish/transgenic 
zebrafish (1B) as analyzed using PubMed. A search for ‘transgenic (TG) 
zebrafish in ecotoxicology’ returned only 12 publications in the last 15 
years.  
 
(Lee et. al. 2015, see appendix) 
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Transgenic fish have been developed as model systems for understanding 
genetic mechanisms, developmental processes and for pharmaceutical 
discovery, safety assessment and bio-synthesis.137-139 Recently, transgenic fish 
have also been developed for studies in ecotoxicology to screen and test for 
chemical effects and have the potential to provision more advanced systems for 
integrative health impact assessments of chemicals.49, 50, 77, 140-142 Zebrafish and 
medaka (Oryzias latipes) have become the most popular model species for 
transgenic manipulations. Favourable features of these species for transgenic 
work include their ease of breeding in the laboratory, relatively low associated 
maintenance costs, high fecundity, transparency of the embryos and rapid 
organogenesis (attractive features for studying developmental processes) and 
the availability of sequenced genomes providing extensive genetic resources. 
Additionally, for the zebrafish, the chorion of the egg is relatively soft facilitating 
microinjection of DNA and genetic constructs. The availability of mutant lines of 
these fish, such as casper (roy + nacre mutant zebrafish) that lack skin 
pigmentation also enable studies for observing effects in body tissues, for 
example tracing individual tumor (or cancer) cells as they spread through the 
body.143, 144 The zebrafish has high genome (approximately 70%), structural and 
physiological similarities with humans.145, 146 The zebrafish has been used to 
advance understanding on formation of the embryonic axis, cell lineages, and 
formation of the central and peripheral nervous systems. It has also proven 
valuable for studies on human diseases, notably carcinogenesis, wound 
healing, immunological diseases, behavioural abnormalities, infection and 
Parkinson’s disease.144, 145, 147-152 
The zebrafish and medaka have also become popular model organisms in 
ecotoxicological studies and especially for studies on molecular mechanisms of 
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chemical toxicity and analysis of behavioural outcomes.153-155 Transgenic 
zebrafish and medaka employing fluorescent markers are used not only to 
identify chemically induced target gene activation but also to quantify relative 
uptake and concentration of chemicals into those tissues.  
 
  
 30 
1.5 Transgenic Model Generation 
Creating a transgenic fish first requires production of the gene of interest and 
then its introduction into the organism. The general method for generating the 
gene construct is shown in Figure 2. 
Production of the gene construct  
Several methods are now used to produce transgenic fish, but all involve a 
transgenic construct with a promoter and a gene. The foreign gene for transfer 
(transgene) is constructed using recombinant DNA techniques. Traditionally the 
gene of interest was most commonly expressed using E. coli plasmid vectors 
that replicate at high levels in their host cells. To clone the DNA of interest the 
sequence is inserted into a cloning or expression vector through the use of 
restriction enzymes to create compatible ends and ligase to seal the integration. 
This approach to cloning, however, is time-consuming and relatively inefficient, 
and it can be difficult to find suitable restriction enzymes in the target DNA. 
False positive clones (vector without insert) can be common using this method 
due also to universal nucleotide ligation.156 More efficient methods for cloning 
the DNA target of interest now include In-Fusion cloning (Clontech) and 
Gateway cloning (Life Technologies) which are also considerably faster too.157, 
158 
An emerging area of genome modification for insertion of a transgene is 
targeted genome editing. The process involves engineering of customised 
nucleases to induce DNA sequence-specific double strand breaks (DSBs), 
which are then exploited for sequence alterations. Sequences encoding these 
nucleases are included in the transgene construct. The three techniques 
gaining most attention currently are clustered regularly interspaced short 
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palindromic repeats (CRISPRs), transcription activator-like effector nucleases 
(TALENs) and zinc finger nucleases (ZFNs), each differing in the ease of 
construction methods, potential off-target activities and their theoretical target 
range. ZFNs have been the most widely used to date but the relative difficulty 
and high cost of their construction have meant that CRISPRs are now gaining 
the most attention and show a lot of promise for future transgenic model 
generation as well as other genetic modification studies. For more information 
on these techniques see the review paper (Lee et al. 2014) in the appendix 
chapter.  
Introduction of the gene construct into fish host: 
Having produced the construct, this is then transferred into the cytoplasm of 
fertilized fish eggs at the one cell stage, often using microinjection or 
electroporation. The injected DNA undergoes replication and some cells in the 
embryos will subsequently carry the transgene. Some integration events occur 
subsequent to DNA replication giving rise to mosaic fish, however, which may, 
or may not, contain the transgene in the germline. Animals are then maintained 
to adulthood and confirmation that they carry the transgene is undertaken using 
polymerase chain reaction (PCR) or Southern blot analysis in an external 
tissue, such as fin.159 Southern Blot is commonly used to determine transgene 
copy number and the number of integration sites in the transgenic founder. The 
identification of the integration sites and copy number is important for 
understanding the relationship between the integration site and the specific 
phenotype. 
Founders containing the inherited transgene (F0) are identified by crossing 
founder (transgenic fish) and wild-type fish (non-transgenic fish) and assessing 
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whether the transgene occurs in the F1 generation. The germ-line transmission 
rate from the F0 generation to the F1 generation is variable because F0 are 
mosaic (variable cell expression) and the transgene is unevenly integrated in 
their gonadal tissues. Progeny derived from the F0 fish are crossed with wild-
type fish, and the resulting heterozygous offspring are crossed with each other 
to create a homozygous fish (i.e both alleles are present in the same fish) (see 
Figure 2).  
Crossing established transgenic lines 
Once transgenic lines are established, new models can be generated via 
crossing lines with other transgenic or non-transgenic zebrafish lines. This 
follows a more traditional approach of line generation via the application of 
Mendelian principles to screen progeny for desired gentotypes/phenotypes. 
This approach negates the need for transgenesis techniques as described 
above but can be time consuming, requiring multiple generations to be raised 
and careful analysis of upwards of thousands of larvae to identify the relatively 
small number of F0 individuals expressing the genotype/phenotype of interest. 
However, the biggest attraction of this method is the potential for new models to 
inherit equal sensitivity and specificity of response as the model they were 
derived from. Transgenesis techniques are still relatively inefficient and 
unpredictable, even in the case of next generation technology such as 
CRISPRs, meaning that achieving highly sensitive and consistent transgenic 
lines can still require a large amount of trial and error, which can subsequently 
lead to extended time consummation and increased costs. Hence, the crossing 
of transgenic lines is becoming more and more utilised thanks in part to the 
creation of public transgenic zebrafish model libraries such as the ZFIN 
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(http://zfin.org/) that offers information on established lines and contact 
information for potential acquisition. 
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Figure 2. Procedure for generating transgenic fish: Once the construct is 
made by either restriction enzyme/ligase cloning (A), In-Fusion cloning 
(Clontech) (B), or Gateway cloning (Life Technologies) (C), the plasmid is 
microinjected into one cell stage embryos and the embryos are subsequently 
raised to adulthood. The presence of the transgene is confirmed by 
polymerase chain reaction (PCR) and/or Southern blotting on genomic DNA 
isolated from fin tissue. Single founder (F0) fish are mated with single wild-
type (non-transgenic) fish and their offspring are mated with each other to 
confirm germ-line integration and to establish a homozygous transgenic line. 
(Lee et. al. 2015, see appendix) 
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1.6 Seeing the Response - Reporter Genes  
Reporter genes are used to quantify expression of the transgene and can also 
be used to rapidly determine success of gene transfer techniques and the 
tissue location of their expression in the host organism.160 Most reporter genes 
are placed downstream of the promoter of the inserted transgene. Common 
reporter genes used in transgenic research include E.coli β-galactosidase 
(lacZ), chloramphenicol acetyltransferase (CAT), neomycin phosphotransferase 
(NPT), luciferase (Luc), green fluorescent protein (GFP), Kaede, YFP, DsRed 
and mCherry.161-167 The most common reporter genes used in transgenic fish 
research to date are GFP and Luc (Figure 3). 
Luciferase (Luc), originates from Photinus pyralis (firefly) and encodes the 
enzyme luciferase, and causes the cell that expresses it to catalyse luciferins 
and produce light.168 The luciferase gene is commonly used in cell-base 
reporter assays because it has high sensitivity. Furthermore, there is a high 
signal intensity associated with the luciferase molecule that allows for rapid 
measurements. It is also suitable as a reporter gene for the quantitative 
measurement of gene expression. The luciferase assay is widely used in 
pharmaceutical research (drug screening) for high-throughput analysis of gene 
transcription in living cells because the procedure is simple and requires only a 
small volume of test material. Luciferase as a method however, requires a 
costly substrate and is not stable (luciferase half-life varies from 1.5 to 3 hours 
depending on the host cell and the gene construct).169 Furthermore, the image 
integration time is long to compensate for the low signal intensity.170, 171 
Recently, several groups have shown that luciferase can be detected in live 
zebrafish embryos, larvae and adults 172, 173. 
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GFP is a fluorescent protein isolated from bioluminescent jellyfish Aequorea 
victoria, and can be visualized by microscopy. It can be seen directly in living 
cells and intact organisms and responses can be measured in real time. 
Furthermore, when used in conjunction with zebrafish mutant lines that lack skin 
pigmentation, GFP can be detected in fish for all life stages. Advantages of GFP 
over luciferase include superior brightness, innate fluorescence and relatively 
high photostability. GFP was first used in zebrafish in 1996174 and has since 
been used widely in the study of gene expression patterns, analysis of tissue-
specific promoters/enhancers, tissue/organ development, cell migration and 
mutagenesis screening.175-178 GFP has also been applied in the development of 
biosensor transgenic zebrafish to monitor chemicals such as heavy metals and 
oestrogens.49-51, 77, 142 RFP (red fluorescent protein) has the advantage over 
GFP in that there is less background interference. DsRed, red fluorescent 
protein from Discosoma sp., can be used together with other GFP variants for 
multicolor imaging.179 mCherry is the best general-purpose red monomer due to 
its superior photostability.180  
Photoconvertible fluorescent reporter sequences are starting to be used in 
transgenic (TG) models that can fluoresce different colours upon exposure to 
light in (or near) the ultraviolet (UV) wavelength region.181 An example of a 
photoconvertible fluorescent protein is the Kaede protein (named after the 
Japanese maple where its leaves change from green to red in the autumn.165) 
isolated from the stony coral Trachyphylia geoffroyi165 and which on exposure to 
UV light results in a spectral shift of the native (green) state from 508 nm 
(absorption) and 518 nm (emission) to longer wavelength peaks at 572 nm and 
582 nm, respectively (Figure 3). Photoconversion leads to an almost complete 
conversion of red to green fluorescence and is irreversible and stable under 
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aerobic conditions.165 Photoconvertible proteins offer the ability to track 
individual cells and assess effects on tissues developmentally and have been 
applied in studies on the development of neural networks in the brain and 
craniofacial skeleton in zebrafish.182-184   
Recently, a system has been developed to manipulate further the production of 
incorporated fluorescent proteins, called kaloop. It involves autoactivation (self-
perpetuation) of the fluorescence, and this is being applied as a powerful tool 
for spatiotemporal genetic fate mapping of specific cells types in zebrafish.185  
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Figure 3. Principles of how reporter genes (luciferase (Luc) (A), green 
fluorescent protein (GFP) (B) and kaede (C) enable visualizing target 
gene expression. The reporter genes (Luc, GFP and Kaede) are expressed 
when DNA is transcribed into messenger RNA (mRNA) and then translated 
into a reporter protein. In a reporter gene assay using luciferase, a 
luminescence signal is generated by the reaction of luciferase’s substrate, 
luciferin (A). GFP-expressing cells are detected by fluorescence microscopy 
(B). Kaede protein, when exposed to UV or violet light, is capable of 
irreversible photo-conversion from a green to a red fluorescent form (C).  
 
 
 
A 
B 
C 
(Lee et. al. 2015, see appendix) 
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1.7 Transgenic Fish and Ecotoxicology 
Transgenic zebrafish have considerable potential for use in aquatic 
ecotoxicology as biosensors and as more effective models for informing on 
health impacts of chemical exposure.49, 50, 140-142 Biosensor fish work on the 
premise that specific genes, often enzymes or receptors, are inducible by 
certain chemicals/pollutants. Exposure of the fish to the pollutant of concern, or 
a natural water containing that pollutant, induces the activation of an inducible 
promoter that in turn triggers expression of the reporter (e.g. GFP) (Figure 4).  
Various transgenic fish lines have been developed with an oestrogen 
responsible promoter derived from the vitellogenin (vtg) or choriogenin genes. 
Vitellogenin (vtg) is an egg yolk precursor protein, normally synthesized in the 
liver of females, but also inducible in males in response to oestrogen exposure, 
and is the most widely used biomarker for exposure to oestrogenic chemicals in 
aquatic ecotoxicology. Choriogenins are egg envelope proteins that are 
similarly synthesized in the liver of maturing female fish in response to 
oestrogens. Both vitellogenin and choriogenin respond to oestrogens in low 
ng/L exposure regimes and at sub-nanogramme exposure concentrations for 
the synthetic oestrogen ethinylestradiol.186 
Some of the first transgenic models employing promoters for the vitellogenin 
and choriogenin genes with GFP reporters were developed in medaka. These 
models however, were not sufficiently sensitive for detecting exposure to 
oestrogens for environmentally relevant exposures.187-191 A single GFP 
transgenic zebrafish line has been developed with an oestrogen-inducible 
promoter for a vitellogein gene (vtg1)51 that was reported to detect GFP in the 
liver at  0.1 µg/L E2, 1 µg/L estriol, 1 mg/L BPA, and 10 mg/L BPA. The lack of 
appropriate controls in this work however makes it difficult to provide a robust 
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evaluation of this model. The transgenic medaka and zebrafish lines developed 
incorporating vitellogenin and choriogenin genes in the reporter systems 
reported on above vary in their responsiveness to oestrogen and generally they 
are limited in the use for environmental monitoring as they lack the required 
sensitivity. Responses in all of these transgenic medaka and zebrafish for vtg 
and choriogenin genes are also restricted to the liver, the site of vitellogenin and 
choriogenin synthesis. They do nevertheless, provide systems for screening 
chemicals for oestrogenic activity in vivo in real time and can be applied to 
inform on cumulative responses to oestrogens. 
Transgenic zebrafish have also been developed to examine the effects of 
oestrogenic chemical exposure on development of the brain using the promoter 
of a cyp19 gene. Cytochrome P450 aromatase (cyp19) is enzyme complex that 
catalyses the synthesis of oestrogens, thereby controlling many different 
physiological processes of oestrogens and is mainly expressed in the gonad 
(cyp19ala) and brain (cyp19a1b).192 These are oestrogen target genes. Tong et 
al. (2009) generated a transgenic zebrafish line that expresses GFP under the 
control of the brain aromatase cyp19a1b promoter. In this line GFP expression 
occurred in the radial glial cells in response to oestrogen and was associated 
with endogenous aromatase B expression.77 Exposure of embryos to a variety 
of different oestrogenic chemical classes including natural and synthetic 
steroids, alkylphenolic compounds and phyto- and myco-oestrogens (for 5 
days) induced strong GFP expression in the region between the anterior 
telecephalon and caudal hypothalmus and most of these responses were 
concentration dependent.48 The effective concentrations (EC50) for inducing 
these responses were 0.013 nM (3.9 ng/L) EE2, 0.01 nM (2.7 ng/L) DES, 0.48 
nM (130.8 ng/L) E2, 3303 nM (0.8 mg/L) BPA, 2501 nM (0.7 mg/L) genistein. 
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This zebrafish line provides a very useful model for studies into the roles of 
natural oestrogens, and effects of environmental oestrogens, on brain 
development and function. Models using the cyp19a1a gene promoter are likely 
to be forthcoming in the very near future for studies into the effects of 
oestrogens on gonadal development.    
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Figure 4. Schematic of a biosensor transgenic zebrafish system for 
detecting exposure to aquatic pollutants. The transgenic zebrafish 
containing DNA elements responsive to a toxicant is placed in the exposure 
water and as the contaminants enter and reach the body tissues, activation of 
the response elements occurs that induces the production of GFP in that 
target tissue.  
 
(Lee et. al. 2015, see appendix) 
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1.8 ERE-GFP Models 
There have been a number of transgenic lines developed in zebrafish for 
detecting oestrogens using oestrogen response elements (ERE), which binds 
the oestrogen receptor–ligand complex activating oestrogen responsive genes. 
The first of these transgenic biosensor zebrafish developed by Legler et al. 
(2000) incorporated 3×EREs inserted upstream of TATA minimal promoter and 
luciferase as the reporter 140. Juveniles of this zebrafish transgenic model were 
responsive to E2 at concentrations down to 0.1 nM (27.2 ng/L) (for a 96 h 
exposure) and the testis was the most responsive target tissue.193 Limitations of 
this transgenic model include that measurement of the reporter luciferase 
required termination of the fish and identifying the specific responding tissues 
required their individual dissection and analysis. Work using this transgenic 
model did however, show that the main target tissues (the liver and gonad) 
were responsive down to exposures of EE2 (3 or 10 ng/L) and demonstrated 
also that responses to oestrogenic EDCs differed for different developmental 
stages.141 
Two subsequent transgenic zebrafish models developed incorporated EREs 
with GFP. In 2011, Gorelick and Halpern (2011) reported on a transgenic 
zebrafish containing five-tandem consensus EREs upstream of a mouse c-fos 
minimal promoter and the GFP gene. The transgenic zebrafish embryos were 
exposed to a range of oestrogenic chemicals including E2, DES 
(diethylstilbestrol), BPA, EE2 and NP, with responses see in the heart, brain, 
liver, aorta and ventral fin for exposure to E2 (with a lowest observed effect 
concentration (LOEC) of 100 µg/L), liver and heart for exposure to EE2 (with a 
detection down to 10 ng/L). No GFP expression was detected in embryos 
exposed to NP. Use of this transgenic model indicated that different oestrogenic 
 44 
compounds induced tissue specific differences in their activity.50 A drawback of 
this model was the relatively low sensitivity-very high exposure concentrations 
of oestrogens (1-100 µg/L E2) were employed to induce these responses. 
However, in their more recent work with this model, they were able to observe 
tissue-specific GFP expression for exposure to wastewater effluents.92  
The two transgenic zebrafish models developed have both been derived from a 
well-established transgenic zebrafish model generated by Lee et al. (2012).49 
This was the most recently developed ERE transgenic zebrafish and most 
sensitive transgenic zebrafish system for detecting environmental oestrogens. 
This model includes a 3×tandem ERE and a Tol2 mediated gal4ff-UAS system. 
Figure 5 illustrates how the gal4ff-UAS system helps to amplify GFP expression 
response upon ligand-ER binding to the ERE transgene sequence to improve 
the overall sensitivity of the ERE-GFP model to oestrogenic chemicals. The 
zebrafish embryos and larvae had response sensitivities to the EDCs tested of 
1 ng/L EE2, 5 ng/L E2, 100 µg/L BPA and 1 µg/L NP. Responses in this model 
were detected in a wide variety of tissues including the liver, heart, skeletal 
muscle (somite and cranial), ear/eye ganglions, brain, otic vesicle, lens and 
neuromasts (Figure 5). Skeletal muscle cells, cranial muscle cells, heart cells 
and neuromast cells were especially responsive to oestrogen. There were 
tissue-specific expression patterns for the different environmental oestrogens 
indicating differences in tissues toxicities.49 However, a limitation of this model, 
and other zebrafish models like it, is that beyond 3 days post fertilization skin 
pigmentation starts to block the fluorescence signal from internal tissues. 
Receptor expression, and therefore tissue response, is likely to vary throughout 
development of the zebrafish and hence restricts any conclusions drawn from 
the ERE-GFP model. This problem led groups such as White et al. to identify 
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various pigmentless phenotypes in zebrafish.143 One line in particular, the 
Casper line, was generated through crossbreeding to carry fully silenced roy 
(dark) and nacre (silver) pigment genes. As demonstrated in this thesis, this line 
can be used effectively  to produce transgenic models that can be used at all 
stages of zebrafish development. Very recently, a similar line named “Crystal” 
has been developed that also includes silenced pigmentation in the eyes of the 
zebrafish, further improving imaging of the brain.194  
1.9 Summary 
National and international screening programs currently rely heavily on in vitro 
assays to identify and categorise oestrogenic chemicals and other EDCs due to 
their time and cost effectiveness in comparison to in vivo tools. There is also an 
ethical obligation to reduce, replace and refine the use of animals in scientific 
testing. However, because of this reliance on in vitro assays, risk assessment of 
oestrogenic chemicals is often based on quantification of binding affinity for 
specific ER subtypes using a range of different cell lines and this does not allow 
for the more complex interactions that occur between EDCs and organisms in 
the environment. The development and application of transgenic fish offers 
huge potential for improved understanding on the effects and mechanism of 
effects for EDCs. Furthermore, transgenic fish models allow for more in-depth 
information to be derived from individual animals and therefore allow for more 
integrative health effects assessments. The use of highly informative transgenic 
fish models will result in better use and potential reduction of intact animals 
used in animal testing in line with the principles of the 3Rs (Replacement, 
Reduction and Refinement)195. For this reason, the zebrafish has become an 
attractive option for transgenic modelling due to the large amount of information 
that can be derived from embryos/larvae before first feeding (i.e. non-
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regulated). Favourable features of this zebrafish for transgenic work also 
include their ease of breeding in the laboratory, relatively low associated 
maintenance costs, high fecundity, transparency of the embryos and rapid 
organogenesis (attractive features for studying developmental processes) and 
the availability of sequenced genomes providing extensive genetic resources. 
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Figure 5. Mechanism of amplification of the oestrogenic signal in a 
GAL4FF–UAS transgenic zebrafish. Within the transgenic fish, oestrogen- 
responsive elements (EREs) respond to the oestrogenic signal to drive the 
first reporter, Gal4ff. Gal4ff binds to UAS in the 2nd transgene to drive the 
2nd reporter, a green fluorescent protein (GFP). This two-step reporter 
system amplifies the signal and enhances the sensitivity of the biosensor. 
Induction of GFP in ERE-GFP transgenic zebrafish exposed to oestrogen. 
Four-day-old larvae exposed to clean water alone (control: A) or 17β-
estradiol (100 ng EE2/L: B). GFP expression is observed in the heart (h), 
lens (le), liver (li), neuromast (n) and somite muscle (sm) by confocal 
microscopy (Zeiss) with a X10 objective lens.  
(Lee et. al. 2015, see appendix) 
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1.10 Aims of the thesis 
 
The overall aim of the work presented in this thesis was to develop transgenic 
zebrafish models with good utility for effective analysis of responses to 
oestrogens in zebrafish for different life stages and for application to larval 
screening (semi-automated). The first specific aim of this work was to generate 
two transgenic zebrafish models, each expressing silenced skin pigmentation to 
improve tissue-specific fluorescence detection throughout zebrafish 
development but differing in their expression of a fluorescence reporter 
transgene (GFP and kaede) to allow for different response assessments. This 
was undertaken via crossing of existing established lines that displayed 
silenced pigmentation, transgene stability, high sensitivity and tissue-specific 
responses to oestrogenic chemicals. The second specific aim was to apply the 
first (GFP) of these models for use in semi-automated screening of chemicals 
and high-content analyses to identify target tissues. This work aimed to 
demonstrate how the application of transgenic zebrafish models in semi-
automated imaging and image-analysis systems could provide multifaceted in 
vivo screening assays for oestrogenic chemicals that are highly sensitive and 
highly informative for improved chemical risk assessment. The third specific aim 
of the work looked to identify temporal response dynamics at the early life stage 
of these models, after single and repeated exposures to oestrogens. The work 
investigated the effects of sequential exposures to oestrogens on response 
sensitivity in specific tissues. Further to this, the work aimed to investigate 
whether the sensitivity of specific tissues in the model was dependent on its 
stage of development.   
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These specific aims are described in more detail below: 
Aim 1 (Chapter 3): To develop ERE-GFP-Casper and ERE-Kaede-Casper 
lines. 
The main aim of the work carried out in this chapter was to generate new 
oestrogen responsive transgenic zebrafish lines for their application to larval 
screening (semi-automated) and effective analysis of responses to oestrogens 
in zebrafish for different life stages. The translucent nature of these models was 
intended to facilitate improved fluorescence detection and quantification in 
specific tissues at various body orientations and at later stages of development. 
Rather than using traditional transgenesis techniques, I aimed to generate 
these models via crossing of established lines. This approach was chosen with 
the intention that the new models would inherit the same sensitivity and tissue-
specific responses to oestrogenic chemicals as the oestrogen responsive 
transgenic model they were derived from to facilitate their application in the 
following investigative studies. To generate the ERE-GFP-Casper model, a 
previously established ERE-GFP line was crossed with a Casper line. The 
model was compared with the ERE-GFP model and another oestrogen 
responsive transgenic model (cyp19a1b-GFP) to assess for sensitivity and 
tissue response specificities. The transmission rate of the transgenes from 
individual F0 ERE-GFP-Casper adults to their progeny was also analysed. 
Given the success of this procedure, the ERE-Kaede-Casper was subsequently 
developed via a similar approach crossing of the ERE-GFP-Casper model with 
a UAS-Kaede model. A comparative study was then run with the ERE-GFP-
Casper model to assess for sensitivity and tissue response specificities. 
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Aim 2 (Chapter 4): To apply the ERE-GFP-Casper model in high-content 
analysis of potencies and target tissues of oestrogenic chemicals in addition to 
its application in a medium to high-throughput screening system for the semi-
automated identification and quantification of oestrogenic chemicals.  
The aim set out in Chapter 4 was to apply the ERE-GFP-Casper model in an in 
vivo screening assay for oestrogenic chemicals that is both highly sensitive and 
highly informative for improved chemical risk assessment. To achieve this aim, 
confocal microscopy was used to acquire high-resolution images of the larvae 
to provide high-content information on observable target tissue patterns of the 
varying oestrogenic chemicals and their concentrations. This was to highlight 
the unique tissue-specific “fingerprints” of each chemical and help identify 
commonly susceptible tissues that appeared sensitive to all chemicals. To semi-
automatically screen oestrogenic chemicals, a Cellomics Array Scan system 
was customised to carry out fully automated image acquisition of exposed ERE-
GFP-Casper larvae and (in collaboration with Jeremy Metz at the University of 
Exeter) a Python algorithm was designed to identify larvae within images and 
accurately quantify the fluorescence signal within the animal.  
  
Aim 3 (Chapter 5): To apply the ERE-Kaede-Casper model in early-life stage 
analysis of tissue-specific windows of sensitivity to oestrogens and investigate 
for effects of repeat exposure to oestrogens on response sensitivity. 
Potency analysis for EDCs typically involves single-chemical exposures with 
little, or no, consideration given for animal’s specific stage of development or 
exposure history. Overall the work in this chapter aimed to improve our 
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understanding of the role of oestrogens during development at the early-life 
stage, investigate the importance of oestrogen exposure history in effects 
assessments and subsequently assess the implications for possible adverse 
effects associated with oestrogen exposure. Using the ERE-Kaede-Casper and 
demonstrating first the ability to fully photoconvert the kaede fluorescence 
signal within the model, I looked to identify windows of tissue-specific sensitivity 
to EE2 for exposure during early-life (0-5 days post fertilisation, dpf). Temporal 
dynamics of kaede response would also be assessed after removal from EE2 
exposure (at 2 dpf) and incubation in embryo water (3-5 dpf) to identify any 
potential persistence of response. Finally, the work in this chapter looked to 
investigate whether exposure to oestrogen (EE2) during early life (0-48hpf) 
could affect responsiveness (sensitivity) to different environmental oestrogens 
(EE2, genistein and bisphenol A) for subsequent exposures during 
development.  In conjunction with the repeated exposure study, qPCR analysis 
of ER subtype expression was carried out (in collaboration with Anke Lange at 
the University of Exeter) to identify any potential mechanisms of sensitivity 
alteration.  
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Chapter 2 
General methods 
2.1 General Approach 
A major part of this PhD project involved generating transgenic zebrafish for 
studies into the effects of environmental oestrogens. The first line created, the 
ERE-GFP-Casper model, was generated via crossing of a previously 
established ERE-GFP line and a Casper line, that expresses silenced skin 
pigmentation. The second transgenic line, the ERE-Kaede-Casper, was 
subsequently developed via crossing of the ERE-GFP-Casper model with a 
UAS-Kaede model. After the initial cross, screening of subsequent generations 
was required to identify founder individuals carrying the desired genotype for 
the two models, and then further screening to identify individuals with 
homozygous expression of the transgenes. There was a considerable amount 
of work associated with the generation and subsequent maintenance, breeding 
and screening of zebrafish. The generation and validation of these lines is 
described in detail in Chapter 3 of this thesis.  
The majority of zebrafish lines used for this project expressed fluorescent 
proteins and required fluorescence microscopy techniques to screen for desired 
genotypes and acquire high-quality images. A range of different fluorescence 
microscopes were used in this thesis work including fluorescence dissection 
microscopes, an inverted compound microscope, a confocal microscope and an 
automated “Array Scan” system. The application of these microscopes was 
dependent on the resolution and magnification required for screening or 
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imaging purposes in addition to the throughput capabilities of the microscopes 
to ensure timely completion of experiments. The majority of data presented in 
this thesis have been attained via qualitative and quantitative analysis of 
images attained via fluorescence microscopy. High-content analysis of tissue-
specific responses was conducted by eye. This involved qualification of specific 
target tissues seen to be responding to oestrogenic chemicals within high-
resolution images. Quantification of fluorescence intensity within images also 
featured heavily during the work. This was achieved using image analysis 
software. A semi-automated Python algorithm is presented in Chapter 4 that 
automatically identified larvae within images and quantified whole-body 
fluorescence intensity exclusively within the animal. Larval identification by the 
algorithm was checked by eye using a computer interface. Manual image 
analysis was carried out in work presented in Chapter 5 using Image J software. 
This was to ensure accurate quantification of tissue-specific fluorescence 
response in liver, heart and somite muscle. The details of microscopy and 
imaging techniques used for these studies are included in the methods sections 
of each chapter. A general method for homozygous screening is presented in 
this chapter and includes the use of fluorescent dissection microscopes and 
anaesthesia.  
The preparation of chemical solutions (often oestrogenic) and exposure to 
zebrafish larvae was applied in a consistent manner during the work presented 
in this thesis. The preparation, concentrations and exposure protocols for these 
solutions varied for the different studies presented and details of these 
preparations are included in the relevant chapters. Additional information 
garnered from chemical exposures included measured chemical concentrations 
from exposure water samples via tandem liquid chromatography-mass 
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spectrometry (LC-MS). This was necessary to assess if the concentrations of 
chemicals in exposure water were nominal. In Chapter 5, qPCR analysis was 
used to investigate potential effects on ER subtype expression in the ERE-
Kaede-Casper model after sequential oestrogenic exposures. These analyses 
were conducted in collaboration with colleagues within the University of Exeter 
with details of the methods included in the relevant chapters. 
 
The majority of information on methods used in the work presented in this thesis 
are presented in Chapters 3, 4 and 5. General methods of zebrafish 
maintenance, chemical preparation and storage and homozygous screening are 
presented in this chapter that are referenced extensively throughout the thesis.  
 
2.2 Animal Handling 
All experimental procedures conducted in this research with fish were in 
accordance with UK Home Office regulations for the use of animals in scientific 
procedures and followed local ethical review guidelines ensuring their humane 
treatment. 
2.3 Embryo Water 
The term “embryo water” used throughout this thesis refers to the  water 
solution used for larvae incubation and exposures (control, solvent control and 
chemical solutions). The solution comprises of four salts mixed into deionised 
water and is also referred to as ISO water. Individual salt solutions were first 
prepared using 4x1L deionised water solutions with 11.76 g calcium chloride 
(CaCl2.2H2O), 4.93 g magnesium sulphate (MgSO4.7H2O), 2.59 g sodium 
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bicarbonate (NaHCO3), 0.23 g potassium chloride (KCl) added respectively and 
mixed thoroughly. A 1xISO “neat” stock was prepared using 25 ml of each of 
the neat solutions and made up to 1L using deionised water. This could be 
stored for up to one month at 4°C. From this stock, 1:5 ISO exposure media 
was prepared the day before incubation or exposure by adding 1xISO water to 
deionised water at a 1:5 ratio and oxygenated for three hours.  
2.4 Chemical Preparation 
Chemical solutions used for exposure were prepared using embryo water. Most 
chemicals were purchased in powder form and solvent stocks were prepared 
the day before exposure. Chemicals were typically dissolved in analytical grade 
dimethyl sulfoxide (DMSO) and stored at 4°C. On the day of exposure solvent 
stocks were pipetted into embryo water and incubated to 28°C to produce the 
required exposure solutions. More details on this preparation are included in the 
relevant chapters. All chemical solutions were prepared and stored in acid 
washed glassware.  
2.5 Anaesthesia 
Anaesthesia of zebrafish larvae for screening and imaging purposes was a key 
aspect of the work. Immobilisation of the larvae needed to be complete with 
minimal effects on them as they were often revived for subsequent analyses. 
Tricaine (MS-222, tricaine methanesulfonate) was used as the anaesthetic and 
was prepared by dissolving 400 mg tricaine powder in 97.9 ml embryo water 
and adjusting the pH to 7 by adding around 2.1 ml of 1 M Tris buffer (pH9). This 
gave a 0.4% tricaine stock that was stored at 4°C before use. A 0.008% tricaine 
working solution was then prepared for experimental use by further dilution in 
embryo water to be used as an anaesthetic for zebrafish larvae. For imaging, 
 57 
larvae were anaesthetised for 10 minutes and immediately recovered in embryo 
water. For screening, larvae were anaesthetised for 20 minutes and 
immediately recovered in embryo water.  
2.6 Imaging 
For imaging, zebrafish larvae were mounted in either methylcellulose or 0.7% 
low-melting point agarose (for confocal microscopy only). Larvae were typically 
imaged at the 5 dpf life stage but exact ages are stipulated in results chapters. 
Methylcellulose was used more regularly for mounting as it better enabled 
alteration of larvae orientation during imaging. Methylcellulose was prepared by 
adding 1.5 g powder to 50ml embryo water (0.016% Tricaine), mixed thoroughly 
and placed the solution in a −20°C freezer overnight until frozen then stored in 
the fridge until use.  Further details of microscopy and imaging techniques used 
for these studies are included in the methods sections of each chapter. 
2.7 Screening 
Transgenic zebrafish adults that are homozygous for inserted transgenes were 
found to produce more sensitive and consistent fluorescence responses in their 
larvae. These were used for chemical exposures. It was therefore important to 
consistently screen new generations to ensure that breeding stocks were 
producing offspring with similar sensitivities/responses to oestrogens over 
successive generations for application in this thesis work. To identify 
homozygous transgenic adults, transgenic individuals were screened via pairing 
with wild-type individuals of the opposite sex in mating tanks. Tanks were 
carefully labelled and egg collection chambers were then placed into tanks on 
the afternoon before subsequent egg collections in the following morning (after 
final feeding). On the morning of collection, spawning occurred between 8am 
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and 9am, the period of artificial dawn. Embryos were collected from chambers 
and washed with embryo water between 9am and 10am. Embryos were 
transferred into labelled petri dishes in embryo water and viewed under a 
dissection microscope. Unfertilised embryos were immediately removed using 
Pasteur pipettes. The embryos, were then exposed to 50 ng/L EE2 from 0 dpf 
to 3 dpf or 4 dpf (depending on transgenic model being screened) to induce 
strong fluorescence responses in individuals carrying oestrogen responsive 
transgenes. After exposure, larvae were washed and anaesthetised in embryo 
water containing 0.008% tricaine. Using fluorescent dissection microscopes with 
a GFP filter, larvae were assessed for fluorescence responses by eye and the 
ratio of fluorescent and non-fluorescent larvae was counted. If 100% larvae 
fluoresce, the transgenic adult is considered homozygous. Heterozygous adults 
will typically produce fluorescent larvae at 25%, 50% and 75% ratios. Non-
transgenic adults will not produce any fluorescent larvae. For more detail on the 
analysis of these ratios see Generation of Transgenic Zebrafish Models 
chapter. This process of screening often took one or two months to screen a 
stock tank of transgenic individuals due to the large number of transgenic adults 
that required screening, the limited number of mating tanks available and the 
variable spawning habits of the zebrafish. Once identified, homozygous adults 
were separated from non-homozygous fish to become working stocks and 
breeding stocks for subsequent generations.  
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Chapter 3 
Generation of Transgenic Zebrafish Models 
3.1 Introduction 
An increasing number of oestrogenic chemicals are being identified in the 
environment and this has led to an increased interest in high-content biosensor 
models to assess both the potential short-term and long-term effects of 
oestrogen exposure in wildlife. The zebrafish has become a highly utilised 
model for genetic modification because of a combination of the availability of a 
sequenced genome providing the  associated extensive genetic resources and 
an egg that is transparent with a relatively soft chorion facilitating microinjection 
of genetic constructs. Rapid organogenesis in zebrafish compared with in other 
traditional animal models also makes it an attractive option for in vivo modelling. 
This has lead to an ever-expanding library of transgenic zebrafish lines 
expressing different promoter and response element sequences and reporter 
genes. These models have been generated using a variety of transgenesis 
techniques. However, the current efficiency and success rate of these 
techniques is still limited and can be costly, even with more recently available 
tools such as CRISPR/Cas9.  
In the work presented in this chapter, two novel transgenic zebrafish models 
were developed for application to the identification of oestrogenic chemicals, 
assessing their potencies, target tissues and investigating temporal response 
dynamics after single chemical and multi-chemical exposures. The first of these 
models, the ERE-GFP-Casper, was generated via crossing of an established 
ERE-GFP line and a translucent skin Casper line. Subsequent generations 
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were screened for desired genotypes and homozygous expression of transgene 
sequences. Transmission rates of these transgenes from F0 ERE-GFP-Casper 
adults to F1 progeny were assessed and identified a 100% transmission rate in 
adult females and 90-99% transmission rate in adult males deemed to be 
homozygous. The Casper line showed improved fluorescence response 
detection and quantification across all tissues and body orientations compared 
with the original ERE-GFP model. Comparisons of the ERE-GFP-Casper model 
with another oestrogen responsive transgenic model (cyp19a1b-GFP) 
demonstrated a similar sensitivity to ethinyloestradiol (EE2) exposure, with 
reported EC50 values of 0.04 nM and 0.12 nM respectively. The translucency of 
the ERE-GFP-Casper line enabled the model to be successfully applied in a 
novel medium-throughput oestrogenic chemical screening system that provides 
semi-automated identification of oestrogenic chemicals, quantification of their 
effect and high-content information on their target-tissues (Chapter 4). The 
model has also been used to generate the second transgenic model presented 
in this thesis.  
The ERE-Kaede-Casper model was derived from crossing the ERE-GFP-
Casper line with a UAS-Kaede line. The ERE-Kaede-Casper model expresses 
the photoconvertible fluorescence protein, kaede, enabling the permanent 
conversion of green to red fluorescence in the zebrafish upon exposure to UV 
light. In this chapter the use of photoconversion to screen and identify ERE-
Kaede-Casper individuals is demonstrated. The model had the same 
oestrogenic sensitivity and tissue-specific fluorescence responses to 
oestrogenic chemicals as the ERE-GFP-Casper model. The ERE-Kaede-
Casper model is applied in the identification of windows of tissue sensitivity to 
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oestrogenic chemicals and effects of exposure to EE2 during early life on 
subsequent responses to a series of environmental oestrogens (Chapter 5).  
 
3.2 Methods 
General Outline 
The generation of the two models followed a similar method of development 
and validation. The models were generated via crossing of established 
transgenic and non-transgenic zebrafish lines rather than via transgenesis. 
Once working stocks of the models were established responses of the models 
to oestrogen were compared with established oestrogen responsive transgenic 
zebrafish to assess for possible model differences in tissue-specificity and 
sensitivity. Transmission rates of transgenes from ERE-GFP-Casper founder 
generation (F0) to progeny (F1) larvae were analysed and are discussed in this 
chapter. The photoconversion of kaede in the ERE-Kaede-Casper model is also 
assessed in this chapter.  
3.2.1 Generation of ERE-GFP-Casper 
ERE-GFP x Casper Cross 
The ERE-GFP-Casper transgenic line was derived from a ERE-GFP line 
developed at the University of Exeter,49 and a Casper line from University 
College London (Figure 1). The ERE-GFP line is sensitive to oestrogens and 
the tissue responses are consistent with another ERE-GFP model, developed 
independently by Gorelick et al.50 The Casper line has silenced roy (dark) and 
nacre (silver) pigmentation genes, resulting in highly translucent skin.143 To 
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increase the transmission rate of transgenic sequences to subsequent 
generations and to ensure consistency of oestrogen response sensitivity, the 
ERE-GFP model was initially screened for homozygous adults by pairing with 
wild-type (WIK strain) adults and assessing the ratio of fluorescent/non 
fluorescent offspring. Homozygous adults were then crossed with the Casper 
line in five mating pairs, which were rotated to promote genetic diversity. 
Progeny from these crosses were heterozygous for four genes of interest; the 
ERE:Gal4ff and UAS:GFP transgene sequences and silenced roy and nacre 
pigmentation genes. Crossing of progeny from distinct families produced larvae 
with varying combinations of the genes of interest. These larvae were screened 
for the homozygous ERE/Casper genotype via exposure to 50 ng/L of 17α-
ethinylestradiol (EE2) from 0-3 dpf. Individuals carrying both Casper phenotype 
and GFP expression were raised to sexual maturity as the founder (F0) ERE-
GFP-Casper generation.  
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Figure 1: Generation of ERE-GFP-Casper (F0) line. TG1 indicates ERE-
Gal4ff transgene sequence. TG2 indicates UAS-GFP transgene sequence. 
Expression of pigmentation genes roy (dark) and nacre (silver) are also 
shown. The ERE-GFP model, homozygous for both transgenes, and a 
Casper strain were initially crossed to give a heterozygous generation. In-
breeding within this generation produced progeny with 256 different 
genotypes based on four genes of interest. One in 256 expressed F0 ERE-
GFP Casper genotype of fully silenced pigmentation and homozygous 
transgene expression.  
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F0 Homozygous Screen 
A total of 47 F0 individuals were raised to sexual maturity. Adult fish were 
visually sexed and screened for homozygous individuals using the screening 
protocol previously stated in the General Methods section (Chapter 2) rather 
than by fin clip DNA analysis. For this screen, the exact ratios of GFP and non-
GFP expressing progeny were recorded to both identify the phenotype of the 
adult and also assess the generational transmission of the transgenes. F0 
adults were categorised by the apparent copy-number of transgenes in the 
adult. Adults with ratios of fluorescent to non–fluorescent larvae below 60% 
were categorised as carrying 2 or less transgene copies, those with ratios 60-
85% were categorised as carrying three transgene copies and those above 
85% were classed as homozygous. Total number of progeny per adult collected 
varied, but at least 30 larvae were assessed per adult. For individuals that 
initially appeared to fall within two phenotype groups (three and four 
transgenes), 100-200 larvae were assessed to provide greater numerical 
confidence in the categorisation of homozygous adults.  
Comparison of the responses to oestrogen in the ERE-GFP 
Casper Cross with the ERE-GFP line 
Responses to EE2 in the ERE-GFP-Casper line were compared with our 
original ERE-GFP model to assess for sensitivity and tissue response 
patterning to oestrogenic chemicals. Embryos from both models were exposed 
to 50 ng/L EE2 from 0-5 dpf. Fluorescence response was observed on an 
inverted compound microscope (Zeiss Axio Observer) under GFP excitation 
(180 ms using filter set 38 HE: BP 470/40, FT 495, BP 525/50). Further 
generations have been established, and each generation screened to confirm 
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that only homozygous adults are used for ensuring consistently high sensitivity. 
F1 generation TG(ERE:GFP) Casper larvae were used in the study reported 
here and compared with F6 generation TG(ERE:GFP) larvae.  
Comparison of the responses to oestrogen in the cyp19a1b-
GFP with the ERE-GFP line 
To further assess the sensitivity of the ERE-GFP-Casper model, a comparative 
exposure study was run with the cyp19a1b-GFP line, generated by Brion et al., 
which expresses GFP under control of the cyp19a1b gene that encodes brain 
aromatase. The comparison between the models was run using the “EASZY” 
assay, developed by Brion et al., which utilises their cyp19a1b-GFP model in 
combination with image analysis software to screen oestrogenic chemicals and 
quantify the resulting flourescence responses.48 For this comparison, the ERE-
GFP-Casper model was also applied in the assay. The results from this study 
also contributed towards a validation project (Project 2.46) in the OECD Test 
Guideline Programme. Embryos from both models were exposed to 0.1, 0.05, 
0.025, 0.0125, 0.00625, 0.003125, 0.001525 nM EE2, a DMSO control solution 
and water control solution from 0-5 dpf. Fluorescence response was observed 
on an inverted compound microscope (Zeiss Axio Observer) under consistent 
GFP excitation (134 ms using filter set 38 HE: BP 470/40, FT 495, BP 525/50). 
Larvae were embedded in methylcellulose for imaging with Cyp19a1b-GFP 
larvae orientated for a dorsal view of the brain and ERE-GFP-Casper larvae 
orientated onto their left side for imaging of the liver, the most sensitive tissue in 
the model. All images were acquired using a x10 objective. Photographs were 
analysed using the Axiovision Imaging software and fluorescence quantification 
was determined using an ImageJ software macro developed specifically for 
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quantifying fluorescence in the cyp19a1b-GFP model. For each picture, the 
integrated density was measured, i.e. the sum of the gray-values of all the 
pixels within the region of interest. Data were expressed as a percentage of the 
mean response to the highest EE2 concentration (0.1nM EE2), deemed the 
maximum (100%) response. Standard deviation values were calculated across 
the dosing groups and averaged to compare variation between the two models. 
Concentration–response curves were modelled using the Regtox 7.5 Microsoft 
Excel™ macro (available at 
http://www.normalesup.org/~vindimian/fr_index.html), which uses the Hill 
equation model and allows calculation of EC values. For a given chemical, 
EC50 was defined as the concentration inducing 50% of its maximal effect.  
3.2.1 Generation of ERE-Kaede-Casper 
The ERE-Kaede-Casper transgenic line was derived from the ERE-GFP-Casper 
line and a UAS-Kaede line derived from the Max-Planck Institute of 
Neurobiology, Germany (Figure 2). The UAS-Kaede line has wild-type (WIK) 
pigmentation and expresses an inserted UAS-Kaede reporter transgene 
sequence. To enhance the transmission rate of transgenic sequences to 
subsequent generations and to enhance consistency in oestrogen response 
sensitivity, the ERE-GFP-Casper model was initially screened for homozygous 
adults by pair breeding individuals with wild-type (WIK strain) adults. 
Homozygous ERE-GFP-Casper adults were then crossed with the UAS-Kaede 
line in 10 mating pairs, which were rotated through different pair combinations 
to promote genetic diversity. Progeny from these crosses were heterozygous for 
five genes of interest; ERE:Gal4ff, UAS:GFP and UAS:Kaede transgene 
sequences and silenced roy and nacre pigmentation genes. Crossing of 
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progeny from distinct families produced larvae with different combinations of the 
genes of interest. These larvae were screened for the homozygous ERE-
Fluorescence and Casper genotype via exposure to 50 ng/L EE2 from 1-3 dpf. 
Individuals carrying both Casper phenotype and fluorescence expression, as 
determined by a response to 50 ng/L EE2, were raised to sexual maturity. 
Screening for Kaede expression was not carried out in this first screen due to 
potential developmental effects of UV exposure required for distinguishing the 
protein from GFP. At sexual maturity these fish were paired with wild indian 
karyotype (WIK) line fish and larvae were screened for Kaede expression via 
exposure to 50 ng/L EE2 for 5 days (from 0-5 dpf) and a 2 min UV exposure to 
convert the Kaede excitation and emission response. Adults with progeny 
exclusively expressing Kaede protein (complete conversion to red fluorescence 
upon UV exposure) were identified as the founder generation (F0) of the ERE-
Kaede-Casper line. These fish were then bred to generate an F1 generation 
and subsequently sexually mature F1 fish were screened for homozygous 
expression of the transgene sequences.  
Comparison of the responses to oestrogen in the ERE-Kaede-
Casper with the ERE-GFP-Casper line. 
Responses to EE2 in the ERE-Kaede-Casper line were compared with our 
original ERE-GFP-Casper model to assess for sensitivity and tissue response 
patterning to oestrogenic chemicals. To do so, embryos from both models were 
exposed to 5 and 10 ng/L EE2 from 0-5 dpf and fluorescence response was 
observed using an inverted compound microscope (Zeiss Axio Observer) under 
consistent GFP excitation (180 ms using filter set 38 HE: BP 470/40, FT 495, 
BP 525/50). In addition, ERE-GFP-Casper larvae from the control group were 
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compared with Casper individuals incubated in embryo water to assess for 
auto-fluorescence. Further generations have been established for this line, and 
each generation screened to confirm that only homozygous adults are used to 
ensure consistently of responses of the line.   
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Figure 2: Generation of ERE-Kaede-Casper (F0) line. ERE denotes 
the ERE-Gal4ff transgene sequence, GFP denotes the UAS-GFP 
transgene sequence and Kaede denotes the UAS-Kaede transgene 
sequence. Expression of pigmentation (Pig.) genes roy (dark) and nacre 
(silver) are also shown. The ERE-GFP-Casper model, homozygous for 
both transgene sequences, and a homozygous UAS-Kaede strain were 
initially crossed to produce a heterozygous generation. In-breeding within 
this generation produced progeny with different genotypes based on four 
genes of interest. Larvae expressing F0 ERE-Kaede-Casper genotype 
with fully silenced pigmentation and TG(ERE:Gal4ff)(UAS:Kaede) 
expression were identified by screening for photoconvertible progeny and 
raised to sexual maturity.  
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Photoconversion of kaede in the ERE-Kaede-Casper model 
To determine if full photoconversion of kaede was achievable in all tissues 
within the model, ERE-Kaede-Casper larvae were exposed to 100 ng/L EE2 
over the period 0-5 dpf and exposed to UV light for 2 mins at the 5 dpf stage. A 
further group were exposed to 100 ng/L EE2 over the period 0-5 dpf with no 
exposure to UV light. Larvae were then subjected to imaging at 5 dpf on an 
inverted compound microscope (Zeiss Axio Observer). After imaging, DIC, 
green and red kaede fluorescence images were overlaid and the colour of 
individual tissue response qualified via observable ratios of green (new kaede 
expression), red (‘old’ kaede expression pre-photoconversion) and yellow 
(equal levels of new and old kaede expression) fluorescence. 
Photoconversion during exposure in ERE-Kaede-Casper model 
Photoconverting kaede in the ERE-kaede casper model allowed for assessing 
induction of new responses to oestrogen. In the validation process 
photoconversion of kaede (from green to red) was assessed in response to EE2 
via imaging of the head and brain. ERE-Kaede-Casper larvae were exposed to 
100 ng/L EE2 over the period 0-4 dpf and exposed to UV light for 2 mins at the 
3 dpf stage. Larvae were then mounted in agarose and subjected to imaging 
(lateral and dorsal views) at 4 dpf on a confocal-laser scanning microscope 
(Zeiss LSM510), x10 objective and red and green fluorescent channels (BP 
505-530 11%, LP 560 81.2%). After imaging, DIC, green and red Kaede 
fluorescence images were overlaid and the colour of cell or tissue response 
qualified by eye via observable ratios of green (new kaede expression), red 
(‘old’ kaede expression pre-photoconversion) and yellow (equal levels of new 
and old kaede expression) fluorescence. 
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3.3 Results 
3.3.1 ERE-GFP-Casper model  
A founder F0 generation of ERE-GFP-Casper model was successfully created 
and identified after phenotype screening and raised to sexual maturity (Figure 
1).  
F0 Homozygous Screen 
Sexing of the 47 F0 adults identified 28 males and 19 females. Figure 3 shows 
the percentage of fluorescent larvae for the 47 individuals. In total, 21 
individuals were assumed to express two or less of the four transgene copies 
and 20 assumed to express three of the copies due to ratios of fluorescent to 
non-fluorescent larvae falling below 60% and within 60-85% respectively. One 
individual was found to produce no fluorescent progeny (0%) and was likely 
included in the group in error at the larval stage. These adults were not used for 
generating an F1 generation. Only two individuals (both female) were found to 
produce 100% fluorescing larvae. Four males were found to produce 85+% 
fluorescing larvae. These four males were classed as homozygous and bred 
with the two homozygous F0 females to generate the subsequent F1 
generation.   
Comparing responses to oestrogen in the ERE-GFP and ERE-
GFP-Casper lines 
Comparison of the ERE-GFP Casper line with the original pigmented ERE-GFP 
model (Figure 4) demonstrated that the ERE-GFP-Casper line had a consistent 
tissue-specific responses and similar oestrogenic sensitivity as the original 
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transgenic line. There was an improved fluorescence detection signal with the 
ERE-GFP-Casper due to the lack of skin pigmentation compared with the 
original TG line. The advantages of pigment-free phenotype were most 
apparent from a dorsal view of the brain. Tissue-specific responses in the ERE-
GFP-Casper model have been shown to be consistent in subsequent 
generations for which homozygous-only individuals are mainatained via regular 
screening. In the ERE-GFP-Casper model, auto-fluorescence occurred in the 
yolk sac, and was occasionally seen in the otic vesicle. Images from 
comparison with non-transgenic Casper (Figure 5) show yolk-sac (ys) 
fluorescence in both lines. 
Comparing responses to oestrogen in the Cyp19a1b-GFP and 
ERE-GFP-Casper lines 
The results from the comparison with the cyp19a1b-GFP model using the 
EASZY assay (Figure 6) demonstrated that the ERE-GFP-Casper model 
showed higher sensitivity to EE2 compared to the cyp19a1b-GFP model across 
a wide range of exposure concentrations. Comparison of sensitivity was based 
on EC50 values of 0.04nM EE2 for the ERE-GFP-Casper model and 0.12 nM 
EE2 for the cyp19a1b-GFP. One observable difference between the models 
was the high variability of response to all treatment concentrations in the 
cyp19a1b-GFP model compared with the ERE-GFP-Casper model, with relative 
standard deviation values of 25.3% and 8.2% respectively.   
 74 
 
  
0
10
20
30
40
50
60
70
80
90
100
1.
1
2.
1
4.
1
5.
1
1.
1a
4.
1a
7.
1a
9.
1a
10
.1
a
3.
1a
6.
1a 4.
2
8.
2
6.
2
9.
2
1.
2
2.
3
3.
3
5.
3
6.
3
8.
3
9.
3
10
.3 1.
4
2.
4
5.
4
6.
4
7.
4
9.
4
1.
4a
5.
4a
7.
4a
8.
4a
10
.4
a
2.
4a
4.
4a
6.
4a 7.
5
8.
5
9.
5
10
.5
2.
5a
4.
5a
5.
5a
6.
5a
8.
5a
9.
5a
Fl
uo
re
sc
en
t L
ar
va
e 
(%
) 
ERE-GFP-Casper F0 Adults 
ERETG Casper F0: Percentage of Fluorescent Larvae  Number of Transgenes Blue Bars ≤ 2/4   Green Bars = 3/4   Bright Red Bars = 4/4  Orange Bars = 85-99% 
Figure 3: Screen of F0 ERE-GFP-Casper line for homozygous adults. 
Larvae from pairs of ERE-GFP-Casper and wildtype (WIK) adults were 
exposed to EE2 and assessed using fluorescent microscopy to identify 
percentages of fluorescing larvae from each adult ERE-GFP-Casper. ERE-
GFP-Casper adults were then categorised based on suspected transgene 
genotype.  
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Figure 4: Comparison between ERE-GFP model and ERE-GFP-Casper 
models. Larvae were exposed to 50 ng/L EE2 from 0-5 dpf. Larvae were 
imaged at 5 dpf on an inverted compound microscope (Zeiss Axio 
Observer) at 10x magnification under consistent GFP excitation. Lateral 
and dorsal views are used for comparison. Specific tissue response in the 
liver (li), heart (h), cranial muscle (cm), somite muscle (sm), otic vesicle 
ganglions (ovg) and forebrain (fb) was consistent across the two models.  
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Figure 5: Auto-fluorescence in Casper and ERE-GFP-Casper lines.  
Caspers and ERE-GFP-Caspers were imaged at 5 dpf with no prior chemical 
exposure for comparison of auto-fluorescence on an inverted compound 
microscope (Zeiss Axio Observer). Images show yolk-sac (ys) fluorescence 
in both lines, which may result from naturally accumulated chemicals (such 
as polycyclic aromatic hydrocarbons) that fluoresce at similar excitation and 
emission wavelengths as GFP. GFP expression is additionally seen in the 
Otic vesicle (ov) of the ERE-GFP-Casper line only.   
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Figure 6: Comparison of ERE-GFP-Casper and cyp19a1b-GFP model 
using EASZY assay. Larvae from both models were exposed to a wide 
range of EE2 concentrations using the EASZY assay to generate dosing-
curve profiles for comparison of sensitivity. Fluorescence responses in the 
models were quantified by image analysis (Image J) and presented as 
percentage in relation to the mean response at the highest dose of 0.1 nM 
EE2. Concentration–response curves were modelled using the Regtox 7.5 
Microsoft Excel™ macro (available at 
http://www.normalesup.org/~vindimian/fr_index.html), which uses the Hill 
equation model (optimised for best fit) and allows calculation of EC values to 
compare relative sensitivities of the two models. Final Hill coefficient values 
were 1.13 for cyp19a1b-GFP and 2.57 for ERE-GFP-Casper. 
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3.3.2 ERE-Kaede-Casper Model 
A founder F0 generation of ERE-Kaede-Casper model was identified via 
screening (see Figure 2) and a homozygous F1 generation generated and 
raised to adulthood to serve as a working stock for the exposure studies. 
Tissue-specific responses in the ERE-Kaede-Casper model were consistent in 
subsequent generations for homozygous individuals as assessed via regular 
screening. 
Comparison with the ERE-GFP-Casper model showed there was high 
consistency in the response to oestrogen (tissue specificity and sensitivity) 
between the ERE-Kaede-Casper and the ERE-GFP-Casper models (Figure 7). 
Fluorescence intensity appeared slightly stronger in the muscle somites of the 
ERE-Kaede-Casper model. Under UV illumination kaede fluorescence was 
converted fully from green to red at 5 dpf (see Figure 8). Fluorescence 
responses in the head (lateral and dorsal views) of ERE-Kaede-Casper larvae 
at 4 dpf showed clearly defined temporal expression of kaede, having 
photoconverted kaede response at 3 dpf (Figure 9). Images show specific 
tissues and cells that had higher expression of kaede during the 0-3 dpf period 
(red), the 3-4 dpf period (green) and equal expression over the 0-4 dpf 
exposure period (yellow). Cells in the forebrain and midbrain had notably varied 
responses. Tissue-specific temporal responses are analysed in detail in 
Chapter 5 of this thesis, where the ERE-Kaede-Casper has been further utilised 
in this manner.   
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Figure 7: Comparison of ERE-GFP-Casper and ERE-Kaede-Casper 
models. Sensitivity and tissue response of the two models were compared 
via imaging after 0-5 dpf exposures to embryo water (A), 5 ng/L EE2 (B) and 
10 ng/L EE2 (C). All images were acquired by inverted compound 
microscope (Zeiss Axio Observer) using a 5x objective. Images are 
presented with the GFP filter only.  
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 Figure 8: Kaede conversion analysis. ERE-Kaede-Casper larvae were 
exposed to 100 ng/L EE2 over the period 0-5dpf and imaged at 5dpf either 
without UV exposure (A), or after exposure to UV at 3dpf (B), 4dpf (C) and 5dpf 
(D) to convert Kaede fluorescence from green to red. Images acquired using a 
5x objective on an inverted compound microscope (Zeiss Axio Observer). 
 
Figure 9: Kaede conversion during EE2 exposure. ERE-Kaede-Casper 
larvae were exposed to 100 ng/L EE2 over the period 0-4dpf, treated with UV 
light at 3 dpf and imaged at 4dpf. Images were acquired of the head at ventral 
and dorsal views a 10x objective on a confocal-laser scanning microscope 
(Zeiss LSM510). Red response indicates kaede expression during 0-3dpf and 
green response shows kaede expressed 3-4dpf. Yellow fluorescence indicates 
areas of continual kaede expression 0-4dpf.  
500 μm 
 100 μm 
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3.4 Discussion 
New oestrogen responsive transgenic zebrafish lines were generated and 
validated successfully for application to larval screening (semi-automated) and 
effective analysis of responses to oestrogens in zebrafish for different life 
stages. The translucent nature of these models with the casper gentotype 
facilitated improved fluorescence detection and quantification in specific tissues 
at various body orientations and for later stages of development compared with 
the original ERE-GFP model with pigmented skin. This work has resulted in 
models that are shown to share sensitivity and tissue-specific responses that 
are at least equal to the most sensitive oestrogen responsive transgenic 
zebrafish currently available, after qualitative and quantitative comparison of 
responses with the ERE-GFP and cyp19a1b-GFP models, and is further 
illustrated in their application in investigative studies presented in chapter 4 and 
5 of this thesis.     
Generation of ERE-GFP-Casper 
The ERE-GFP-Casper model enables visualisation of oestrogen induced tissue-
specific transcription in an intact vertebrate in real time. The ability to visualise 
responses to oestrogens in different body tissues simultaneously is valuable for 
establishing interconnections in target tissue responses for building knowledge 
both on the roles of oestrogens in normal function and the effect mechanisms of 
environmental oestrogen in vertebrates.  
The required time to generate F0 ERE-GFP-Casper individuals via crossing of 
two separate zebrafish lines, was 5-6 months. Another 2-3 months was then 
required to raise the stock of F1 individuals. An alternative approach to 
generating the ERE-GFP-Casper would have been to use similar techniques 
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that were used to generate the ERE-GFP model; inserting ERE:gal4ff and 
UAS:GFP transgene sequences into the Casper embryos via microinjection (as 
opposed to the wild-type ‘WIK’ line). The use of transgenesis techniques offered 
the potential to generate the ERE-GFP-Casper model in a shorter time-span but 
this approach is less reliable due to varying degrees of efficiency of this 
approach.196  
The ERE-GFP-Casper model had a consistent level of sensitivity and tissue 
specific responses to oestrogenic chemicals in comparison with the ERE-GFP 
model and the translucency of the ERE-GFP-Casper model appeared to reduce 
the effect of fluorescence signal-blocking caused by pigmentation, improving 
tissue response identification and potential quantification.  
Screen for F0 Homozygous adults  
The results from the F0 ERE-GFP-Casper screen identified a relatively small 
number (6 from 47) of homozygous individuals deemed suitable for producing a 
subsequent F1 generation. These six adults (four male, two female) were pair-
bred on rotation to encourage genetic diversity in the F1 generation, however, 
this remains a low breeding population and risks associated inbreeding should 
be considered. Heavily inbred lines are found to differ in their susceptibility to 
chemical stressors in comparison with wild-type zebrafish lines197 and can 
display altered gonadal development rates and sex ratios.198 Future outcrossing 
of the line may be necessary to prevent altered sexual development or reduced 
sensitivity to oestrogenic chemicals. 
For the majority of F0 ERE-GFP-Casper individuals, identification of genotypes 
was straightforward, with ratios of fluorescent to non–fluorescent larvae 
consistently falling within the <2/4, 3/4 and 4/4 transgene category stipulations. 
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However, of the six individuals categorised as homozygous (4/4 transgenes) 
only two females produced 100% fluorescent progeny, the other four individuals 
were males that produced fluorescent progeny at a 90+% transmission rate. 
This was consistently and significantly higher than ratios reported in adults 
deemed to express 3/4 transgene ratio (60-85% fluorescent progeny) and 
raises a question of inefficient transgene transmission to progeny from 
homozygous adult males in this model. Future analysis of a larger population of 
homozygous adults would be necessary to investigate this further. Information 
on average germline transmission rates using specific transgenesis techniques 
is well-documented196 but transmission rates of transgenes through subsequent 
generations of established transgenic lines is less well known.  
Comparing responses to oestrogen in the ERE-GFP-Casper 
lines and cyp19a-GFP 
As a final element in assessing the new ERE-GFP-Casper model, the model 
was compared with the cyp19a1b-GFP model, a highly sensitive oestrogen 
biosensor and well-established transgenic line. This study showed that the 
ERE-GFP-Casper model displayed higher levels of sensitivity to EE2 using the 
EASZY assay protocol. It should be noted that the EC50 value for the 
cyp19a1b-GFP model reported here (0.12 nM) was significantly higher than the 
value reported in the published study using the EASZY assay (0.01 nM),48 a 
value much closer to the EC50 result using the ERE-GFP-Casper model (0.04 
nM). This is likely due to the high variation of response seen across the 
replicates using the cyp19a1b-GFP model (Figure 6). It is possible that this may 
have been caused by the presence of a large percentage of heterozygous and 
non-transgenic adults present in the cyp19a1b-GFP working stock at the 
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University of Exeter. Unlike the ERE-GFP-Casper line, this stock was not 
screened for homozygous individuals and these results indicate the importance 
of this process in maintaining high consistency in responses, as shown for the 
relatively low variation in responses to oestrogen seen for the ERE-GFP-Casper 
model.  
The results from this study are based on an image analysis macro used to 
automatically identify and quantify fluorescence in the brain of the cyp19a1b-
GFP model, but was also successfully applied to quantify fluorescence in the 
liver of the ERE-GFP-Casper model. Application of an image analysis macro 
designed specifically for the ERE-GFP-Casper may improve the overall 
sensitivity of fluorescence detection and quantification. Such an automated 
image analysis tool was generated using a Python algorithm for the ERE-GFP-
Casper model and is presented in Chapter 4 of this thesis.  
The results of the comparative studies conducted for the different models have 
demonstrated the ERE-GFP-Casper model responds to oestrogenic chemicals 
with high sensitivity and consistency. The model was subsequently applied in a 
novel chemical screening system that provides both semi-automated screening 
and high-content analysis of oestrogenic chemicals and their target tissues. The 
results from this screening system are presented in Chapter 4 of this thesis 
under “High-content and semi-automated screens (ERE-GFP-Casper)”.  
The ERE-Kaede-Casper line 
The ERE-Kaede-Casper model has a silenced skin pigmentation and high 
sensitivity to oestrogenic chemicals comparable with the ERE-GFP-Casper 
model (Figure 7). The screening process for the generation of the ERE-Kaede-
Casper model differed to that of the ERE-GFP-Casper model, as two (not one) 
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fluorescent proteins were expressed in heterozygous progeny after the initial 
cross. This required the use of photoconversion of progeny in subsequent 
generations to identify individuals expressing the kaede transgene only, in 
addition to the casper phenotype. Hence, this generation of the ERE-Kaede-
Casper model required an additional in-crossed heterozygous generation (2-3 
months) to account for this screening step. The total time taken to establish a 
homozygous F1 working stock, therefore, was 11-12 months compared to the 8-
9 months required for the ERE-GFP-Casper line. This demonstrates the greater 
challenges in crossing two transgenic lines compared with crossing with a 
transgenic and non-transgenic line. The requirement of photoconversion for 
screening also extended the time needed to generate the ERE-Kaede-Casper 
line.  
The kaede chromophore was successfully photoconverted in living intact 
individuals in all responding tissues and for high levels of kaede expression 
(Figure 8). Translucency of the skin likely assisted efficiency of photoconversion 
as pigmentation normally blocks UV light penetration into the deeper tissues in 
larvae. Photoconversion of response in the ERE-Kaede-Casper model during 
exposure was used to identify windows of sensitivity to EE2 for specific tissues 
during early development (Figure 9). The ability to photoconvert the kaede 
fluorescence response in the ERE-Kaede-Casper model provides a more 
dynamic model for studies into temporal tissue response and assessment of 
sequential exposures to oestrogens compared with the ERE-GFP-Casper 
model. Results from these investigations using the ERE-Kaede-Casper model 
are provided in Chapter 5 of this thesis under “A novel transgenic model reveals 
increased sensitivity to repeated oestrogen exposure”.  
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4.1 Abstract 
Rapid embryogenesis, together with genetic similarities with mammals, and the 
desire to reduce mammalian testing, are major incentives for using the 
zebrafish model in chemical screening and testing. Transgenic zebrafish, 
engineered for identifying target gene expression through expression of 
fluorophores, have considerable potential for both high-content and high-
throughput testing of chemicals for endocrine activity. Here we generated an 
oestrogen responsive transgenic zebrafish model in a pigment-free ‘Casper’ 
phenotype, facilitating identification of target tissues and quantification of these 
responses in whole intact fish. Using the ERE-GFP-Casper model we show 
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chemical type and concentration dependence for green fluorescent protein 
(GFP) induction and both spatial and temporal responses for different 
environmental oestrogens tested. We also developed a semi-automated 
(ArrayScan) imaging and image analysis system that we applied to quantify 
whole body fluorescence responses for a range of different oestrogenic 
chemicals in the new transgenic zebrafish model.  The zebrafish model 
developed provides a sensitive and highly integrative system for identifying 
oestrogenic chemicals, their target tissues and effect concentrations for 
exposures in real time and across different life stages. It thus has application for 
chemical screening to better direct health effects analysis of environmental 
oestrogens and for investigating the functional roles of oestrogens in 
vertebrates. 
 
4.2 Introduction 
There is increasing evidence that exposure to endocrine disrupting chemicals 
(EDCs) may be linked to a range of endocrine-related disorders and the need to 
identify and assess EDCs is crucial for safe guarding long term human and 
environmental health.1, 2 EDCs shown to interact with the oestrogen signalling 
pathway have gained major attention over the last 20 years.1 To date, over 200 
chemicals have been identified that are oestrogenic.3 Many EDCs enter the 
aquatic environment via waste discharges and for certain environmental 
oestrogens there are strong associations between known exposures and 
adverse health effects in individual fish4, 5 and fish populations.6, 7 In mammals, 
exposure to environmental oestrogens has been associated with decreases in 
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semen quality/sperm count,8 heart disease and diabetes9. In fish there have 
been strong links to feminization of males4 and alteration of sexual behaviour.10 
Estrogen signalling occurs via oestrogen binding to oestrogen receptors (ERs) 
in the nucleus, which then dimerise and bind to oestrogen response elements 
(EREs) located in promoters of target genes.11 There are two receptor subtypes 
in mammals, ESR1 and ESR2,12 and three in zebrafish, ESR1, ESR2a and 
ESR2b.13, 14 ESR1 and ESR2 subtypes in humans and zebrafish are 
corresponding orthologs with high amino acid sequence similarity for their 
respective ligand binding domains of 64% and 71%.15 In addition, oestrogen-
related receptors (ERRs), a small group of orphan nuclear receptors, share 
some target genes with ERs.16 Membrane ERs (mERs) also occur, and 
although some of their features have been shown to be very similar to nuclear 
ERs, their role(s) and mechanism(s) of action are still unclear.17, 18 The 
expression of these different receptors in organs and tissues can change 
throughout development and later life and the affinity of ligands for these 
subtypes varies between oestrogenic chemicals influencing the physiological 
targets and subsequent downstream effects.19 Tissue-specific expression of 
oestrogen receptor subtypes in humans is well characterised20, 21 but is less 
well established in other organisms. Gene ontology studies suggest 
endogenous oestrogen signalling plays a number of important roles in early 
stage zebrafish development, including regulation of metabolism, transcription, 
tissue development and protein folding and trafficking.22 oestrogens are 
fundamental in the growth and development of both the female and male 
gonads.23-25 In addition, oestrogens are known to play key roles in immune 
responses, the central nervous system, and normal somatic cell growth.26, 27  
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Concern over EDCs has resulted in the establishment of national and 
international screening and testing programmes, including for environmental 
oestrogens.28-30 In vitro approaches with cell lines using reporter gene 
sequences typically focus on oestrogen receptor binding and/or activation by a 
chemical ligand and they have been used to compare oestrogenic chemical 
specificity for fish and human receptor subtypes.31, 32 In some instances, 
however, different assays employing the same ER have been shown to have 
different sensitivities to the same oestrogenic chemicals.33, 34 Furthermore, 
oestrogen signalling is complex and in vitro systems are limited in their ability to 
predict potency, illustrate tissue selectivity or the possible functional 
consequences of a chemical in an intact organism. In vitro systems are also 
much less able at detect pro-estrogenic compounds due to the fact that most 
are limited in their capacities for chemical metabolism.35 
Transgenic zebrafish models (TG) offer potential for both high-content and high-
throughput testing of chemicals for endocrine activity in EDC screening 
frameworks. Various TG models have been developed for studying the effects 
of xenoestrogens36-39 and one is now being applied in screening systems for 
identifying and quantifying responses to oestrogenic chemicals. This assay, the 
EASZY assay, developed by Brion et al.36 operates through aromatase 
induction (an oestrogenic response pathway) and is currently a validation 
project (Project 2.46) in the OECD Test Guideline Programme.40  
Here we describe the development of a new TG zebrafish with a fluorescent 
Oestrogen Response Element (ERE) reporter37 and silenced skin pigmentation 
(Casper phenotype) and its application both for high content analysis and semi-
automated chemical screening with image analysis for quantifying whole body 
responses to oestrogenic chemicals.  
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4.3 Methods and Materials 
Fish Husbandry and experiments 
All experimental procedures conducted in this research with fish were in 
accordance with UK Home Office regulations for the use of animals in scientific 
procedures and followed local ethical review guidelines ensuring their humane 
treatment. 
Generation of ERE-GFP-Casper 
The ERE-GFP-Casper transgenic line was derived from a ERE-GFP line 
developed at the University of Exeter,37 and a Casper line from University 
College London (Figure 1). The ERE-GFP line is sensitive to oestrogens and 
the tissue responses are consistent with another ERE-GFP model, developed 
independently by Gorelick et al.38 The Casper line has silenced roy (dark) and 
nacre (silver) pigmentation genes, resulting in highly translucent skin.41 To 
increase the transmission rate of transgenic sequences to subsequent 
generations and to ensure consistency of oestrogen response sensitivity, the 
ERE-GFP model was initially screened for homozygous adults by pairing with 
wild-type (WIK strain) adults and assessing the ratio of fluorescent/non 
fluorescent offspring. Homozygous adults were then crossed with the Casper 
line in five mating pairs, which were rotated to promote genetic diversity. 
Progeny from these crosses were heterozygous for four genes of interest; the 
ERE:Gal4ff and UAS:GFP transgene sequences and silenced roy and nacre 
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pigmentation genes. Crossing of progeny from distinct families produced larvae 
with varying combinations of the genes of interest. These larvae were screened 
for the homozygous ERE/Casper genotype via exposure to 50 ng/L of 17α-
ethinylestradiol (EE2) from 0-3 dpf. Individuals carrying both Casper phenotype 
and GFP expression were raised to sexual maturity. Finally, these fish were 
screened for homozygous expression of the transgene sequences to produce 
the founder generation (F0) of the ERE-GFP-Casper line. We compared 
responses to EE2 in the ERE-GFP-Casper line with our original ERE-GFP 
model to assess for sensitivity and tissue response patterning to oestrogenic 
chemicals. Embryos from both models were exposed to 50 ng EE2/L from 0-5 
dpf. Fluorescence response was observed on an inverted compound 
microscope (Zeiss Axio Observer) under consistent GFP excitation (180 ms 
using filter set 38 HE: BP 470/40, FT 495, BP 525/50). Further generations 
have been established, and each generation screened to confirm that only 
homozygous adults are used for ensuring consistently high sensitivity. F1 
generation TG(ERE:GFP) Casper larvae were used in the study reported here 
and compared with F6 generation TG(ERE:GFP) larvae.  
Zebrafish embryo chemical exposures  
Five chemicals were chosen for testing and screening with our model; 17α-
ethinylestradiol (EE2, Chemical Abstracts Service CAS no. 57-63-6) used in the 
contraceptive pill, bisphenol A (BPA, 80-05-7), used widely as a plasticizer, 4-
nonylphenol mix (NP, 84852-15-3), a breakdown product from 
nonylphenolethoxylates used in industrial surfactants,42 genistein (Gen, 446-72-
0), a phytoestrogen, and ketoconazole (KCZ, 65277-42-1), a fungicide shown to 
be mildly anti-androgenic. EE2, NP, genistein and BPA are well documented 
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oestrogenic chemicals and commonly found on prioritised chemical lists for 
international EDC screening programmes. Ketoconazole was used as a 
negative control. BPA (99+%) was purchased from American Chemistry 
Council, all other chemicals were purchased from Sigma-Aldrich Chemical Co. 
(≥98%). Dosing for each chemical comprised of six to eight different 
concentrations ranging between mean measured environmental exposure 
concentrations obtained from published literature and no observed effect 
concentrations (NOECs) measured in this and other published studies. Stock 
chemicals for each concentration were dissolved in analytical grade dimethyl 
sulfoxide (DMSO) and stirred vigorously in glass vials 24 hours before exposure 
and stored at 4˚C. Required volumes of stock solution were pipetted into 40-
50mL embryo culture water and stirred vigorously to give 1.25x final nominal 
concentration working solutions prepared on the morning of exposure. 800µl of 
1.25x working solution was pipetted into each well of a 24-well plate, one plate 
per concentration. ERE-GFP-Casper embryos were pipetted into individual 
wells in 200µl embryo water, giving a final 1x nominal chemical concentration in 
the well and a DMSO concentration of 0.5%. The embryos were exposed from 4 
to 120 hours post fertilisation (hpf) at 28˚C with no media changes. All 
chemicals were run on separate days and exposures were repeated three 
times.  
Analysis of chemicals in exposure water 
To assess the concentrations of chemicals in the exposure water in the 24 well 
plates, nominal aqueous exposure concentrations were tested at day 0 and day 
5 of exposure (i.e. 0 and 5 dpf).  Solvent control, minimum and maximum 
concentrations were sampled for each chemical from three random wells per 
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plate. For all chemicals, with exception of EE2, water samples were diluted in 
acetonitrile (ACN) before analysis by tandem liquid chromatography-mass 
spectrometry (LC-MS). Due to the low concentration of EE2, samples were 
initially run through solid phase extraction (SPE) cartridges (Sep-Pak Plus C18) 
into ACN, to achieve a detectable concentration for LC-MS analysis (“Water 
Chemistry: LC-MS Method” in Supporting Information).  
Target Tissue Analysis 
To resolve tissue-specific oestrogen responses, high quality images of exposed 
larvae were acquired for one of the three repeated chemical exposures by 
conducting confocal imaging during the automated ArrayScan imaging (see 
below). Five live larvae per concentration were washed and anaesthetised in 
embryo water containing 0.008% tricaine and mounted in 0.7% low melting 
agarose in embryo culture medium and placed into a glass bottom 35mm dish 
(MatTek). Larvae were orientated left side down and images obtained using a 
Nikon A1R confocal microscope with a 4x objective under consistent ‘GFP’ 
laser excitation only. After acquisition, all images were re-orientated and 
combined for presentation using GIMP software (Version 2.8.14, 
https://www.gimp.org/). Tissue-specific GFP expression was qualified, but not 
quantified, for the target tissue analyses.  
ArrayScan imaging 
After exposures, larvae were washed and anaesthetised in embryo water 
containing 0.008% tricaine. Twelve larvae per concentration were pipetted into 
a 96-half well plate and, where possible, orientated onto their left side. An 
ArrayScan II high-content reader (Cellomics, Inc., Pittsburgh, PA) was used for 
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image acquisition. The system was customised by installation of a nonstandard 
×1.25 magnification objective (Olympus) to achieve whole embryo capture in 
one image. A form factor program was generated for the half-well plates to 
ensure the objective was correctly centred above each well and the auto-focus 
tool used to attain clear images. A single 512x512 pixel image capturing the 
whole organism GFP response was acquired for each well using a 16 second 
fluorescent light (488 nm) exposure. With the autofocus tool selected, a full 96-
well plate imaging took approximately one hour and 30 minutes.  
Image analysis 
We developed a custom Python pipeline to quantify larvae-specific fluorescence 
in the ArrayScan images (“Semi-Automated Image Analysis” in Supporting 
Information). The algorithm first identified the well within the image and then 
applied a mask (a tracing of the larvae outline) around the larvae, which was 
checked and confirmed by eye using a web-based interface (Figure S1). An 
average intensity value of the top 100 pixel intensity values within the mask was 
then used as a quantification of fluorescence response, as these represented 
the strongest response values. These steps improved the speed and sensitivity 
of fluorescence measurement, as well as removing influence of anomalous 
reflective particles in the well.  
Statistical Analysis  
In the ArrayScan analyses, intensity values were averaged per concentration 
from three repeated exposures. All values are presented as mean ± SEM. 
Statistical significance is indicated at the p˂0.05(*) or <0.01(**) level and 
calculated using an ANOVA and Games-Howell post-hoc test. EC50 values and 
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their confidence intervals (±CI 95) were calculated using Regtox 7.5 Microsoft 
Excel™ macro (available at 
http://www.normalesup.org/~vindimian/fr_index.html), which uses the Hill 
equation model. EC50 was defined as the concentration inducing 50% of a 
chemicals maximal fluorescence response from a basal control response.  
4.4 Results  
ERE-GFP-Casper model  
After crossing the ERE-GFP model and Casper line and their progeny, the 
founder F0 generation of ERE-GFP-Casper model was successfully identified 
after phenotype screening and raised to sexual maturity (Figure 1). The results 
of the comparison with the original pigmented ERE-GFP model (Figure 2) 
demonstrated that the ERE-GFP-Casper line had maintained consistent tissue-
specific responses and oestrogenic sensitivity as the original transgenic line. 
There was, however, an improved observable fluorescent signal in certain 
tissues with the ERE-GFP-Casper due to the lack of skin pigmentation 
compared with the original TG line. The advantages of pigment-free phenotype 
were most apparent from a dorsal view of the brain. Tissue-specific responses 
in the ERE-GFP-Casper model have been shown to be consistent in 
subsequent generations in which we maintain homozygous-only individuals via 
regular screening.  
Water Chemistry Analysis 
In all solvent control samples chemicals were less than the limit of quantitation 
(LOQ). For genistein, BPA, and EE2 measured concentrations were highly 
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consistent, at between 99% and 133% of day 5 nominals across the 
concentration ranges tested. The highest measured ketoconazole concentration 
(nominal 5000 µg KCZ/L) was consistent over the exposure period (93-108%), 
but the measured concentrations for the lower nominal concentration (40 µg 
KCZ/L) were significantly lower on day 5 compared with day 0 (12% and 28%, 
respectively). Measured concentrations for NP were also somewhat lower than 
nominal. For the highest NP exposure concentration (nominal 2000 µg NP/L), 
the measured concentration was 84% of nominal on day 0, and 34% on day 5, 
and for the lower exposure (nominal 125 µg NP/L) the measured concentrations 
were 54% and 13% of nominal on days 0 and 5, respectively. Chemical analysis 
of the working solutions prepared in glassware for these two chemicals showed 
the measured concentrations were 101% of nominal (156.25 µg NP/L) and 79% 
of nominal (50 µg KCZ/L) for NP and ketoconazole, respectively on day 0. 
Exposure concentrations are reported as ng/L or µg/L in text but nM 
concentrations are included where direct comparisons between chemicals are 
made in both text and figures. Results for the full water chemistry analysis are 
provided in Table S3.  
Target Tissue (High Content) Analysis 
ERE-GFP-Casper larvae were analysed by confocal microscopy to assess the 
sensitivity of the model and compare tissue-specific fluorescence responses 
between different chemicals across a range of chemical concentrations. 
Confocal images, shown in figures 3A-D, demonstrate that the oestrogenic 
chemicals induced responses in different tissues and differed in their potencies 
(Figure 4). In the model auto-fluorescence occurred in the yolk sac, and 
occasionally in the otic vesicle.  
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The ERE-GFP-Casper model detected responses for exposures to 
environmentally relevant concentrations of EE2. In the confocal images, 
fluorescence responses in individual liver cells were detected for exposures as 
low as 1 ng EE2/L (Figure 3A). At 2.5 ng EE2/L, multiple liver cells and somite 
muscle tissue were seen to fluoresce strongly and faint fluorescence was also 
observed in the heart valves. Exposure to 5 ng EE2/L resulted in strong 
fluorescence in all these tissues with a response also seen in the otic vesicle. 
Neuromast cells in close proximity to the caudal fin and cells in the pelvic fins 
(thought to be erythrophores) were also seen to fluoresce. There were also faint 
responses in the cranial muscle and corpuscle of Stannius. Response in the 
eye lens and forebrain was observed at exposure concentrations of 25 ng 
EE2/L and above. At the highest exposure concentration adopted (100 ng 
EE2/L) oestrogenic responses occurred across a very wide range of tissues 
types with high intensity, including the gut. BPA exposure resulted in a different 
response profile compared with EE2. There was a very weak GFP signal 
detected in the heart valves at the lowest exposure concentration adopted (62.5 
µg BPA/L; Figure 3B), that was more intense at higher concentrations of BPA. 
At an exposure of 500 µg BPA/L tissues responses were detected in somite 
muscle, corpuscle of Stannius and a small number of liver cells. For high 
concentration exposures to BPA (1000 - 2000 µg BPA/L) there was a strong 
hepatic response. In a similar manner to that seen for BPA, genistein induced 
highly localised GFP expression in the heart valves (62.5 µg genistein/L) and in 
the corpuscle of Stannius (Figure 3C). Responses to genistein were also 
detected in somite tissue and fin cells for an exposure to 125µg genistein/L, that 
were not seen for the BPA exposure. For exposures to genistein at between 
250 – 1000 µg genistein/L liver, somite muscle, cranial muscle, eye lens and 
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gut cells showed strong expression of GFP. The response pattern for exposure 
to 1000 µg genistein/L (3700 nM) was similar overall to that for 100 ng EE2/L 
(0.374 nM). NP exposure induced a similar response to that seen for genistein, 
with an apparent higher potency based on equi-molar concentrations (Figure 
3D). A notable difference between NP and genistein was the apparent lack of 
GFP expression in the corpuscle of Stannius for NP (even for the highest 
exposure concentration, 1000-2000 µg NP/L). There were 
teratogenic/toxicological effects for NP at exposures of 1000 and 2000 µg NP/L. 
Confocal images of larvae exposed to ketoconazole showed no specific 
responses, with some natural auto-fluorescence detected in the yolk sac and 
otic vesicle only.  
Semi-automated ArrayScan Imaging for Responses to 
Oestrogenic Chemicals 
After chemical exposure, the ArrayScan system was used to automatically 
acquire images of exposed larvae in a 96 half-well plate. The automated 
masking correctly masked 80% of larvae (as assessed by the interactive online 
interface) and those not masked correctly were discounted. GFP responses in 
masks were quantified to produce response curves (Figure 5). The semi-
automated screening assay identified correctly the four oestrogenic chemicals; 
ketoconazole (the negative control) was the only chemical that did not show an 
oestrogenic response. Lowest statistically significant response (LSR) values 
were calculated to indicate the potency of the test chemicals to induce an 
oestrogenic response (Table 1). EC50 values were calculated as alternative 
measurements of oestrogenic potency and both values were used to compare 
the sensitivity of the screening assay with other in vivo and in vitro assays. The 
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quantified responses to the different oestrogens accurately reflected the relative 
potencies observed by confocal microscopy in the target tissue analyses 
described above. EE2 showed a >10,000 fold higher overall (whole body) 
potency compared with the other oestrogenic chemicals tested with 
substantially lower LSR and EC50 values at 0.005 µg EE2/L (0.0093nM) and 
0.0096 µg EE2/L (0.0178 nM), respectively. NP and genistein had similar 
overall potencies, with genistein showing a lower LSR of 125 µg genistein/L 
(462.5 nM) to NP’s 250 µg NP/L (1135 nM) but a higher EC50 of 463.4 µg 
genistein/L (1689 nM) to NP’s 212.2 µg NP/L (1187 nM). BPA was the least 
potent oestrogenic chemical screened with an EC50 of 1226 µg/L (5393 nM). 
The response curves for EE2 and genistein showed a similar sigmoidal 
response profile. The BPA response curve indicated a steeper response 
gradient, which is most likely due to the strong fluorescence response in the 
liver at 1000 µg BPA/L. At the two highest exposure concentrations for NP 
(1000 and 2000 µg NP/L) there were teratogenic/toxic effects (as seen in the 
target tissue analysis Figure 3D), and this was reflected by reduced 
fluorescence responses in the automated ArrayScan analyses (these toxic 
exposures were not included in the oestrogen response curve in Figure 5). 
There was a very high consistency in the responses between individual 
embryos for the different chemicals and exposure concentrations as illustrated 
by the low variance in the data (SEM across all chemical and exposure 
concentrations were <±14% of mean intensity). 
4.5 Discussion  
We have generated an oestrogen responsive transgenic model ERE-GFP-
Casper for application to both chemical screening and high content analysis of 
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oestrogenic chemicals with high sensitivity and consistency. The model enables 
visualisation of oestrogen induced tissue-specific transcription in an intact 
vertebrate in real time. The ability to visualise responses to oestrogens in 
different body tissues simultaneously will help establish interconnections in 
target tissue responses for building knowledge both on the roles of oestrogens 
in normal function and the mechanisms of environmental oestrogen effects in 
vertebrates. In the target tissue analysis liver cell responses to EE2 were 
detected for exposures down to 1 ng EE2/L, showing the model can be applied 
to test for environmentally relevant exposure concentrations of EE243 and the 
model is equally/more sensitive than for other oestrogen responsive zebrafish 
models currently available,36, 38 and the most commonly used in vitro assays.44-
46 A major attribute of the ERE-GFP-Casper model is the lack of skin 
pigmentation facilitating its application to high content tissue analysis, allowing 
for more effective analysis of responses in deeper body tissues, and 
(semi)automated screening where problems associated with body orientation on 
fluorescence detection and quantitation are much reduced compared with 
pigmented TG lines. Skin translucency in the ERE-GFP-Casper model makes it 
more effective for detecting oestrogen responses in older life stage fish for 
visualising the roles of oestrogens on gonadal sexual differentiation (that occurs 
between 35-42 dpf in zebrafish)47 and in brain development (A. Takesono, 
pers.comm). Problems associated with fluorescence detection, however, are 
not overcome completely in our ERE-GFP-Casper model and in older fish (more 
than 30 dpf) the thickness of the body wall does reduce fluorescence detection 
for tissues seated deeply in the body cavity (our own unpublished data). 
Responses to the chemicals tested showed the heart, liver, muscle somites, 
cranial muscle and fin responded to each of the selected oestrogens with 
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varying sensitivities. Other tissues such as brain, eye lens, gut, corpuscle of 
Stannius and otic vesicle responded only to certain chemicals. EE2 was by far 
the most potent oestrogen tested, as expected and induced responses in a very 
wide range of tissues, including heart, liver, somite muscle, corpuscle of 
Stannius, cranial muscle and forebrain, highlighting the potential for a wide 
range of biological effects following exposure to this synthetic oestrogen.  
Responses in the brain are consistent with reported adverse effects of EE2 
exposure on brain tissue and effects on sexual behaviours in both mice and 
zebrafish.48-50 The diverse tissue responses we observed are reflective of the 
wide range of known target tissues for the natural oestrogen (estradiol, E2) 
including sexual organs, bone, liver, brain, pancreas, adipose tissue, skeletal 
muscle and cardiovascular systems.27, 51 BPA induced a different response 
pattern to EE2, with only the heart responding strongly, except for very high 
exposure concentrations where the liver and muscle somites were also shown 
to be responsive. Genistein and NP appeared to be similar in the tissue 
responses induced (and relative potencies), but even here there were clear 
differences, with a response in the corpuscle of Stannius and cells in the gut for 
genistein, but not for exposure to NP. In addition to the response seen in the 
brain for exposure to EE2, there were responses seen also in the brain at the 
highest exposure concentrations for BPA and genistein (as illustrated in Fig 3A) 
and this is consistent with those observed in our previously developed 
(pigmented) ERE-GFP model,36  and for other studies on fish exposed to these 
chemicals. At higher magnification and using a dorsal orientation of the larvae, 
GFP expression in the brain was more clearly visible and occurred for 
exposures at lower exposure concentrations for BPA, genistein and NP. 
Nevertheless, the ERE-GFP-Casper model can provide a fingerprint for 
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oestrogenic compounds based on the pattern of tissue-specific responses. The 
high-content target tissue analysis we present may also have applications in 
screening selective oestrogen receptor modulators (SERMs), a diverse group of 
chemicals that display tissue specific oestrogenic agonist and antagonist 
activity.52 
The high sensitivity of the heart to oestrogenic chemicals is consistent with 
responses seen in another oestrogenic responsive transgenic zebrafish line 
exposed to environmental water samples53 and mounting data linking BPA to 
potential adverse effects on the cardiovascular system.54 The corpuscle of 
Stannius in fish is an endocrine tissue thought to mimic the role of the 
parathyroid gland in other vertebrates in regulating calcium metabolism.55 In 
humans oestrogens play a key role in regulating bone formation (density).56 
Here the high sensitivity of the corpuscle of Stannius to both genistein and EE2 
suggests that exposure to these chemicals could have implications for bone 
formation and integrity in fish. 
In the exposures studies for NP, unlike that for all the other oestrogenic 
chemicals tested, measured levels were considerably lower than nominals (on 
day 5), which may have caused us to underestimate the potency of NP in the 
effects analyses reported for this chemical. This finding for alkylphenolic 
chemicals, such as NP, is not uncommon10 and probably relates to its 
absorptive properties and its tendency to stick the culture plate walls, or even to 
‘creep’ (move out of culture well plates) in well plate culture systems.57 
We emphasize that GFP responses seen in this study are from the inserted 
ERE and surrounding sequence, which may not be effective for all oestrogenic 
signalling systems. ERs that work through Sp1 or AP1 sites would not be 
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detected by this assay. The mechanisms of action for each of the selected 
oestrogens are still largely unclear, but different tissue-specific responses can 
be used to guide further work in this area. In vivo studies are required to further 
understand the interactions of oestrogenic chemicals with ERs, including the 
recruitment of different co-factors and/or co-opting of other receptors linked to 
the oestrogen signalling pathway.  
Our TG model is designed to capture responses to all ER subtypes (the ERE 
element will bind all 3 ER subtypes in zebrafish), and thus we cannot say from 
the responses seen whether the different chemicals tested are mediating GFP 
responses via the same or different ERs or potentially ERRs and mERs. 
Studies combining our model with morpholinos for antagonising specific ER 
subtypes, or CRISPR-Cas or TALENS used to silenced ER subtype expression 
could help to elucidate the specific mechanisms of action for different 
environmental oestrogens.  
We show our ERE-TG Casper zebrafish model can relatively easily be applied 
to a semi-automated in vivo screening assay. The assay is simple to carry out. 
The process of checking the masking was fast, with hundreds of images 
accepted or rejected in less than an hour, enabled by a simple visual interface. 
The resulting response curves derived from the image analysis showed that the 
screening assay correctly identified the chemicals with oestrogenic activity and 
reflected the responses observed in the target tissue analysis. A developmental 
toxicity (teratogenic) response at the higher concentrations of NP was reflected 
in a reduced fluorescence response detected by the system. The sensitivity of 
the assay system compares favourably with other in vivo and in vitro oestrogen 
assays. Automated high-throughput reporter quantification in zebrafish models 
have been hampered in previous systems due to melanophores and iridophores 
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that diminish the capacity to detect reporter signals and our ERE-TG Casper 
avoids this limitation without the need for use of additional chemical exposure to 
melanin synthesis inhibitors such as 1-phenyl-2-thiourea, required for 
pigmented zebrafsh lines.58  
Comparing the ArrayScan analyses with the confocal images in the work 
presented shows that the sensitivity of the semi-automated screening assay 
could be improved. Challenges for generating a high throughput automated 
system for the detection of oestrogenic responses across the body tissues 
include the ability to detect responses in small focal regions in the body. As an 
example of this, in our Arrayscan system a statistically significant response to 
BPA in the heart valves was detected only for an exposure to 1000 µg BPA/L, 
whereas via confocal microscopy a response was seen for an exposure to 
62.5 µg BPA/L (Figure 3B). This lower sensitivity relates in part to the 
comparatively lower quality images in the automated assay compared with 
confocal microscopy. Enhancement in the ArrayScan approach could be 
achieved also with a more consistent lateral orientation of the larvae in the 
microtitre plate to improve upon the current rate (80%) of successful larval 
masking for the python algorithm. In addition, the algorithm used could be 
developed further to identify, mask and measure specific organs in the zebrafish 
model and hence automate responses to the level of specific tissues. Auto-
fluorescence generally was low with low variability between control fish and was 
not a major factor affecting GFP quantification in the transgenic assay (see 
comparison with Casper line in Figure S2). Quantification of GFP at the level of 
individual target tissues would remove any interference in GFP quantification 
that might be associated with auto-fluorescence.  
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Some in vitro EDC screening tools are limited in their predictive capabilities for 
potential effects on specific tissues and organs within an organism and they are 
highly focused on specific mechanisms of receptor interaction and activation. 
Despite recent concerns over reported mosaicism and random reporter 
insertion in the genome of certain transgenic animal models, the generational 
consistency in fluorescence intensity and specific tissue response to different 
oestrogenic chemicals has demonstrated that transgenic models such as ERE-
GFP-Casper can be utilised for accurate and reliable quantification of both 
whole body and individual tissue responses to chemicals. Our study further 
highlights the potential for transgenic models, and in particular, here translucent 
models such as the ERE-GFP-Casper, for application in automated in vivo high-
content, and potentially high-throughput, screens for quantitative and 
informative analysis of potential EDCs. In combination with exposure 
assessments and in vitro effects screening tools, in vivo screens such as the 
one reported here, allow us to more effectively and accurately identify EDCs, as 
well as improve our ability to predict potentially adverse outcomes in humans 
and wildlife populations.  
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4.7 List of Figures 
Figure 1: Generation of ERE-GFP-Casper (F0) line. TG1 indicates ERE-
Gal4ff transgene sequence. TG2 indicates UAS-GFP transgene sequence. 
Expression of pigmentation genes roy (dark) and nacre (silver) are also shown. 
The ERE-GFP model, homozygous for both transgenes, and a Casper strain 
were initially crossed to give a heterozygous generation. In-breeding within this 
generation produced progeny with 256 different genotypes based on four genes 
of interest. One in 256 expressed F0 ERE-GFP Casper genotype of fully 
silenced pigmentation and homozygous transgene expression.  
Figure 2: Comparison between ERE-GFP model and ERE-GFP-Casper 
model. Larvae were exposed to 50 ng/L EE2 from 0-5 dpf. Images of larvae 
were acquired 5 dpf on an inverted compound microscope (Zeiss Axio 
Observer) at 10x magnification under consistent GFP excitation. Lateral and 
dorsal views are used for comparison. Specific tissue response in the liver (li), 
heart (h), cranial muscle (cm), somite muscle (sm), otic vesicle ganglions (ovg) 
and forebrain (fb) was consistent across the two models.  
Figure 3A-D: Confocal microscopy images of ERE-GFP-Casper larvae (5 days 
post fertilisation) after five day chemical exposure to different concentrations of 
(A) EE2 (B) genistein (C) BPA and (D) Nonylphenol.  Specific tissue response 
in the liver (li), heart (h), somite muscle (sm), otic vesicle (ov), fin (f), cardiac 
muscle (cm), corpuscle of Stannius (cs), brain (b), eye (e), neuromast (n) and 
gut (g).  
Figure 4: Fluorescence in body tissues of ERE-GFP Casper zebrafish 
exposed to estrogens. Tissue responses were analysed using confocal 
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microscopy after 5 days chemical exposures. Graph shows the concentration 
ranges that induced a fluorescence response in a selection of different body 
tissues.  C.o.S. = Corpuscle of Stannius, C.M. = Cranial Muscle.  
Figure 5: Responses to chemicals in ERE-GFP Casper quantified using a 
semi-automated imaging system. Data are reported as mean ± SEM (asterisk 
indicate significant difference compared with the control, * p <0.05 and ** 
p<0.01). 
Table 1: Lowest Significant Response (LSR), effective concentrations 
(EC50), EC50 confidence intervals (±CI 95) and developmental toxicity 
concentration (Tox) for exposures to  various oestrogens. LSR is the 
lowest exposure concentration of a chemical that gave a fluorescence response 
statistically higher (p˂0.05) than the control response. Statistical significance 
values were calculated using ANOVA and Games-Howell post-hoc test. EC50 
values are the concentrations inducing 50% of the maximal fluorescence 
response for that chemical and, in addition to their confidence intervals (±CI 95)  
, were based on a Hill equation model. The only chemical found to induce 
developmental toxicity (Tox) was 4-Nonylphenol (NP). 
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Figure 1: Generation of ERE-GFP-Casper (F0) line.  
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Figure 2: Comparison between ERE-GFP model and ERE-GFP-
Casper model.  
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Figure 4: Fluorescence in body tissues of ERE-GFP Casper 
zebrafish exposed to estrogens.  
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Figure 5: Responses to chemicals in ERE-GFP Casper quantified 
using a semi-automated imaging system.  
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Table 1: Lowest observed effect concentration 
(LOEC), effective concentrations (EC50), EC50 
confidence intervals (±CI 95) and developmental 
toxicity concentration (Tox) for exposures to various 
estrogens.  
µg/L 
(nM) 
EE2 Gen BPA NP Keto 
LOEC 0.005 
(0.0093) 
125  
(462.5) 
1000 
(4380.32) 
250 
(1134.56) 
n/a 
EC50 0.0096 
(0.0178) 
463.4 
(1715) 
1226 
(1370) 
212.2 
(963.2) 
n/a 
±CI 95 
(EC50) 
0.0089 
– 
0.0103 
455.6 
– 
469.7  
1169 – 
1310  
193.6 – 
229.2  
n/a 
Tox n/a n/a n/a 1000 
(4380.32) 
n/a  
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4.8 Supporting Information 
Water Chemistry: LC-MS Method (Include Table S1 and S2) 
Analyses of water samples for exposure were performed using a Surveyor MS 
Pump plus a HPLC pump with an HTC PAL autosampler coupled to a TSQ 
Vantage triple quadrupole mass spectrometer. The mass spectrometer was 
equipped with a heated electrospray (HESI II) source (all ThermoFisher 
Scientific, Hemel Hempstead, UK).  
Chromatographic separation was achieved using a reversed-phase, 3 µm 
particle size, C18 Hypersil GOLD column (50 mm × 2.1 mm i.d., Thermo 
Scientific, San Jose CA, USA).  
Analytes were separated using a linear gradient of (A) aqueous phase and (B) 
organic solvent containing additives specific for analysed compounds and are 
listed together with initial conditions in the table below (Table S1). Solvent B 
increased to 100% in 4.5 min for BPA and 1.5 min for other analytes. This was 
maintained for 1 min for BPA and 1.5 min for remaining compounds, before 
returning to the initial condition. The flow rate was 500µL/min. Temperature of 
autosampler was set at 8˚C while column was kept at a room temperature.  
The HESI probe was operating in both negative and positive mode; an ion-
spray voltage of -2.75 kV was applied for analysis of genistein, +3.75 kV for 
ketoconazole and -4.0 kV for remaining compounds. The heated capillary 
temperature was set at 275 °C and the vaporizer temperature was 60 °C for 
BPA, 500°C for nonylphenol and 350°C for remaining compounds. Nitrogen 
was employed as a sheath and auxiliary gas at a pressure of 60 and 2 arbitrary 
units, respectively.  
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The argon CID gas was used at a pressure of 1.5 mTorr and the optimum 
collision energy (CE) for each transition was selected. Quantification of the 
target compounds was performed by monitoring two characteristic multiple 
reaction monitoring (MRM) transitions (Table S2). 
 
Semi-Automated Image Analysis  
We developed a custom Python pipeline to quantify larvae-specific fluorescence 
in the arrayscanner images. The first processing step involved detecting the 
well within each image using a series of circular Hough transforms to detect the 
location and size of the well. Once the well had been identified, the image was 
filtered using a median filter and the background subtracted (to reduce noise 
and background gradients respectively). The resulting filtered image was 
passed through a Sobel edge detection algorithm and median-absolute-
deviation thresholding to pick out the edges of the image. After applying a 
distance transform to grow the edges (to close small gaps in the outline), the 
largest contiguous region was selected as representing the larvae outline. The 
full larval mask was then calculated as the convex hull of the outline image.  
Figure S1: Semi-automated image analysis. Fluorescence responses to 
chemical were quantified using a Python macro developed in house. The macro 
identified the well within the image (yellow circle) and subsequently masked the 
larvae (green mask) for fluorescence intensity measurement. Larval masking 
was accepted or rejected using a interactive internet interface.   
Table S3: Measured chemical concentrations in the embryo incubation 
water.  Chemical content was measured by LC-MS in controls, and in the 
highest and lowest exposure concentrations for each chemical tested. 
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Figure S2: Auto-fluorescence in Casper and ERE-GFP-Casper lines.  
Caspers and ERE-GFP-Caspers were imaged at 5 dpf with no prior chemical 
exposure for comparison of auto-fluorescence on an inverted compound 
microscope (Zeiss Axio Observer). Images show yolk-sac (ys) fluorescence in 
both lines, likely due to naturally accumulated chemicals (such as polycyclic 
aromatic hydrocarbons) that fluoresce at similar excitation and emission 
wavelengths as GFP. GFP expression is additionally seen in the Otic vesicle 
(ov) of the ERE-GFP-Casper line only.   
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Table S1: Separation of analytes using a linear gradient of (A) aqueous 
phase and (B) organic solvent containing additives specific for analysed 
compounds (with initial conditions). 
Table S2: Quantification of the target compounds using two characteristic 
multiple reaction monitoring (MRM) transitions at optimum collision 
energies (CE). 
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Figure S1: Semi-automated image analysis.  
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Table S3: Measured chemical concentrations in the embryo incubation 
water.  
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500 μm 
Figure S2: Auto-fluorescence in Casper and ERE-GFP-Casper 
lines.  
ys 
ov 
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5.1 Abstract 
Background: Oestrogen plays fundamental roles in a range of developmental 
processes and exposure to oestrogen mimicking chemicals has been 
associated with various adverse health effects in both wildlife and human 
populations. Oestrogenic chemicals are found commonly as mixtures in the 
environment and can have additive effects, however risk analysis is typically 
conducted for single-chemicals with little, or no, consideration given for animal’s 
exposure history. 
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Objectives: To develop and apply a novel oestrogen sensitive transgenic 
zebrafish to establish responses to environmental oestrogens for repeated 
exposures during early life. 
Methods: We crossbred two transgenic zebrafish lines (ERE-GFP-Casper and 
UAS-Kaede) to create an oestrogen responsive transgenic zebrafish with a 
photoconvertible fluorophore (Kaede) in a skin pigment-free mutant element 
(ERE)-Kaede-Casper model. This was applied to quantify tissue-specific 
fluorescence biosensor responses for combinations of oestrogen exposures 
during early life using fluorescence microscopy and image analysis. Expression 
of oestrogen receptor subtypes (ER) in whole larvae was also quantified using 
qPCR analysis.   
Results: Our ERE-Kaede-Casper model was sensitive to oestrogen exposure 
and photoconvertion of induced Kaede protein (green to red) was rapid upon 
exposure to UV light. Using this model we identify windows of tissue-specific 
sensitivity to ethinylestradiol (EE2) for exposure during early-life (0-5 dpf) and 
illustrate that exposure to oestrogen (EE2) during 0-48 hpf enhances 
responsiveness (sensitivity) to different environmental oestrogens (EE2, 
genistein and bisphenol A) for subsequent exposures during development. 
Conclusions: Our findings illustrate the importance of oestrogen exposure 
history in effects assessments for oestrogens and wider implications for the 
possible health effects associated with oestrogen exposure.  
 
5.2 Introduction 
Endocrine Disrupting Chemicals 
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There is strong evidence that exposure to endocrine disrupting chemicals 
(EDCs) is linked with a range of adverse health disorders and further 
understanding of EDCs effects is crucial for safe guarding long-term human and 
environmental health.1, 2 Over the last 20 years, EDCs shown to interact with 
the oestrogen signaling pathways have gained considerable attention and more 
than 200 chemicals are known to have oestrogenic activity.1, 3 Oestrogens are 
fundamental for gonad growth and development in both females and males,4-6 
and they are crucial also for immune responses, central nervous system 
function, and normal somatic cell growth.7, 8 In zebrafish, oestrogens also play 
important roles in regulating metabolism, transcription, tissue development and 
protein folding and trafficking during early life.9   
Many EDCs with oestrogenic activity enter the aquatic environment via waste 
discharges and there are strong associations between exposures to specific 
environmental oestrogens (e.g. the contraceptive oestrogen, 17D-
ethinylestradiol, EE2) and adverse health effects in individual fish10, 11 and fish 
populations.12, 13 Laboratory based studies on fish have illustrated associations 
between various environmental oestrogens and feminization of males10, 14 and 
alteration of sexual behavior.15 In mammals too, exposure to environmental 
oestrogens has been associated with decreases in semen quality/sperm 
count,16 heart disease and diabetes.17 Exposure to oestrogenic chemicals 
during early life-stages in both mammals and fish has received much recent 
attention with reports of significant adverse physical and behavioral effects.18-20 
Exposures to oestrogens in the natural environment occurs predominantly as 
mixtures and both in vitro studies with reporter gene assays21-23 and in vivo 
studies in fish24 and mammals25, 26 have illustrated the capacity for additive (and 
more than additive) effects. Furthermore, it has been shown that other EDCs, 
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such as anti-androgens, can modulate the responses for oestrogenic chemicals 
when combined as mixture in vitro27 and in vivo.28 Studies on chemical mixtures 
have also suggested enhanced tissue-specific effects may occur, for example 
as seen for responses to EDC mixtures in mammary gland development in male 
and female rats.25, 26 Effects analysis for exposures representative of real world 
scenarios is therefore complicated by mixture permutations, chemical 
interactions and tissue-specific responses. 
Estrogen Signaling 
Estrogen signaling occurs via oestrogen binding to oestrogen receptors (ERs) in 
the nucleus, which then dimerise and bind to oestrogen response elements 
(EREs) located in promoters of target genes.29 There are two ER subtypes in 
mammals, Esr1 and Esr2,30 and three in zebrafish, Esr1, Esr2a and Esr2b.31, 32 
Esr1 and Esr2 subtypes in humans and zebrafish are corresponding orthologs 
with high amino acid sequence similarity for their respective ligand binding 
domains (64% and 71%, respectively).33 Membrane ERs (mERs) and 
oestrogen-related receptors (ERRs), a small group of orphan nuclear receptors 
that share some target genes with ERs,34 also occur  but their role(s) and 
mechanism(s) of action are less clear than for the nuclear ERs.35, 36 
Transcriptional co-factors also play an important role in regulating the 
interaction of ERs with oestrogen related response elements and their 
downstream expression sequences.37, 38 The expression of ER subtypes in 
organs and tissues can vary during development, and in later life, and the 
affinity of ligands for these ER subtypes also varies for different oestrogenic 
chemicals, influencing the physiological targets and subsequent downstream 
effects.39 Tissue-specific expression of ER subtypes in humans is better 
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characterized than for other organisms.40, 41 In zebrafish, expression levels of 
esr1, esr2a and esr2b differ and vary significantly during the first 120 hours of 
development.42 Expression of esr1 and esr2b increases during the first 120 
hours and esr1 expression is comparatively higher. Esr2a expression is 
significantly lower than the expression of esr1 and esr2b during this period. At 
sexual maturity, these ER subtypes show tissue-specific expression also with 
the liver, brain and heart expressing all three ERs at relatively high levels 
compared with other somatic tissues.42 Exposure to oestrogenic chemicals 
during early life has been shown to increase expression of ERs and EREs with 
tissue-specific targeting for these chemicals.42, 43 This effect of sensitization and 
increased responsiveness has been shown to persist even after a prolonged 
phase of depuration.44 
Transgenic Fish Models 
Transgenic zebrafish models (TG models) have emerged as effective systems 
for investigating EDC exposure effects in vivo, and they have been applied to 
study responses in real time and to better establish chemical effect 
mechanisms.45 Highly sensitive oestrogen responsive models have been 
developed with an inserted oestrogen response element (ERE) transgene43, 46, 
47 or brain-specific cyp19a1b transgene24 and applied to study various 
environmental oestrogens including EE2, the plasticizer bisphenol A (BPA) and 
the phytoestrogen genistein. Transgenic zebrafish are typically generated by 
inserting a reporter fluorescent protein sequence for GFP, and the expression 
of this reporter sequence is driven by ligand-receptor binding to either 
endogenous or inserted response elements for the target of interest (e.g. via the 
ERE for ER TG models). Alternative fluorescent reporter sequences to GFP 
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used in TG models now include those that are photoconvertible upon exposure 
to light in (or near) the ultraviolet (UV) wavelength region.48 An example of a 
photoconvertible fluorescent protein is the Kaede protein (named after the 
Japanese maple where, in the autumn, the leaves change from green to red)49 
which on exposure to UV light results in a spectral shift of the native (green) 
state from 508 nm (absorption) and 518 nm (emission) to longer wavelength 
peaks at 572 nm and 582 nm, respectively. Photoconversion leads to an almost 
complete conversion of green to red fluorescence and is irreversible and stable 
under aerobic conditions.49 Photoconvertible proteins offer the ability to track 
individual cells and assess effects on tissue development.50-52   
In this study we generated ERE-Kaede-Casper zebrafish, a novel oestrogen 
responsive transgenic zebrafish model with a Kaede photoconvertable (green to 
red) fluorescent protein and applied it to assess both for windows of tissue-
sensitivity to oestrogen exposure during early-life and to investigate how 
exposure to oestrogen during early life affects responsiveness to environmental 
oestrogens for subsequent exposures.  
5.3 Methods  
Chemicals 
17α-ethinylestradiol was purchased from Sigma-Alderich Chemical Co. (CAS 
no. 57-63-6, ≥98% pure), bisphenol A was purchased from the American 
Chemistry Council (BPA, 80-05-7, 99%+pure), and genistein, a phytoestrogen, 
was purchased from Sigma-Aldrich Chemical Co. (Gen, 446-72-0, ≥98% pure). 
Animal Experiments 
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All experimental procedures with fish were conducted in accordance with UK 
Home Office regulations for the use of animals in scientific procedures and 
followed local ethical review guidelines ensuring their humane treatment. 
Generation of the ERE-Kaede-Casper Zebrafish Model 
The ERE-GFP-Casper transgenic line was derived from an ERE-GFP-Casper 
line previously developed at the University of Exeter (Green et al 2016), and a 
UAS-Kaede53 line from Max-Planck Institute of Neurobiology, Germany (Figure 
1). The ERE-GFP-Casper line is sensitive to oestrogens, with GFP expression 
detected in hepatocytes for an exposure to 1 ng EE2/L, and shows tissue-
specific responses to different oestrogenic chemicals.43 The ERE-GFP-Casper 
line has silenced roy (dark) and nacre (silver) pigmentation genes (the “Casper” 
phenotype),54 resulting in a translucent phenotype and as a consequence 
improved GFP signal detection via fluorescence image analysis. The UAS-
Kaede line has wild-type (WIK) pigmentation and expresses an inserted UAS-
Kaede reporter transgene sequence. To enhance both the transmission rate of 
transgenic sequences to subsequent generations and consistency in oestrogen 
response sensitivity, the ERE-GFP-Casper model was initially screened for 
homozygous adults by pair breeding individuals with wild-type (WIK strain) 
adults and assessing the ratio of fluorescent/non-fluorescent offspring produced 
(homozygous ERE-GFP-Casper adults produce 100% fluorescent offspring 
whereas heterozygous ERE-GFP-Casper adults produce 75% or a lower 
proportion of fluorescent offspring). Homozygous ERE-GFP-Casper adults were 
then crossed with the UAS-Kaede line in 10 different mating pairs, rotating the 
pair combinations to promote genetic diversity. Progeny from these crosses 
were heterozygous for five genes of interest; ERE:Gal4ff, UAS:GFP and 
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UAS:Kaede transgene sequences and silenced roy and nacre pigmentation 
genes. Crossing of progeny from distinct families produced larvae with different 
combinations of the genes of interest. These larvae were screened for the 
homozygous ERE-Fluorescence and Casper genotype via exposure to 50 ng 
EE2/L from 1-3 days post fertilisation (dpf). Individuals carrying both Casper 
phenotype and fluorescence expression, as determined by their response to 50 
ng EE2/L, were raised to sexual maturity. Screening for Kaede expression was 
not carried out in this first screen due to potential developmental effects of UV 
exposure required for distinguishing the protein from GFP. At sexual maturity, 
these fish were screened for Kaede expression via exposure to 50 ng EE2/L for 
5 days (from 0-5 dpf) and a 2 min UV exposure to convert the Kaede excitation 
and emission response. Adults with progeny exclusively expressing Kaede 
protein (complete conversion from green to red fluorescence upon UV 
exposure) were identified as the founder generation (F0) of the ERE-Kaede-
Casper line. These fish were then bred to generate an F1 generation and 
sexually mature F1 fish were screened for homozygous expression of the 
transgene sequences as described for F0. We compared responses to EE2 in 
the ERE-Kaede-Casper line with our original ERE-GFP-Casper model to assess 
for sensitivity and tissue response patterning to oestrogenic chemicals. To do 
so, embryos from both models were exposed to 10 ng EE2/L from 0-5 dpf and 
fluorescence response was observed using an inverted compound microscope 
(Zeiss Axio Observer) under consistent GFP excitation (180 ms using filter set 
38 HE: BP 470/40, FT 495, BP 525/50). Further generations have been 
established for the ERE-Kaede-Casper line, and each generation has been 
screened to confirm that only homozygous adults are used for ensuring 
consistently high sensitivity.  
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Tissue responses to EE2 during early life in the ERE-
Kaede-Casper model 
We investigated tissue responses to EE2 (over 0-5 dpf) and the ability to 
photoconvert oestrogen induced green fluorescence in the Kaede-Casper 
model. ERE-Kaede-Casper larvae were exposed to 100 ng EE2/L over the 
period 0-5 dpf and exposed to UV light for 2 mins at the intervals of 3 dpf, 4 dpf 
and 5 dpf. A further group was exposed to 100 ng EE2/L throughout the period 
0-5 dpf with no exposure to UV light. Larvae were then subjected to imaging at 
5 dpf on an inverted compound microscope. After imaging, differential 
interference contrast (DIC), green and red Kaede fluorescence images were 
overlaid and the color of individual tissue response qualified via the ratios of 
green (new Kaede expression), red (‘old’ Kaede expression pre-
photoconversion) and yellow (equal levels of new and old Kaede expression) 
fluorescence. 
 Development of a protocol for multiple oestrogen 
exposures in ERE-Kaede-Casper model  
To investigate for effects of oestrogen exposure during early life on the 
subsequent responsiveness (sensitivity) to a further oestrogen challenge we 
first developed an appropriate experimental protocol to identify an appropriate 
exposure interval and concentration for the EE2 primary exposure. EE2 was 
adopted for these exposure studies because of its effects on a wide range of 
tissues in the ERE-GFP-Casper model, including at environmentally relevant 
concentrations, and strong environmental relevance. The temporal dynamics of 
oestrogen induced fluorescence response was investigated for exposures to 
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(nominal) 10 and 50ng EE2/L. Twenty larvae were exposed to each of the two 
test EE2 concentrations and six larvae per concentration were imaged and 
subjected to photoconversion every 24 hours (2-5 dpf) to compare the patterns 
and levels of new (green) and old (red) fluorescence induction at each time 
step.  
Quantifying responses to EE2 in the primary exposure  
The experimental protocol for the multiple exposures studies is presented in 
Figure 2. The initial -exposure period was for 48 hours (0-2 dpf) to an EE2 at a 
concentration of 10 ng/L (see results section). For the primary dosing to EE2, 
embryo-larvae (0-2 dpf) were cultured in embryo water either with (10 ng EE2/L, 
“E”) or without (DMSO solvent control group, “C”) oestrogen treatment. Using 
multi-well plates, each treatment comprised of 6 wells, each containing 12 
embryos.  After the exposure, larvae were removed from the incubation 
solutions, washed three times in embryo water and re-plated in their groups in 
oestrogen (and solvent) free embryo water for a depuration period of 24 hours 
to allow for complete (including any delayed) Kaede expression in the 
oestrogen treated larvae. At 3 dpf, 6 larvae from each of the two treatment 
groups were imaged and all larvae were subjected to UV illumination to 
photoconvert any green fluorescence.  Prior to imaging and UV illumination 
larvae were washed and anaesthetised in embryo water containing 0.008% 
tricaine and mounted in methylcellulose in embryo culture medium and placed 
into a glass bottom 35mm dish (MatTek). Larvae were orientated to rest on their 
left side and images captured using an inverted compound microscope using 
GFP, RFP and DIC filters (1500 ms using filter set 38 HE: BP 470/40, FT 495, 
BP 525/50) with a 5× objective. After imaging at the 3 dpf stage, all larvae were 
 142 
mounted and exposed to 2 × 1min bursts of UV light (DAPI filter) at 5× 
magnification to fully convert the expressed Kaede to red fluorescence 
excitation and emission response wavelengths. 
Responses to environmental oestrogens after early life 
exposure to EE2  
Three oestrogenic chemicals were chosen for the second exposures of the 
ERE-Kaede-Casper larvae, namely, EE2, BPA and genistein, all of which 
induce oestrogen responses in different body tissues in zebrafish and have 
environmental relevance.43 Single chemical concentrations were adopted for 
these studies specifically: EE2 (10 ng/L), genistein (500 µg/L), BPA (2000 µg/L) 
and were based on activation of a low level of Kaede expression in the liver of 
the ERE-Kaede-Casper from initial screening trials (5 dpf larvae for a 48 h 
exposure) ensuring any potential increase or decrease in Kaede expression in 
the liver caused by EE2 pre-exposure would be both identifiable and 
quantifiable. Stock chemicals for each concentration were dissolved in 
analytical grade dimethyl sulfoxide (DMSO) and stirred vigorously in glass vials 
for 24 hours and stored at -20˚C. Required volumes of stock solution were 
pipetted into 50 mL embryo culture water and stirred vigorously to give final 
nominal concentration working solutions (0.1% DMSO concentration) prepared 
on the morning of exposure.  
ERE-Kaede-Casper larvae from the initial 48 h exposure (0.1% DMSO solvent 
control “C”, and EE2-exposed “E”), after 24 h depuration, followed by UV 
photoconversion and imaging and at 3 dpf, (see Figure 2) were then exposed to 
EE2, BPA or genistein. They were first incubated in EDC (and solvent) free 
embryo medium for periods of either 0, 48 or 144 hours (embryo water changes 
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were conducted every 24 h) prior to the second oestrogen treatment. For these 
exposures, larvae were separated into four dosing groups; C-Water, C-
Chemical, E-Water and E-Chemical (where Water denotes solvent control 
water, and Chemical is the second oestrogen treatment – either EE2, BPA or 
genistein). ERE-GFP-Casper embryos (in embryo water) were pipetted into six-
well plates, with twelve embryos per well. Each treatment regime consisted of 3 
well replicates each containing 12 larvae. The larvae were exposed to embryo 
water (Water) or oestrogen treatment (Chemical) for a 48 h period. The 
exposure regimes were:  EE2 3-5 dpf, 5-7 dpf and 9-11 dpf; BPA 3-5 dpf and 
genistein 3-5 dpf. The imaging protocol was identical to that described for the 
first exposure studies (3 dpf stage for EE2) and was carried out at 5 dpf (EE2, 
BPA, genistein), 7 dpf (EE2), and 11 dpf (EE2). Images were also collected for 
specific tissues, including the liver, heart and somite muscle using a 10× 
objective and green fluorescent Kaede expression quantified using ImageJ™ 
software. These tissues of interest were masked (outlined) manually to give a 
specific quantifiable region of interest (ROI, see Figure S1 in Supplemental 
Material). The mean pixel intensity value from this ROI was used as a 
quantification of fluorescence response for the individual tissues.  
Analytical Chemistry 
To assess stock concentrations of the chemicals used in this study, two 
concentrations of each chemical were measured at 0 dpf and 5 dpf using 
tandem liquid chromatography-mass spectrometry (LC-MS), as described in 
Green et al 2016. For all chemicals, with the exception of EE2, water samples 
were diluted in acetonitrile (ACN) before analysis by LC-MS. Due to the low 
concentration of EE2, samples were initially run through solid phase extraction 
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(SPE) cartridges (Sep-Pak Plus C18) into ACN, to achieve a detectable 
concentration for LC-MS analysis (see Green et al., 2016, Supplemental 
Material for full protocol details and results). 
qPCR  
Relative expression levels of the three oestrogen receptor genes (esr1, esr2a 
and esr2b) in whole bodies of ERE-Kaede Casper zebrafish were analyzed 
using quantitative polymerase chain reaction qPCR at 5 dpf after the exposures 
to EE2 (primary and a secondary exposure). Efficiency-corrected relative 
expression levels7 were determined by normalizing to the reference gene 
ribosomal protein L8 (rpl8), which was measured in each sample. For full details 
of the qPCR protocol see Supplemental Material and details on primer 
sequences, sizes of PCR products and PCR assay conditions are provided in 
Table S1.   
Statistical Analysis  
For the imaging data in the definitive oestrogen exposure studies tissue-specific 
intensity values from the four treatment groups C-Water, E-Water, C-Chemical 
and E-Chemical were converted to a fold- increase value over their respective 
controls (C-Water repeat average intensity value). Tissue specific percentage-
increases for the three repeats (final n = 18) for each treatment group were then 
averaged to give a single fold-increase value per treatment group. All values 
are presented as mean ± SEM. Statistical significance between treatment 
groups is indicated at the p˂0.05(*) or <0.01(**) level and calculated using an 
ANOVA and Games-Howell post-hoc test. Using mean fold-increase data, 
responses from the E-Chemical groups were compared to C-Chemical groups 
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and presented as percentage-increase values in the text, so as to differentiate 
from fold-increase over C-Water values. The two control groups (C-Water and 
E-Water) that were incubated in embryo water during the second exposure 
period were expected to produce no new (green) fluorescence response in 
tissues after the second exposure period. However, it could not be assumed 
that there would be complete Kaede photoconversion (green to red 
fluorescence) by UV light following the initial exposure period. Therefore, if the 
pre-exposed control group (E-Water) showed a statistically significant fold-
increase to the equivalent C-Water control tissue value, the other pre-exposed 
group (E-Chemical) results were then normalized based on this fold-increase on 
the assumption that green fluorescence had remained after incomplete 
photoconversion at the 3 dpf stage.  
After qPCR analysis, relative esr subtype expression values from the four 
treatment groups C-Water, E-Water, C-Chemical and E-Chemical were 
converted to an increase value over their respective control (C-Water repeat 
average value).  ER subtype percentage-increases for the three repeats (final n 
= 3) for each treatment group were then averaged to give a single fold-increase 
value per treatment group. All values presented as mean ± SEM and statistical 
significance was calculated using an ANOVA.  
 
5.4 Results  
ERE-Kaede-Casper model  
A founder F0 generation of the ERE-Kaede-Casper model was established (see 
Figure 1) and a homozygous F1 generation generated and raised to adulthood 
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for subsequent use for the exposure studies. Tissue-specific responses in the 
ERE-Kaede-Casper model were consistent in subsequent generations for 
homozygous individuals as assessed via regular screening and there was high 
consistency in the response to oestrogen (tissue specificity and sensitivity) 
between the ERE-Kaede-Casper model and the original ERE-GFP-Casper 
model (Figure S3).  
Water Chemistry Analysis 
In all water control samples chemicals were less than the limit of quantitation 
(LOQ). For genistein, BPA, and EE2 measured concentrations were highly 
consistent, at between 99% and 133% of day 5 nominals across the 
concentration ranges tested. Exposure concentrations are reported as ng/L or 
µg/L in text but nM concentrations are included where direct comparisons 
between chemicals are made in both text and figures. Results for the full water 
chemistry analysis are provided in Table S2.  
Tissue responses to EE2 during early life in the ERE-
Kaede-Casper model 
Under UV illumination Kaede fluorescence was converted fully from green to 
red at the intervals tested over the life period 0-5 dpf (see Figure 3D) thus 
enabling visualisation and quantification of tissue responses to oestrogen for 
multiple time windows and for repeat (see later) exposures in the same 
individual. 
Exposure to EE2 induced a wide range of tissues responses over early life (0-
5dpf) in the ERE-Kaede-Casper model. Without photoconversion, tissues such 
as liver, heart, gut, brain, somite muscle, Corpuscle of Stannius and cranial 
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muscle all showed high levels of fluorescence when imaged at 5 dpf after EE2 
exposure (Figure 3A). However, UV conversion of Kaede at 3 and 4 dpf, 
indicated differences in the temporal responses to EE2 stimulation for the 
different tissues.  The heart and liver responded consistently to EE2 over the 0-
5 day study period with new Kaede protein (green) expressed subsequent to 
UV photoconversion at 3 dpf and 4 dpf. Other tissues showed more variable 
temporal responses to EE2 during this period of development. Photoconversion 
highlighted different temporal expression of Kaede across regions of the tail. 
Muscle somites at the tip of the tail (caudal peduncle) showed a stronger 
response to EE2 between 3-5 dpf compared with the muscle somites nearer the 
tail head, which appeared to become less responsive by 3 dpf (Figure 3B). This 
difference in sensitivity can be seen more clearly after the 4 dpf 
photoconversion (Figure 3C). Muscle surrounding the cranium appeared to be 
most responsive to EE2 after 4 dpf, with little or no Kaede expression before 
this time (no red fluorescence). The Corpuscle of Stannius (identified in this 
model by Rod Wilson at the University of Exeter), a collection of cells located in 
the tail above the anus and involved in calcium homeostasis, responded most 
strongly to the EE2 treatment during 3-5 dpf. Response in the brain to EE2 also 
appeared to differ temporally for the early life exposures (see Takesono et al., in 
prep.).  
Protocol for investigating multiple oestrogen exposures in 
the ERE-Kaede-Casper model  
Tissue response patterns after the 48h exposure to 10 ng EE2/L and 50 ng 
EE2/L were similar, but response intensity increased with exposure 
concentration (Figure S4). Photoconvertion of the Kaede fluorescence and 
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subsequent imaging after 24 h (at 3 dpf) demonstrated further delayed Kaede 
expression in liver and muscle somites for the 50 ng EE2/L treatment, but not 
for the 10 ng EE2/L treatment. Based on these findings, the protocol we 
adopted for priming with EE2 prior to subsequent exposure to environmental 
oestrogens, was to expose embryo-larvae (0-48 hpf) to 10 ng EE2/L for 48 h 
followed by a 24 h incubation of the larvae in an oestrogen-free embryo culture 
medium followed by photoconversion of the Kaede fluorescence via treatment 
with UV light for 2 minutes (see Figure 2).   
Responses to environmental oestrogens after early life 
exposure to EE2 
Autofluorescence was detected in the yolk sac and otic vesicle only at 5, 7 and 
11 dpf in control groups (C-Water and E-Water; Figure S5, Supplemental 
Material), as has been shown to occur previously for the ERE-GFP-Casper 
model.43 No green fluorescence was detected for the C-Water treated groups at 
3, 5, 7 or 11 dpf, or for the E-Water controls with the exception that at 5 dpf 
there was a 15% higher average pixel intensity in the liver (as determined 
quantitatively by image analysis, Figure 4A). Responses in the liver in the E-
Chemical groups were thus normalized against the pixel intensity of the E-
Water exposure for all time-points to account for the higher average pixel 
intensity in this tissue.  Pixel intensity values for the heart and somite muscle in 
E-Water groups did not differ from the C-Water groups.  
Responses to the different oestrogenic chemicals were highly consistent 
between individual embryo-larvae as illustrated by the low variance in the data 
(Figure 4). Exposure to EE2 during early life (0-48 hpf) affected subsequent 
responses to the exposures to EE2, BPA and genistein (3-5 dpf). In the liver at 
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5 dpf (3-5 dpf exposure) for exposure to EE2 (10 ng/L) and BPA (2000 µg/L) 
expression of GFP in E-Chemical groups was 682% and 98% higher than C-
Chemical responses, respectively (Figure 4B). This was also the case for 
responses in heart tissue at 5 dpf  (3-5 dpf exposure), where responses to 
genistein and BPA were 105% and 206% higher respectively in E-Chemical 
groups than in C-Chemical groups (Figure 4C).  There was an apparent 
enhanced response to BPA in the somite muscle at 5 dpf, but the difference 
between C-B and E-B groups was not statistically significant (the data were 
more highly variable compared with other tissues) (Figure 4D). A small, but 
statistically significant difference, in somite muscle response occurred in the 
groups exposed to genistein (C-G and E-G) but neither of the groups’ 
fluorescence response was significantly higher compared with the C-Water 
control (Figure 4D). There was higher fluorescence induction in the liver (342%) 
in the E-E treatment compared with the C-E groups for the exposures at 7 dpf 
(5-7 dpf exposure, Figure 5), but no such difference between these treatment 
groups for the exposure at 11 dpf (9-11 dpf exposure, Figure 5). Fluorescence 
images for the quantified results (Figure 5) are presented in Figure 6.  
qPCR 
Expression levels of the three oestrogen receptor genes (esr1, esr2a and 
esr2b) in whole bodies of ERE-Kaede-Casper zebrafish at 5 dpf after the 
exposures to EE2  (primary and a secondary exposures) are shown in Figure 
S6. For all three genes, expression appeared to be highest in the E-EE2 group, 
most notably for the esr2b gene, compared to C-Water larvae, but there were 
no statistically significant differences for the expression of any of the esrs 
between the different treatments.  
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5.5 Discussion  
ERE-Kaede-Casper Model 
We generated a novel oestrogen responsive transgenic model ERE-Kaede-
Casper and have shown that it has great utility for studies into the effects of 
environmental oestrogens. Using the ERE-Kaede-Casper model we have 
illustrated the dynamics of tissue responses to EE2 exposure, provided new 
information on ontogeny of these responses and shown enhancements in 
sensitivity in different body tissue for exposure to environmental oestrogens 
following an exposure to EE2 during early life (0-2 dpf). The zebrafish model, 
generated by crossing two established transgenic models and phenotypic 
screening of subsequent generations, has a (high) sensitivity to oestrogenic 
chemicals, comparable with our previously developed ERE-GFP-Casper model 
(Figure S3)43 and a silenced skin pigmentation that enhances fluorescence 
detection. We have shown that the Kaede chromophore can be successfully 
photoconverted in living intact individuals in all responding tissues and for high 
levels of Kaede expression, without any overt indication of development toxicity 
(Figure 3). Translucency of the skin assisted efficiency of photoconversion as 
pigmentation normally blocks UV light penetration into the deeper tissues in 
larvae. The ability to photoconvert the Kaede fluorescence response in the 
ERE-Kaede-Casper model provides a more dynamic model for studies into 
temporal dynamics and mixture responses to oestrogen compared with the 
ERE-GFP-Casper model. For the liver only, in some instances we found 
persistence of the green fluorophore of Kaede after applying two 1-minute UV 
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light exposures. This may have been due to an incomplete conversion of the 
Kaede chromophore 49 or as a consequence of the higher optical density and/or 
thickness of the liver, compared with some of the other responding body tissues 
(e.g. heart and somite muscle), that may also have limited UV penetrance and 
consequently inhibited the photoconversion process. However, this reduced 
Kaede photoconvertion efficiency in the liver of embryo-larval stages was easily 
accounted and adjusted for when calculating the response to oestrogens in this 
tissue versus controls. It is likely that photoconversion efficiency in other body 
tissues may be reduced with further growth and development of the fish. 
Tissue responses to EE2 during early life in the ERE-
Kaede-Casper model 
We show windows of sensitivity to EE2 for specific tissues during early 
development with our ERE-Kaede-Casper model. The heart and liver 
responded in a consistent manner to EE2 during the life period studied, 
between 0-5 dpf. In contrast, other tissues, including muscle somites and the 
brain appeared to vary in their responses over this life period. The development 
of zebrafish tissues and organs have been studied extensively55 but the role 
and importance of oestrogens in the development of individual somatic tissues 
is lacking. In mammals, oestrogen has been shown to regulate growth and 
differentiation of a wide range of tissues including specific regions of the brain, 
bone, liver, and the cardiovascular system.56 The major expression sites of ERs 
in mammals during fetal development are the ovaries, testes and adrenal gland, 
but other tissues with notable ER expression include the brain, bone, heart, 
lung, kidney and intestines.32 In mammals, oestrogen has been shown to play a 
key role in early development of the brain via the regulation of apoptosis and 
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synaptogenesis, with estradiol inhibiting these actions in some regions but 
promoting it in others.57 In zebrafish, studies have shown that phytoestrogens, 
such as genistein, can affect brain development when exposed during the early 
life-stage of growth.58 Oestrogen has recently been linked to cardiovascular 
maintenance and repair in zebrafish also59 and appears to play an important 
role in the development of the peripheral nervous system (PNS) within skeletal 
muscle.60 These roles of oestrogens are reflected in the tissue-specific 
responses observed in the ERE-Kaede-Casper model, and in other oestrogen 
responsive transgenic zebrafish lines during early life-stages.43, 61   
Temporal dynamics of the oestrogen response to EE2 in 
the ERE-Kaede-Casper model 
The ERE-Kaede-Casper model was used to study tissue-specific responses 
following 0-2 dpf exposure to EE2. Embryo-larvae were subject to 
photoconversion at 24 h intervals after the initial 48 h exposure to EE2. The 
results (Figure S4) show that fluorescence induction continued after the EE2 
exposure for periods that varied depending on the exposure concentration. 
Kaede expression continued in the liver, heart, brain and somite muscle for 24 
hours and 48 hours after exposure to 10 ng EE2/L and 50 ng EE2/L, 
respectively. Kaede expression was most prominent in the liver. This illustrated 
the ERE-Kaede-Casper model’s capability for studying temporal response 
dynamics to oestrogenic chemicals exposures using photoconversion. The 
factors behind the different dynamics of response across the different 
responding body tissues over time are not known but they may involve 
differences in accumulation, metabolism and excretion of the chemical within 
these tissues, as well as possible differences in the number and types of ER 
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that are expressed and dynamics concerning the conscription of cofactors. 
Zebrafish have been applied successfully for in vivo toxicokinetic studies 
assessing uptake, metabolism and excretion of oestrogenic chemicals.62 These 
are challenging studies however as only small amounts of plasma can be 
obtained for analytical chemistry measurements, placing major practical 
restrictions on what can be done relating to studying the uptake dynamics of the 
chemical. The ERE-Kaede-Casper could provide a valuable model for 
supporting such toxicokinetic studies. The ability to photoconvert Kaede 
fluorescence could potentially be applied as a proxy to assess for both the 
presence and persistence of the exposure chemical in the target tissues. This 
would operate on the assumption that the level of Kaede expression is directly 
correlated with the parent chemical and assumes that the products of 
metabolism are not biologically (estrogen) active. This may not always be the 
case for oestrogens, for example for BPA, where the metabolite MBP (in 
mammals) is more potent as an oestrogen than the parent compound. In many 
(most) cases however, where the parent compound only is oestrogen active the 
ERE-Kaede-Casper model could potentially offer an effective system to non-
destructively study the toxicokinetics of oestrogenic chemicals in zebrafish in 
real time.  
Responses to environmental oestrogens after early life 
exposure to EE2 
There is a reliance on single chemical exposures for environmental effects 
assessments, but in contrast wildlife and humans are exposed intermittently, or 
continuously, to complex mixtures of chemicals, including EDCs. Many studies 
have now shown interactive (including additive) effects of oestrogens and other 
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EDCs.24-26 Studies have also shown that exposure to oestrogens during early 
life stages can result in adverse health outcomes in later life, including learning 
deficits,20 breeding and behavior effects18 in zebrafish. Studies have also 
suggested tissue-specific effects may be enhanced by chemical mixtures, for 
example as seen for responses to EDC mixtures in mammary gland 
development in male and female rats.25, 26 Almost nothing, however, is known 
for the effects of repeated or sequential exposures to oestrogens on tissue 
responses or on the health implications for these exposures, which will occur for 
many (most) ambient environments.63  
Using the ERE-Kaede-Casper model, we show that exposure to EE2 during 
early life (0-48 hpf) has a significant bearing on the subsequent responsiveness 
of body tissues to further oestrogen exposure, here EE2, genistein and BPA, 
three oestrogens of environmental concern. Furthermore, we show that the 
enhancement of the response differed for these three environmental chemicals, 
the highest percentage-increase occurring after the second exposure to EE2. 
Of the three responding tissues analyzed in detail by image analysis, the liver 
appeared to be the most affected (sensitized) after the initial early life exposure 
to EE2, with secondary EE2 exposure leading to a 682% increase in 
fluorescence induction compared with relevant control. In the heart, 
fluorescence induction in response to genistein following an early life exposure 
to EE2 was two-fold higher compared with the relevant control. The heart 
appears to be especially responsive to phytoestrogens, including genistein, in 
comparison to other tissues 43 and this has been associated with adverse 
implications for cardiovascular maintenance and repair in zebrafish.59 
Oestrogenic responses to BPA were enhanced for an early life exposure to EE2 
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in the liver (98%) and heart (206%). BPA has been consistently linked to 
cardiovascular defects and abnormal liver enzymes in mammals.17, 64 
Response to EE2 was detected strongly in the liver only at 7 dpf (5-7 dpf 
exposure) and 11 dpf (9-11 dpf exposure) and only weakly so, or not at all, in 
the heart and somatic muscle (data not presented), which concurs with the 
results seen for the tissue ontogeny response study (Figure 3). The sensitized 
response of the liver to EE2 after an initial early life stage exposure to EE2 was 
found to diminish at later stages of development, from 682% at 5 dpf (3-5 dpf 
exposure), to 342% at 7 dpf (5-7 dpf exposure), to no significant change at 11 
dpf (9-11 dpf exposure). There also appeared to be an increase in variation of 
liver fluorescence response in the later life stages. 
The mechanisms leading to the enhancement in responsiveness of certain 
tissues, and not others, are not clear. Nor is it clear why this sensitization effect 
diminishes at later stages of development, as measured specifically in the liver 
in this study. Changes in ER(s) number is proposed as a potential mechanism 
and is discussed further below. In addition, changes in response to oestrogenic 
chemicals may have epigenetic origins via DNA methylation or histone 
acetylation of gene sequences (collectively known as the epigenome) related to 
oestrogen signaling. Oestrogen signaling genes are regulated, in part, through 
DNA methylation of their promoter regions in a gender- and region-specific 
manner 65.  For example, exposure to E2 in adult zebrafish has been shown to 
increase DNA methylation levels in the 5′ flanking region of the vitellogenin I 
gene in the liver and brain, and to a greater extent in the livers of males.66 
Exposure to BPA, on the other hand, did not show any association with DNA 
methylation levels in the 5′ flanking region of esr1 in adult zebrafish, but altered 
the transcription of key enzymes involved in DNA methylation maintenance.67 
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Furthermore, DNA methylation and subsequently the transcription levels of ER 
genes are influenced substantially by exposure to environmental chemicals at 
developmental sensitive windows such as embryogenesis and early postnatal 
stages.68-70 Although it is now widely accepted that chemicals affect the 
epigenome, epigenetic mechanisms are not yet considered in chemical risk 
assessment or utilized in the monitoring of the exposure and effects of 
chemicals and environmental change.  
ER Expression 
The expression of the oestrogen receptor genes esr1, esr2a and esr2b was 
quantified in whole bodies using qPCR to investigate whether changes in 
receptor expression occurred for the different subtypes for the different 
treatment regimes (Figure S6). There was no change, however, in the 
expression of any of the subtypes across the different exposure groups. There 
was an indication that expression was higher for all ER subtypes in the E-E 
group treatment, but this was not statistically significant. In other studies, E2 
(0.1 µM) has been shown to induce a significant increase in esr1 expression 
after 96 h in zebrafish, using a similar exposure protocol and qPCR analysis.9 
Collectively, the findings suggest that changes in ER(s) number may not be the 
major effect mechanism for the enhancement seen in the responses to 
environmental oestrogens after an early life exposure to EE2.  However, we say 
this with caution as measuring responses in whole body extracts is a relatively 
crude approach and tissue level effects analyses are needed to provide any 
degree of certainty on this assumption. Furthermore, as the qPCR analysis was 
conducted at 5 dpf and there may have been changes in the level(s) of esr 
expression prior to this analysis time-point that we could not account for (ER 
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responses to oestrogen have been shown to occur within 48 h in zebrafish) 9. In 
summary, even with the above caveats we did not observe a clear trend in the 
esr expression dynamics that could be directly related to the sensitized 
responses to environmental oestrogens caused by early life exposure to EE2.  
Conclusion 
Our study illustrates the need to consider exposure history of animals in 
environmental risk assessments and highlights the potential for interactive 
effects for environmental oestrogens. Applying a novel ERE-Kaede-Casper 
model we have both identified windows of tissue-sensitivity to oestrogens and 
illustrated how exposure to EE2 during early life affects responsiveness to 
environmental oestrogens in subsequent exposures in later stages of 
development. We show also, however, that the enhanced responsiveness to 
oestrogen may decay with time, as seen in the exposure to EE2 where at 11 
dpf no enhancement in the oestrogenic response (in the liver) was seen after an 
initial early life (0 to 2 dpf) exposure to EE2. 
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5.7 Figure Legends 
Figure 1: Generation of ERE-Kaede-Casper (F0) line. ERE denotes the ERE-
Gal4ff transgene sequence, GFP denotes the UAS-GFP transgene sequence 
and Kaede denotes the UAS-Kaede transgene sequence. Expression of 
pigmentation (Pig.) genes roy (dark) and nacre (silver) are also shown. The 
ERE-GFP-Casper model, homozygous for both transgene sequences, and a 
homozygous UAS-Kaede strain were initially crossed to produce a 
heterozygous generation. In-breeding within this generation produced progeny 
with different genotypes based on four genes of interest. At sexual maturity, F0 
ERE-Kaede-Casper adults were identified by screening for photoconvertible 
progeny with fully silenced pigmentation and TG(ERE:Gal4ff)(UAS:Kaede) 
expression.  
Figure 2: Exposure Protocol Outline. ERE-Kaede-Casper embryos were 
initially separated into 48h control (C) and EE2 (10 ng/L) initial-exposure (E) 
groups. After a subsequent 24h non-exposure period larvae were imaged and 
Kaede expression underwent photoconvertion (green to red fluorescence, 3 
dpf). Various intervals of non-exposure were then adopted before a second 
oestrogen exposure was conducted. Larvae from the two initial treatments (C 
and E) were each divided into two groups; one control exposure (C-Water and 
E-Water) and the second an oestrogenic chemical exposure (C-Chemical and 
E-Chemical). Imaging was carried out at the final time point with subsequent 
image analysis for quantification of Kaede expression. The expression of the 
three nuclear oestrogen receptor subtypes was also quantified at the final time 
point using qPCR. 
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Figure 3: Kaede conversion analysis. ERE-Kaede-Casper larvae were 
exposed to 100 ng EE2/L over the period 0-5 dpf and imaged at 5 dpf either 
without UV exposure (A), or after exposure to UV at 3dpf (B), 4dpf (C) and 5dpf 
(D) to convert Kaede fluorescence from green to red. Specific tissue response 
in the liver (li), heart (h), somite muscle (sm), otic vesicle (ov), cardiac muscle 
(cm), corpuscle of Stannius (cs), brain (b), neuromast (n), and gut (g). 
Figure 4: Quantification of target tissue responses in ERE-Kaede-Casper 
transgenic zebrafish exposed to oestrogens during early life, as 
determined by fluorescence induction. Green fluorescence intensity was 
quantified in liver, heart and somite muscle (S.M.) in controls (A) at 5 dpf. 
Control (non-exposed) larvae and larvae exposed initially to 10 ng EE2/L over 
the period of 48h (0-2 dpf) and green fluorescence intensity in liver (B), heart 
(C) and S.M. (D) were quantified after EE2 (10 ng/L), genistein (500 µg/L) and 
BPA (2000 µg/L) exposures for 3-5 dpf. Quantification of liver responses in the 
E-Chemical (E-E, E-G or E-B, respectively) treatment groups were normalized 
against their respective C-W controls (A), which were set to a value of 1. Data 
are reported as mean fold induction ± SEM (n=18). Statistical significance 
values were calculated using ANOVA and Games-Howell post-hoc test (* p 
<0.05 and ** p<0.01). 
Figure 5: Quantification of liver responses in ERE-Kaede-Casper 
transgenic zebrafish exposed to EE2 at different stages of development, 
as determined by fluorescence induction. Responses in the liver were 
quantified after EE2 exposure at 3-5 dpf, 5-7 dpf and 9-11 dpf. Quantification of 
liver responses in the E-Chemical treatment groups were normalised against 
their respective controls. Data are reported as mean fold induction ± SEM 
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(n=18). Statistical significance values were calculated using ANOVA and 
Games-Howell post-hoc test (* p <0.05 and ** p<0.01). 
Figure 6: Sensitivity to ethinylestradiol for repeated exposures. Control 
(non-exposed) larvae and larvae exposed initially to 10 ng EE2/L over the 
period of 48h (0-2 dpf) were imaged at 3 dpf (A) and the Kaede response was 
then converted fully from green to red fluorescence via UV exposure (B). Both 
groups of photoconverted larvae (control and EE2-exposed)  were then 
exposed to 10 ng EE2/L over the period 3-5 dpf (C),  5-7 dpf (D) or 9-11 dpf (E) 
and imaged on final day of exposure (n=18). Newly generated Kaede 
expression (green fluorescence) in liver, heart and somite muscle green was 
quantified by image analysis. All images were acquired by inverted compound 
microscope  using a 5× objective. A and B images were acquired using GFP, 
RFP and DIC filters. C, D, and E are presented with the GFP filter only. Specific 
tissue response in the liver (li), heart (h), somite muscle (sm), otic vesicle (ov), 
cardiac muscle (cm) and neuromast (n).  
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Figure 1: Generation of ERE-Kaede-Casper (F0) line.  
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Figure 2: Exposure Protocol Outline.  
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Figure 3: Kaede conversion analysis.  
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Figure 4: Quantification of target tissue responses in ERE-Kaede-
Casper transgenic zebrafish exposed to estrogen treatment, as 
determined by fluorescence induction.  
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Figure 5: Quantification of liver responses in ERE-Kaede-Casper 
transgenic zebrafish exposed to EE2 treatment at different stages of 
development, as determined by fluorescence induction.  
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Figure 6: Sensitivity to ethinyloestradiol is enhanced for repeated 
exposures.  
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5.8 Supporting Information 
Figure S1: Image analysis. Fluorescence induction for specific tissues was quantified 
via initially masking manually that tissue (see: yellow outline for liver (A), heart (B) and 
somite muscle (C) ) and quantified using ImageJ™ software.  
qPCR Protocol 
Effects of the initial exposure to EE2 were assessed on the expression of esr1, esr2a 
and esr2b for the secondary EE2 exposure via qPCR. Three pools of 15 embryos from 
the secondary exposure to EE2 exposure (at the 3-5 dpf stage) were collected from 
each treatment regime after imaging at 5 dpf, snap frozen in liquid nitrogen and stored 
at -80 °C until analysis. Total RNA was extracted using Tri reagent (Sigma-Aldrich, UK) 
according to the manufacturer’s protocol. The quantity and quality of the RNA was 
assessed spectrometrically using a NanoDrop 1000 Spectrophotometer.  Two µg total 
RNA were treated with RQ1 RNase-Free DNase (Promega, Southampton, UK) and 
subsequently reverse transcribed into cDNA using M-MLV Reverse Transcriptase 
(Promega) and random hexamers (Eurofins Genomics), following manufacturer’s 
instructions.  The expression of target mRNA was subsequently determined by qPCR 
using target-specific SybrGreen assays on a CFX96 Real-Time PCR Detection System 
(Bio-Rad Laboratories Ltd., Hercules, CA, US) followed by melt curve analysis to 
validate amplification of a single PCR product. Efficiency-corrected relative expression 
levels were determined by normalising to the reference gene ribosomal protein L8 
(rpl8), which was measured in each sample. Details on primer sequences, sizes of 
PCR products and PCR assay conditions are provided in Table S1. 
Figure S2: qPCR Alignment. Alignments of qPCR primers to their respective ESR 
sequences. 
Table S1: Target genes, primer sequences (1), amplicon size, annealing temperature 
and PCR efficiency for the RT-QPCR assays used in this study.  
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Figure S3: Comparison of ERE-GFP-Casper and ERE-Kaede-Casper models. 
Sensitivity and tissue response of the two models were compared via imaging after 0-5 
dpf exposures to embryo water (A), 5 ng/L EE2 (B) and 10 ng/L EE2 (C). All images 
were acquired by inverted compound microscope (Zeiss Axio Observer) using a 5x 
objective. Images are presented with the GFP filter only.  
Figure S4: Temporal analysis of fluorescence induction after a single 48h 
exposure exposure to EE2. ERE-Kaede-Casper embryos were exposed to 10 ng/L 
and 50ng/L EE2 for 48 hours then washed and incubated in embryo water up to 5 dpf. 
At intervening 24 hour time-points larvae were imaged to assess new Kaede 
expression, then immediately exposed to UV light to photoconvert Kaede fluorescence 
from green to red. All images were acquired by inverted compound microscope (Zeiss 
Axio Observer) using a 5x objective. Images are presented with the GFP filter only and 
therefore only 24 hours worth of Kaede expression is shown in each image. 
Figure S5: Kaede expression in control groups C-Water and E-Water. Control (non 
exposed) larvae and larvae that were exposed initially to 10 ng EE2/L over the period 
0-2 dpf were imaged at 3 dpf (A) and the Kaede response then converted fully from 
green to red fluorescence via UV exposure (B). Both groups of larvae (control and  
EE2-exposed) were then exposed to embryo water over the period 3-5 dpf (C),  5-7 dpf 
(D) or 9-11 dpf (E) and imaged on final day of exposure (n=18). Newly generated 
Kaede expression (green fluorescence) was not observed (there was some auto-
fluorescence). All images were acquired by inverted compound microscope (Zeiss Axio 
Observer) using a 5x objective. A and B images were acquired using GFP, RFP and 
DIC filters. C, D, and E are presented with the GFP filter only.  
Figure S6: qPCR quantification of esr1, esr2a and esr2b gene expression. Results 
from qPCR analysis of esr gene expression in the four treatment groups from the 3-5 
dpf second EE2 exposure treatment. Larvae were sampled at 5 dpf. Expression of the 
individual esr genes were compared for each treatment group. Data are reported as 
mean fold-induction ± SEM (n=3).  
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Figure S1: Image analysis. 
 
 
 Alignment of the zebrafish esr1 sequence (NM_174862.3 Danio rerio estrogen receptor 1 
(esr1), mRNA) with the qPCR primers (underlined) used. 
 
 
NM_152959.1            GATACATCAGTGAGAGAGAGAAAGCATCCAGCCTGTAATGGGACTCAAGT 50 
 
NM_152959.1            AAAACATCAGAGGAGTGAACATTTTGACCAGCGGAGAGGCTGTTGGTGCC 100 
 
NM_152959.1            AGGCAGCGACGCAGGACCAGCCCGATTCCTGAGAGAGAAGCCCTGGAGGA 150 
 
NM_152959.1            ACCTTCCTCGCCACCTGCCGCCCACAAACTCTCACCCATGTACCCTAAGG 200 
 
NM_152959.1            AGGAGCACAGCGCGGGGGGCATCAGCTCCTCTGTCAACTACCTAGATGGA 250 
 
NM_152959.1            GCTTATGAGTACCCGAACCCCACACAGACCTTCGGCACCTCGTCGCCTGC 300 
 
NM_152959.1            AGAGCCTGCTTCAGTGGGATACTACCCGGCTCCCCCAGACCCCCACGAGG 350 
 
NM_152959.1            AACATCTACAGACGCTTGGCGGTGGATCAAGCAGCCCCCTCATGTTCGCA 400 
 
NM_152959.1            CCCTCCAGCCCACAGCTGTCCCCGTATCTGAGCCATCACGGAGGACACCA 450 
 
NM_152959.1            CACCACCCCTCATCAGGTGTCCTACTACCTGGATTCCTCGTCCAGCACCG 500 
 
NM_152959.1            TCTACAGGTCCAGTGTGGTGTCCTCTCAGCAGGCAGCCGTGGGCCTGTGT 550 
 
NM_152959.1            GAGGAGCTGTGCAGTGCCACTGACAGGCAGGAGTTGTACACTGGATCCAG 600 
 
NM_152959.1            AGCGGCTGGAGGCTTTGATTCAGGGAAAGAGACTCGCTTCTGTGCGGTGT 650 
 
NM_152959.1            GCAGTGACTACGCCTCTGGATATCATTACGGAGTCTGGTCGTGTGAGGGA 700 
 
NM_152959.1            TGCAAAGCTTTCTTCAAGAGAAGCATTCAAGGTCACAATGACTATGTTTG 750 
 
NM_152959.1            TCCAGCGACCAACCAGTGCACTATTGACAGAAACCGTCGAAAGAGCTGCC 800 
 
NM_152959.1            AAGCATGCAGACTGCGCAAGTGTTATGAAGTAGGCATGATGAAAGGAGGT 850 
 
NM_152959.1            ATTCGTAAAGATCGCGGAGGGCGTTCTGTCAGGCGTGAGAGAAGGAGAAG 900 
 
NM_152959.1            CAGTAATGAAGATCGAGACAAGAGCAGCAGTGATCAGTGCAGCCGTGCTG 950 
 
NM_152959.1            GCGTGAGGACGACTGGCCCACAGGACAAGAGGAAGAAGCGCAGTGGTGGG 1000 
 
NM_152959.1            GTGGTCAGCACTTTATGCATGTCGCCTGACCAGGTGCTGCTGCTGCTGCT 1050 
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NM_152959.1            GGGGGCTGAGCCACCCGCTGTCTGCTCACGACAGAAACACAGCCGGCCCT 1100 
 
NM_152959.1            ACACAGAGATCACCATGATGTCCCTGCTCACCAACATGGCTGACAAAGAA 1150 
 
NM_152959.1            CTCGTCCACATGATCGCCTGGGCCAAGAAAGTGCCAGGATTCCAGGATCT 1200 
 
NM_152959.1            GTCTCTGCATGACCAGGTTCAGTTGTTGGAGAGCTCTTGGCTGGAAGTGT 1250 
 
NM_152959.1            TGATGATTGGCCTCATATGGAGGTCCATTCATTCCCCTGGAAAACTCATC 1300 
 
NM_152959.1            TTTGCTCAGGATCTCATCCTGGATAGGAGTGAAGGAGAATGTGTTGAGGG 1350 
 
NM_152959.1            CATGGCTGAGATTTTCGACATGCTCTTAGCAACTGTGGCTCGATTTCGGA 1400 
 
NM_152959.1            GTCTCAAGCTCAAGCTGGAGGAATTTGTGTGTCTCAAAGCCATCATACTC 1450 
 
NM_152959.1            ATCAATTCTGGTGCATTTTCATTCTGCTCCAGTCCAGTGGAGCCGCTGAT 1500 
 
NM_152959.1            GGACAACTTCATGGTGCAGTGCATGCTGGACAACATCACTGATGCCCTCA 1550 
 
NM_152959.1            TTTACTGCATCAGTAAATCAGGAGCGTCGCTGCAGCTGCAGTCCCGTCGC 1600 
 
NM_152959.1            CAGGCCCAGCTCCTGCTGCTGCTCTCACACATCAGACACATGAGCAACAA 1650 
 
qPCR_esr1 _sense                  ..........................CGAGTGCCGCTGT 
NM_152959.1            AGGAATGGAGCACTTATACCGAATGAAATGTAAGAATCGAGTGCCGCTGT 1700 
 
qPCR_esr1_sense        ATGAC 
NM_152959.1            ATGACCTGTTGCTGGAGATGCTGGACGCTCAGCGGTTCCAGTCTTCAGGG 1750 
 
NM_152959.1            AAGGTGCAGCGAGTGTGGTCTCAGAGCGAGAAAAACCCTCCATCTACACC 1800 
 
NM_152959.1            CACAACCAGCAGCAGCAGCAGCAACAACAGTCCAAGAGGAGGAGCTGCAG 1850 
qPCR_esr1_antisense    CACAACCAGCAGCAGCA 
 
NM_152959.1            CCATTCAGTCCAACGGCGCCTGTCACAGCCATAGCCCTGACCCCTGACCT 1900 
 
NM_152959.1            GTGCACTGCCACCATATACACATTATACACAATTTGAAGAGCAGAAATGA 1950 
 
NM_152959.1            GGACTAGGACTTCAGTCTCTTCTTGTGCCTTACGAGAGTCTACTATTGAA 2000 
 
NM_152959.1            ACCGAGACATTCGAAAGAGAATTTGTTTATAGAAAAAAAAGTCTGTAAAT 2050 
 
NM_152959.1            AAGAATAAGCCTCCCAAACACTATATATTGAGGATCTTTTTACGGTTGAT 2100 
 
NM_152959.1            TTCGCTCGGTTTTTGTGGAAGCTGATTACAGGAATTTGTTTTTCCCATAC 2150 
 
NM_152959.1            ACTTGAGAGAAACAGAGAGAGATGCTTAACTCATCTTTTATTCTTTTACA 2200 
 
NM_152959.1            ATTTGTGACCGTTTGACATCACAAACTCACTTAAAGCTCTCATACTGATC 2250 
 
NM_152959.1            ATATGGCAGTCAAAAAATATTGATTTAATTTTCAATAATTAATATATTAT 2300 
 
NM_152959.1            AATAGTATATTAGTGTTAAAATAGTATTTTGTATTTTTAGAGTATTTTAT 2350 
 
NM_152959.1            TGTCATAAATAATGTTAATGCAATAGTAATTATCCATTTATGACCAGATA 2400 
 
NM_152959.1            TTACAAAGTTTTAAGAAACAGATCTGAAAATGAAATTTCCAACTTTTAAA 2450 
 
NM_152959.1            TGTTGAATGCAGAAATGAAAAAGTTCCACATCCACACAGTAGGCTACCAA 2500 
 
NM_152959.1            AAAACAAGTAAATTAAGTTTAAACGCTGCTCTGATTTCCTCATCTACATT 2550 
 
NM_152959.1            CTTTATAGTATAGCTTATGTTTGCATTGCAAAAAAAGAAAAAAAAGAATG 2600 
 
NM_152959.1            AAAGAAGGGATAATTGTTTTTTTAACTACTCAAGTTCTTCTAGTTGACGC 2650 
 
NM_152959.1            ATGTGCCAACTTTTTCTTGCCAATCTTAAGCCAATTGTAATGTTTCGTTT 2700 
 
NM_152959.1            TTAGTTCAATTTGGAATTTCCACAACTTTGGCAGAGATCGGGGGATCAGA 2750 
 
NM_152959.1            GTGAGCGCTCCTACTTGGCCCCACCCTGATCAAGAAAGGCATAAATTAAA 2800 
 
NM_152959.1            GCGCTCTGACTGAATTTTATGATTGGTCCAGTATTATTACTGACATGCTT 2850 
 
NM_152959.1            AAATATTTTTTGTTTGTTTTTTGCTTTTACTTATTTTTATTGAATTCTTA 2900 
 
NM_152959.1            ATTTGTTAAAATATTAGCCTGTTTTGCTTTTCTTTCTTTTTTTTTTTTAA 2950 
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NM_152959.1            AGATCCTGTTTACACACAATTCCCTAAACAGATTACGGACGTTGCTATTA 3000 
 
NM_152959.1            AATAACAGTTTTTCATGTTAATAAGCTTTTTATCTAAAATAACATGAGCT 3050 
 
NM_152959.1            CTGCGATATAAAGTGTGAACAGACAGAAAACAGCCCAGGAGAAAAGTTAC 3100 
 
NM_152959.1            TCTTAGAACAAACGGGGAAAAACCTGATTACTTGTAAAAGGGGCTTTATG 3150 
 
NM_152959.1            TTAATGAAGTGAGTCTTTTCATTGCAATCAGGGATATATTATGGATCTAA 3200 
 
NM_152959.1            ATCCCTCTTCTATTTTAAACGTTGATATGTAATTTAATGGGGAAAAACTG 3250 
 
NM_152959.1            CTCAGTGATCAGTGGTAACATTATAGCTGCATCTTATTTGNGCAAAAATG 3300 
 
NM_152959.1            TTTACTTGTTGGTTAATATGAAATGATTTTTTTAATTGCTGTTCTTGTTA 3350 
 
NM_152959.1            CAGTGCTGTCTGTCATTGTTGATTTTATTGCTATCTTAACAGATTACTGC 3400 
 
NM_152959.1            TTGAAAAGAAAGCCCAATTTCAACATTGTGAAGGTCGAA 3439 
 
 
Alignment of the zebrafish esr2a sequence (NM_180966  Danio rerio estrogen receptor 2a 
(esr2a), mRNA) with the qPCR primers (underlined) used. 
 
 
NM_180966.2               AGAGACAGTGTGGTATACCGCCTTGCTCACTGTCTTGCTACAACACTGAG 50 
 
NM_180966.2               GAGTATCGAGGACTGAGAAGTTCACCATGACACACATCAACAGTCCCCCG 100 
 
NM_180966.2               TTACTGATGCGACAGCTCTGAACTCATCCGCCTTCACCATGTCCGAGTAT 150 
 
NM_180966.2               CCCGAAGGAGACAGTCCTCTTCTTCAGCTGCAGGAAGTGGACTCAGGCCG 200 
 
NM_180966.2               TGTGGGAGGTCACATCCTCTCCCCCATCTTCAACTCATCCTCTCCATCTC 250 
 
NM_180966.2               TGCCAGTGGAGAATCACCCCATCTGCATCCCATCGCCCTACACAGACCTT 300 
 
NM_180966.2               GGCCACGACTTCAGCACTCTGCCCTTTTACAGTCCCGCTCTGCTGGGGTA 350 
 
NM_180966.2               CAGCACATCGCCTTTATCGGACTGCTCGTCTGTGCGCCAGTCGCTAAGCC 400 
 
NM_180966.2               CGACTTTATTTTGGCCACCTCACAGCCATGTTTCCTCACTCACATTGCAA 450 
 
NM_180966.2               CAACAGAGTCGACTTCAACAGAACCATGCTACTAGTGGGACTTGGACAGA 500 
 
NM_180966.2               ACATACACCACATGATCATGTTGAAGAGGAAAACAGCAAACCACTGGTGA 550 
 
NM_180966.2               AGCGGGTAGCAGATACAGAGGAGACGTCTGTGTCTCTGAGAGGTAAAGCT 600 
 
NM_180966.2               GACATGCACTACTGTGCCGTCTGCAGTGATTACGCCTCTGGATATCATTA 650 
 
NM_180966.2               TGGAGTGTGGTCGTGTGAAGGCTGCAAAGCCTTTTTCAAGAGGAGTATAC 700 
 
NM_180966.2               AAGGACACAATGACTACATCTGTCCTGCCACAAACCAATGCACTATCGAC 750 
 
NM_180966.2               AAGAACCGCCGCAAAAGCTGCCAGGCCTGCCGACTCCGAAAGTGCTATGA 800 
 
NM_180966.2               AGTTGGAATGATGAAATGTGGGTTGCGGCGAGATCGTAGCAGCTACCAAC 850 
 
NM_180966.2               AAAGAGGAGCACAGCAGAAACGACTGGTCCGATTCTCTGGCAGAATGAGA 900 
 
NM_180966.2               ATGACTGGTCCGAGGTCTCAAGAGATAAAGAGTATCCCGCGTCCTCTCAG 950 
 
NM_180966.2               TGGGAATGAGGTGGTGCGCATATCACTGAGCCCAGAGGAGCTAATCTCCC 1000 
 
NM_180966.2               GGATCATGGAAGCAGAGCCGCCGGAGATTTATCTCATGAAAGACATGAAG 1050 
 
NM_180966.2               AAGCCCTTCACTGAGGCAAACGTCATGATGTCACTGACCAACCTGGCTGA 1100 
 
NM_180966.2               CAAAGAGCTTGTGCACATGATCAGCTGGGCCAAGAAGATCCCAGGTTTTG 1150 
 
NM_180966.2               TGGAGCTCAGTCTTTTCGATCAGGTGCATTTGTTGGAGTGCTGCTGGTTA 1200 
 
NM_180966.2               GAGGTGCTTATGCTGGGATTGATGTGGCGCTCCGTTAATCACCCTGGAAA 1250 
 
NM_180966.2               GCTCATTTTCTCTCCAGACCTCTGTCTCAGCAGGGATGAAAGCAGCTGTG 1300 
 
NM_180966.2               TGCAGGGGTTGGTGGAGATCTTTGATATGCTGCTGGCAGCCACGTCCAGA 1350 
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NM_180966.2               TTCAGAGAGTTGAAGTTACAGAGAGAAGAGTACGTGTGTCTCAAAGCCAT 1400 
 
NM_180966.2               GATCCTCCTGAACTCCAACATGTGTCTGGGCTCGTCTGAGGGAGGAGAAG 1450 
 
NM_180966.2               ATCTGCAGAGCCGCTCCAAGCTGCTGTGTCTGCTGGACTCGGTGACTGAC 1500 
 
NM_180966.2               GCTCTGGTTTGGGCCATCTCGAAGACCGGCCTTAGCTTCCAGCAGCGCTC 1550 
 
NM_180966.2               CACCAGACTGGCCCATCTGCTCATGCTGCTCTCACACATACGCCACGTCA 1600 
 
NM_180966.2               GTAACAAAGGCATGGACCACCTGCACTGCATGAAGATGAAGAAGATGGTT 1650 
 
NM_180966.2               CCTCTGTATGACCTGCTCCTGGAGATGCTGGACGCTCACATCATGCACAG 1700 
 
NM_180966.2               CTCCCGTTTGTCTCACTCCGGCCCTCGAGCCCCTGCTGCTCACAAAGACA 1750 
 
NM_180966.2               ACAAGAGTGTCCAGGAGGCCTTTCCCTGCAGCTCACAGCACGGACCCTAA 1800 
 
NM_180966.2               ACACGGCCCTCACAGTCACACAAACACAGTACTTAAGGATGATCTGTAGT 1850 
 
NM_180966.2               TTCGGGAGGATGGACAACCAAAACACCCACATAAAAGCAAGGAGTAGGAT 1900 
 
NM_180966.2               TTCACAAGACGAAAAGCATCATGGATATCTTGAATGTTTTTCCTGTTTTT 1950 
 
NM_180966.2               AAATGTTGGCAATTGCTGTGAAATCTCTTTATTGTTTCCACACAACTCTG 2000 
 
NM_180966.2               ACAACTTTTTAATGATTTTATGTAGCACAACTGCAAAAGAAAAGAAAAAA 2050 
 
NM_180966.2               AGAAATGAATACCCACATTGGATTTCAAGAGATTTTTGGAAACTTCATTA 2100 
 
NM_180966.2               CACGGTGAACTATAATTTCTGGCATTATATGCATAATGGAGGCCATCTAG 2150 
 
qPCR_esr2a_sense           AGGAGAAAACCAAGTAAACCAATC   
NM_180966.2               TAGGAGAAAACCAAGTAAACCAATCATGCCCACCTTCTTTTTTAAAAGAA 2200 
                           ************************ 
 
NM_180966.2               CCAGTTCAAACTCAATTGAGAGAGTGCATTGGTGCCATGACCCGGATGAC 2250 
 
NM_180966.2               AGTAGGTTTTATTAAATCTGTCATCTCTGGCCTTGAGAGACTGTGGCCTT 2300 
 
NM_180966.2               TAGCATTAGCCTTGTTAGCAGCCTGCCTCTCAAGTACTCACCAGTTCAGA 2350 
qPCR_esr2a_antisense      ...CATTAGCCTTGTTAGCAGCCT 
                             ********************* 
 
NM_180966.2               TCCCGCTGTAAGTAGGACGGGGTTATAATGTCCATGAAAGTTTTGGCCTC 2400 
 
NM_180966.2               ATTTTCATGACATCCGTGACAACATGGACAAGAGCAGTGTGCGATCTCTA 2450 
 
NM_180966.2               CTTTTTCTCTTTCTTACATAAGCTTGCTGCTTTCACATTTTGTAAAATGA 2500 
 
NM_180966.2               AACAAAATATCGTAAACTCATTACTTTCGACAATACTGGCAGTAAAATCA 2550 
 
NM_180966.2               AATTTGATTTAGTCTGTTGTAAATGGACAGAATCATTCCTGATAGATGAG 2600 
 
NM_180966.2               ACAAAGCATTGTATGCTGAGTGAGCAAACCATATTCTGGACTAAGGGCAA 2650 
 
NM_180966.2               GCAGTATTTTAGACTTACAAAACAAAAAACCTGAATGATTGAATGAATGT 2700 
 
NM_180966.2               CAGCTGGATGTTTCATTTACATCTGTTGTTATTGAGAAATGGAACCATTG 2750 
 
NM_180966.2               CAAAATGGCCTCGTGCACATTTTAGTGATTAATTCTTTTTTGCAAACAAA 2800 
 
NM_180966.2               CATTTATGTACAGGAGTGACAGCCGCATTTTACAGCCATCGCCGTGACCA 2850 
 
NM_180966.2               TATCTTGAACATTGGAGGGTTTGTGTTAGAAATTATAAAGTAGGACATTT 2900 
 
NM_180966.2               CAGGCCTAATTCTAGTGGAAAGGTATTTGCAAAAAAAAAATTACAAAATC 2950 
 
NM_180966.2               AATTTGTAAACCTAATATGTTTCACATTCAGTTAGAAAAGACTATAATTA 3000 
 
NM_180966.2               GGTAACATCTCAGTTCACAATGATGAAATCTGAGTTAAAAAGCATCATTA 3050 
 
NM_180966.2               CTGCTGGCTATTGAATATTTCTACCATAAAACCATTTGTATAACAAAAAA 3100 
 
NM_180966.2               AAAAAAAAAAA  3111 
 
Alignment of zebrafish esr2b sequences (NM_174862.3 Danio rerio estrogen receptor 2b 
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(esr2b), mRNA and AJ414566.1 Danio rerio mRNA for estrogen receptor beta1 protein) and 
alignment of qPCR primers (underlined) used.  Asterisks indicate nucleotides in agreement 
between both published sequences.  NM_174862.3 is the provisional NCBI reference sequence 
(accessed 31.01.2017) whereas AJ414566 is the original database used to design the primers 
used in the study. 
 
 
NM_174862.3      --------------------ACAGTTGGGCCTGAGATGCAGTAGTGTGTCAGGCCAGGGT 40 
AJ414566.1       CACATCACCTGCTGCCTGCTAACGTTGGGCCTGAGATGCAGTAGTGTGTCAGGCCAGGGT 60 
                                     *  *********************************** 
 
NM_174862.3      CTCTCTTGTGTTCTCCAGCATGAGCTCCTCCCCTGGACCTGCCCCTGTCCTGGACTCCAG 100 
AJ414566.1       CTCTCTTGTGTTCTCCAGCATGAGCTCCTCCCCTGGACCTGCCCCTGTCCTGGACTCCAG 120 
                 ************************************************************ 
 
NM_174862.3      CAAGGCCGATCGAGGGGCCTCGCCTGCCCTCTTACCCCGGCTCTACGCCTCCCCGCTCGG 160 
AJ414566.1       CAAGGCCGATCGAGGGGCCTCGCCTGCCCTCTTACCCCGGCTCTACGCCTCCCCGCTCGG 180 
                 ************************************************************ 
 
NM_174862.3      CATGGACAACCAGACCGTCTGCATTCCTTCCCCATATGTGGAGGCCTGTCAGGATTACTC 220 
AJ414566.1       CATGGACAACCAGACCGTCTGCATTCCTTCCCCATATGTGGAGGCCTGTCAGGATTACTC 240 
                 ************************************************************ 
 
NM_174862.3      TCCACCGCATGGGGGAGAGTTCAACCACGGAGCCCTAACGCTCTACAGCCCCGTCTCCTC 280 
AJ414566.1       TCCACCGCATGGGGGAGAGTTCAACCACGGAGCCCTAACGCTCTACAGCCCCGTCTCCTC 300 
                 ************************************************************ 
 
NM_174862.3      TGCAGTGCTCGGCTTCCATCGTCCTCCTGTGTCCGAAAGCCTCGTCCCGCTTAGTCCCAC 340 
AJ414566.1       TGCAGTGCTCGGCTTCCATCGTCCTCCTGTGTCCGAAAGCCTCGTCCCGCTTAGTCCCAC 360 
                 ************************************************************ 
 
NM_174862.3      AATCCTGTGGCCGCCTCACTCTCTGCACTACCCGCCTCCGCTGGCCTACAGCGAAACACG 400 
AJ414566.1       AATCCTGTGGCCGCCTCACTCTCTGCACTGCCCGCCTCCGCTGGCCTACAGCGAAACACG 420 
                 ***************************** ****************************** 
 
NM_174862.3      TTCACACAGCGCCTGGGAGGAGGCCAAGACACACACGCTCAGCCAGAGCAGTTCTGTCCT 460 
AJ414566.1       TTCACACAGCGCCTGGGAGGAGGCCAAGACACACACGCTCAGCCAGAGCAGTTCTGTCCT 480 
                 ************************************************************ 
 
NM_174862.3      TAGTCATACAAAGCTGTTAGGACAGCAGCTAGAAGGTGACAATGGCTTGAATCCCTCCGC 520 
AJ414566.1       TAGTCATACAAAGCTGTTAGGACAGCAGCTAGAAGGTGACAATGGCTTGAATCCCTCCGC 540 
                 ************************************************************ 
 
NM_174862.3      GAGCATTGTGGGTAAAGGAGACACTCACTTCTGCGCCGTGTGCCATGACTACGCTTCTGG 580 
AJ414566.1       GAGCATTGTGGGTAAAGGAGACACTCACTTCTGCGCCGTGTGCCATGACTACGCTTCTGG 600 
                 ************************************************************ 
 
NM_174862.3      ATATCACTATGGTGTCTGGTCATGTGAAGGGTGCAAGGCTTTCTTCAAGCGTAGCATTCA 640 
AJ414566.1       ATATCACTATGGTGTCTGGTCATGTGAAGGGTGCAAGGCTTTCTTCAAGCGCAGCATTCA 660 
                 *************************************************** ******** 
 
NM_174862.3      AGGTCACAATGACTATATTTGTCCAGCCACCAACCAGTGCACTATTGACAAGAGCAGACG 700 
AJ414566.1       AGGTCACAATGACTATATTTGTCCAGCCACCAACCAGTGCACTATTGACAAGAGCAGACG 720 
                 ************************************************************ 
 
NM_174862.3      CAAGAGCTGTCAGGCCTGTCGACTCCGCAAGTGCTATGAAGTGGGCATGATGAAGTGTGG 760 
AJ414566.1       CAAGAGCTGTCAGGCCTGTCGACTCCGCAAGTGCTATGAAGTGGGCATGATGAAGTGTGG 780 
                 ************************************************************ 
 
NM_174862.3      TGTGAGGAGGGAGCGCTGCAGTTATCGAGGTGCTCGACATCGTCGTAACCCCCAAATCAG 820 
AJ414566.1       TGTGAGGAGGGAGCGCTGCAGTTATCGAGGTGCTCGACATCGTCGTAACCCCCAAATCAG 840 
                 ************************************************************ 
 
NM_174862.3      AGACAGCTCTGGCGGGGTGGTAGGGCTCAGAGGTCAATCCCAGCAGCATCTAGAGTTCCC 880 
AJ414566.1       AGACAGCTCTGGCGGGGTTGTAGGACTCAGAGGTCAATCCCAGCAGCATCTAGAGTTCCC 900 
                 ****************** ***** *********************************** 
 
NM_174862.3      CCTCAGTCCCTCTCAGCACCTCTTTCCTTCAGGGGGCAGAGCCGAGGGACGGGGCCTGAA 940 
AJ414566.1       CCTCAGTCCCTCTCAGCACCTCTTTCCTTCAGGGGGCAGAGCCGAGGGACGGGCCCTGAA 960 
                 ***************************************************** ****** 
 
NM_174862.3          CTATTCCCCTGAACAATTGGTTAGCTGTATTCTAGAGGCGGAGCCACCTCAAATTTACCT 1000 
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AJ414566.1           CTATTCCCCTGAACAATTGGTTAGCTGTATTCTAGAGGCGGAGCCACCTCAAATTTACCT 1020 
                     ************************************************************ 
 
NM_174862.3          GAGAGAGCCGGTGAAAAAGCCATACACTGAGGCTAGCATGATGATGTCACTAACAAGCCT 1060 
AJ414566.1           GAGAGAGCCGGTGAAAAAGCCGTACACTGAGGCTAGCATGATGATGTCACTAACAAGCCT 1080 
                     ********************* ************************************** 
 
NM_174862.3          CGCCGACAAGGAGCTAGTGCTCATGATTAGCTGGGCGAAGAAGATACCAGGTTTTGTAGA 1120 
AJ414566.1           CGCCGACAAGGAGCTGGTGCTCATGATTAGCTGGGCGAAGAAGATACCAGGTTTTGTAGA 1140 
                     *************** ******************************************** 
 
NM_174862.3          GTTGACTTTGTCAGATCAGGTGCATTTGCTGGAATGCTGCTGGCTGGATATTCTGATGTT 1180 
AJ414566.1           GTTGACTTTGTCAGATCAGGTGCATTTGCTGGAATGCTGCTGGCTGGATATTCTGATGTT 1200 
                     ************************************************************ 
 
NM_174862.3          AGGATTGATGTGGAGATCTGTGGATCATCCTGGGAAACTCATCTTCACCCCTGACCTCAA 1240 
AJ414566.1           AGGATTGATGTGGAGATCTGTGGATCATCCTGGGAAACTCATCTTCACCCCTGACCTCAA 1260 
                     ************************************************************ 
 
NM_174862.3          GCTCAACAGGGAGGAAGGGAATTGTGTTGAAGGCATCATGGAGATTTTCGACATGCTGCT 1300 
AJ414566.1           GCTCAACAGGGAGGAAGGGAATTGTGTTGAAGGCATCATGGAGATTTTTGACATGCTGCT 1320 
                     ************************************************ *********** 
 
NM_174862.3          GGCCACCACCTCTCGATTCAGAGAGCTGAAGCTGCAGAGAGAGGAATACGTCTGTCTCAA 1360 
AJ414566.1           GGCCACCACCTCTCGATTCAGAGAGCTGAAGCTGCAGAGAGAGGAATACGTCTGTCTCAA 1380 
                     ************************************************************ 
 
NM_174862.3          AGCCATGATCCTGCTCAACTCTAATAACTGTTCGAGTTTGCCACAGACTCCTGAGGATGT 1420 
AJ414566.1           AGCCATGATCCTGCTCAACTCTAATAACTGTTCGAGTTTGCCACAGACTCCTGAGGATGT 1440 
                     ************************************************************ 
 
NM_174862.3          GGAGAGTCGCGGGAAGGTGCTGAATCTGCTGGACTCAGTGACCGATGCTCTGGTGTGGAT 1480 
AJ414566.1           GGAGAGTCGCGGGAAGGTGCTGAATCTGCTGGACTCAGTGACCGATGCTCTGGTGTGGAT 1500 
                     ************************************************************ 
 
NM_174862.3          CATCTCCAGAACGGGTCTGTCCTCACAACAACAGTCCATCCGGCTCGCTCATCTGCTAAT 1540 
AJ414566.1           CATCTCCAGAACGGGTCTGTCCTCACAACAACAGTCCATCCGGCTAGCTCATCTGCTAAT 1560 
                     ********************************************* ************** 
 
NM_174862.3          GCTGCTCTCACACATCCGACACCTCAGCAACAAAGGCATCGAGCATCTGTCAAACATGAA 1600 
AJ414566.1           GCTGCTCTCACACATCCGACACCTCAGCAACAAGGGCATCGAGCATCTATCTAACATGAA 1620 
                     ********************************* ************** ** ******** 
 
NM_174862.3          GAGGAAAAACGTGGTGCTGCTGTACGATCTTCTGCTAGAGATGCTGGACGCAAACACGTC 1660 
AJ414566.1           GAGGAAAAACGTGGTGCTACTGTACGATCTTCTGCTAGAGATGCTGGACGCAAACGCGTC 1680 
                     ****************** ************************************ **** 
 
NM_174862.3          TCAGAGCAGCCGGATGCTGGAAGACAGACAACAGAGCCCAGAAAACCTTCACACATCCAG 1720 
AJ414566.1           TCAGAGCAGCCGGATGCTGGAAGACAGACAACAGAGCCCAGAAAACCTTCACACATCCAG 1740 
                     ************************************************************ 
 
qPCR_esr2b_sense                                                           TGAGGA 
NM_174862.3          ACCGCAGCCTGACCTGAAAGACAGCGACCAGGAGACCCCACACAGTCCACGGGCTGAGGA 1780 
AJ414566.1           ACCGCAGCCTGACCTGAAAGACAGCGACCAGGAGACCCCACACAGTCCACGGGCTGAGGA 1800 
                     ************************************************************ 
 
qPCR_esr2b_sense     GATGGTGAACAAGAC 
NM_174862.3          GACGGTGAACAAGACATTGCATTCTAGTCTGCTTCGAGAGGACATGGACACAAACTGACA 1840 
AJ414566.1           GATGGTGAACAAGACATTGCATTCTAGTCTGCTTCGAGAGGACATGGACACAAACTGACA 1860 
                     ** ********************************************************* 
 
NM_174862.3          GTCACAGACTTTTGTGGGGGGGGGGGGGGACTCTGGATCTGGCATTTCATTCATCCATCC 1900 
AJ414566.1           GTCACAGACTTTTGTGGGGGGGG-GGGGGACTCTGGATCTGGCATTTCATTCATCCATCC 1919 
                     *********************** ************************************ 
qPCR_esr2b_antisense                                           CATTTCATTCATCCATCC 
 
NM_174862.3          ATCAGTTTTCCAGTCTGCATTTTTTGCATGTGGGATTAAGACATGAAAAAAGGAACATCA 1960 
AJ414566.1           ATCAGT------------------------------------------------------ 1925 
                     ******                                                       
qPCR_esr2b_antisense ATCAGT 
 
NM_174862.3      GGTGATCGACGACAACCTGAACCAAACAGGGCTTTCAAACAGCACTCAGTCCTGCTTCAA 2020 
AJ414566.1       ------------------------------------------------------------ 1925 
                                                                              
 
NM_174862.3      CACAATGCTACTACAACACTACATTGTTTTCCTTTAACAGAGGAATCATTCTCATCTCAT 2080 
AJ414566.1       ------------------------------------------------------------ 1925 
                                                                              
 
NM_174862.3      TTGTTCAAGAAAATCTTCAATGAAACATTTTATGGCTCTATCTGGTTCTGTATGTGGTAA 2140 
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AJ414566.1       ------------------------------------------------------------ 1925 
                                                                              
 
NM_174862.3      AGGTGAAGTGTGTCATTTCTGTGCCGCTAGAAGAATGAAAACAACAACAACAACAACAAC 2200 
AJ414566.1       ------------------------------------------------------------ 1925 
                                                                              
 
NM_174862.3      AACAACAAGATTCAAACACTCCCAAAGTCTGCCATTGCAACCAGGAAGCCCAGCCCCAAA 2260 
AJ414566.1       ------------------------------------------------------------ 1925 
                                                                              
 
NM_174862.3      AATCACACCATTGGCTGAGACAGTTACATAGCGTTTATTTTGTTTTAATCAAACTGTAAA 2320 
AJ414566.1       ------------------------------------------------------------ 1925 
                                                                              
 
NM_174862.3      TGTTTCTTTTGCCATCCAAGATTTCAGACTGAACTATTGATTAACGAAAACGGTGCGCAC 2380 
AJ414566.1       ------------------------------------------------------------ 1925 
                                                                              
 
NM_174862.3      ACTTCTAATAGTTTATGCATTTTGTACTTTGTGTTTCTGTAAGTCGTTGGAATGTCATTT 2440 
AJ414566.1       ------------------------------------------------------------ 1925 
                                                                              
 
NM_174862.3      GCTGTCCTGTAGTGCTTTTCGTGGTTTATAAAGTACTTGTCATTGACAGTAAATATGTCT 2500 
AJ414566.1       ------------------------------------------------------------ 1925 
                                                                              
 
NM_174862.3      TTGTGAGTTGATGCCTCTTTTGGCTCCAAAACCCAAATGATACACACAAAAGTGTGTAGC 2560 
AJ414566.1       ------------------------------------------------------------ 1925 
                                                                              
 
NM_174862.3      TCTCACTCTCAGAAACACACTTGTTCCTAAAGGGTCTATAATGGTAGCCTAAAAATGCTA 2620 
AJ414566.1       ------------------------------------------------------------ 1925 
                                                                              
 
NM_174862.3      ATTAGAATTTTGAAAGCTATGTACTAATATTTACCTTGTGGTATTAATATGGACTCTTTA 2680 
AJ414566.1       ------------------------------------------------------------ 1925 
                                                                              
 
NM_174862.3      AATACAAATGTGTATGTTTTGAAAAAAAAAAAAAAAAA 2718 
AJ414566.1       -------------------------------------- 1925 
                                                        
 
Figure S2: qPCR Alignment. 
 
Table S1 
 
Table S2: Measured chemical concentrations in the embryo incubation water.  
 
Gene name  gene 
symbol 
sense primer  antisense primer  Product 
size (bp) 
Ta 
(°C) 
E(2) 
estrogen receptor 1  esr1  CGAGTGCCGCTGTATGAC  TGCTGCTGCTGGTTGTG  130  59.5  1.97 
estrogen receptor 2a  esr2a  AGGAGAAAACCAAGTAAACCAATC  AGGCTGCTAACAAGGCTAATG  173  59.0  1.91 
estrogen receptor 2b  esr2b  TGAGGAGATGGTGAACAAGAC  ACTGATGGATGGATGAATGAAATG    131  57.8  2.03 
ribosomal protein L8   rpl8  CCGAGACCAAGAAATCCAGAG  CCAGCAACAACACCAACAAC  91  59.5  2.09 
(1) … primers sequences from Filby et al. (2010)     (2) … E = PCR efficiency 
132 
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Figure S3: Comparison of ERE-GFP-Casper and ERE-Kaede-Casper models. 
Figure S4: Temporal analysis of fluorescence induction after a single 48h 
exposure to EE2.  
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Figure S5: Kaede expression in control groups C-Water and E-Water.  
 
Figure S6: qPCR quantification of esr1, esr2a and esr2b gene expression.    
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Chapter 6 
Thesis Discussion 
The work presented in this thesis demonstrates that transgenic zebrafish 
models can be developed with good utility for effective analysis of responses to 
oestrogens for different early-life stages and for application to larval screening 
(semi-automated). National and international screening programs currently rely 
heavily on in vitro assays, meaning risk assessment of oestrogenic chemicals is 
often based on quantification of binding affinity for specific ER subtypes using a 
range of different cell lines and this does not allow for the more complex 
interactions that occur between EDCs and organisms in the environment. This 
work further highlights that the development and application of transgenic fish 
offer huge potential for improved understanding on the effects and mechanism 
of effects for EDCs and therefore allow for more integrative health effects 
assessments. The use of informative transgenic fish models can also result in 
better use and potential reduction of intact animals used in animal testing in line 
with the principles of the 3Rs (Replacement, Reduction and Refinement).195  
The ERE-GFP-Casper and ERE-Kaede-Casper Models 
Over the last ten years, multiple transgenic zebrafish models have been 
generated in an attempt to better understand the potency and effects of 
oestrogenic chemicals in living organisms. However, these models have 
consistently been limited in their sensitivity or tissue specificity of response, as 
highlighted in the literature review included in the appendix of this thesis. The 
ERE-GFP model, previously developed at the University of Exeter using a 
modified reporter system, displayed considerably enhanced sensitivity in a 
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variety of tissues compared to previously established models, allowing the 
detection of responses to chemical exposures at environmentally relevant 
concentrations. A limitation however of this model and others, was the 
development of skin pigmentation in the animal, causing fluorescence signal-
blocking and restricting accurate response assessment to the early life stage 
using non-dorsal orientations for microscopy and imaging.  
The work presented has demonstrated the development and application of 
transgenic systems using skin pigment-free lines. The translucent phenotype 
present in both transgenic zebrafish lines created was crucial for improved 
signal quantification in the screening system and high-content analysis 
presented in Chapter 4. The transgenic casper models have also been applied   
to a range of other studies in the Exeter laboratory including charting the 
development and role of oestrogens in the brain in zebrafish (Takesono et al., in 
prep), assessing effects of chronic exposure to Bisphenol A on heart 
development and function (Brown et al., in prep) and an analysis of effects of 
exposure to oestrogenic wastewater treatment works across different life stages 
on sexual development in zebrafish (Cooper et al., in prep).  Thus the casper 
models  (ERE-GFP and ERE-Kaede) I have created in my thesis work are being 
exploited widely. There are imitations with the casper models relating to 
fluorescence detection however as in post-larval stages (more than 30 dpf) the 
thickness of the body wall reduces fluorescence detection (quenching of the 
signal) for tissues seated deeply in the body cavity. Very recently, a similar line 
named “Crystal” has been developed that also includes silenced pigmentation 
in the eyes of the zebrafish, further improving imaging of the brain and may 
provide improved translucency at later stages of development than the casper 
phenotype.194  
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The results from Chapter 5 of this thesis have demonstrated that by utilising the 
simple mechanism of fluorescence photoconversion, the ERE-Kaede-Casper 
model provides a more dynamic model for studies into temporal tissue response 
and assessment of sequential exposures to oestrogens compared with the 
ERE-GFP-Casper model. Photoconvertible proteins have been previously used 
to track individual cells and assess effects on tissues developmentally, 67, 182, 184 
and in this model kaede was used to identify dynamics of tissue-specific 
response during exposure to oestrogenic chemicals. Importantly, 
photoconversion of green fluorescence to red at multiple time-points allowed for 
continual analysis of individuals during exposure without the need of termination 
or multiple groups of larvae.  
The transgenic models were generated via crossing of established lines rather 
than the use of transgenesis techniques and this resulted in models that 
inherited the same high sensitivity and tissue-specificity of response as the 
original ERE-GFP model. The models presented in this thesis are comparable 
to the most sensitive in vivo and in vitro oestrogen responsive systems currently 
available.48, 107, 113, 114 One initial concern with generating transgenic lines via 
crossing was the possibility of eventual silencing of the transgene response 
over multiple generations, which would have resulted in individuals with either 
mosaic or fully silenced progeny.199 Screening of the ERE-GFP-Casper line 
identified a 90-99% transmission rate of transgenes from homozygous F0 males 
to F1 progeny that was lower than the 100% (expected) rate observed using 
homozygous F0 females but this was inconclusive due to the small sample size. 
Analysis of response consistency and sensitivity in subsequent generations 
suggested that the transgene sequences are very stable within the three 
separate models (ERE-GFP, ERE-GFP-Casper and ERE-Kaede-Casper).  
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To produce stable transgenic fish lines via crossing requires careful planning 
and genotype screening is labour intensive as assessment is required of 
thousands of larvae using fluorescent microscopy. Inbreeding within 
heterozygous stocks is also required for this process and therefore subsequent 
generations need to be tested on a regular basis through routine screening of 
their responses to ensure consistency. This avoids potential problems 
associated with inbreeding, such as issues with sexual development198 and 
altered susceptibility to chemical stressors in comparison with wild-type 
zebrafish lines.197 Consistency in responses of specific transgenic lines is 
crucial for any standardized chemical testing. Thus homozygous working stocks 
need to be maintained, as demonstrated in Chapter 3 (p73-74) by the high 
variation of response seen in the unscreened cyp19a1b-GFP line in comparison 
to the more consistent responses seen in the homozygous ERE-GFP-Casper 
line. However, the development and maintenance of transgenic fish lines is not 
a trivial exercise and more easily undertaken in large, well-funded laboratories. 
This being the case, transgenic lines created should be made available, on 
request, to other research laboratories to maximize their utility and model 
uptake and independent validation. The work presented in this thesis was only 
made possible thanks to this policy of collaboration. 
In summary, transgenic zebrafish have been applied widely in studies in 
developmental biology and medicine but to date only a few models have been 
developed for studies in ecotoxicology that have both the required specificity 
and sensitivity for application to understand environmental health effects. The 
development of translucent lines such as the ERE-GFP-Casper and ERE-
Kaede-Casper have opened the door for further applications of transgenic 
zebrafish within ecotoxicology assessment, as discussed below. Transgenic 
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zebrafish lines that can be utilised during a wider range of life stages may also 
prove particularly beneficial in elucidating of adverse outcome pathways of 
chemicals. 
In vivo Screening 
Large-scale screening assays conducted by national and international 
governing bodies have helped ensure that potential oestrogenic chemicals in 
the environment (and other EDCs) are continually assessed and identified. The 
use of high-throughput in vitro screening tools has made this process both time- 
and cost-effective in comparison to the use of traditional in vivo screening 
systems. However, these in vitro screening assays are very limited in their 
ability to accurately predict potency, tissue-specificity and potential adverse 
effects of these chemicals in living organisms. As discussed in the introduction 
to this thesis in the examples of EE2, genistein and BPA, potency and ER 
receptor subtype affinity values attributed to oestrogenic chemicals via in vitro 
screens can underrepresent the equivalent values and associated adverse 
effects reported using in vivo screens and environmental and clinical data.  
The work presented in this thesis demonstrate that transgenic zebrafish, when 
applied in suitable screening and assay systems, can provide advantages 
characteristic of both in vitro and in vivo systems for testing oestrogenic 
chemicals or other EDCs. The screening assays presented in Chapter 4 
showed high-sensitivity identification and quantification of oestrogenic 
chemicals and their tissue-specific potencies. The results showed unique 
tissue-specific affinities of individual oestrogenic chemicals and also identified 
tissues that were consistently sensitive to exposure from all oestrogenic 
chemicals. The high sensitivity seen in the heart is consistent with responses 
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seen in another oestrogenic responsive transgenic zebrafish line exposed to 
environmental water samples200 and mounting data linking BPA to potential 
adverse effects on the cardiovascular system.201 
As embryos/larvae, the models presented can be utilised as reasonably rapid 
screening systems with high sensitivity and good repeatability. They can also be 
relatively cheap to use, once the models have been established, and especially 
so when compared with similar mammalian models. Equally however, there are 
reasonably high costs, most notably in skilled time, to develop novel transgenic 
models using transgenic techniques and then in maintaining the lines. 
Nevertheless, these costs can be justified if screening systems such as the one 
presented in Chapter 4 are further improved upon to become fully automated, 
high-content, high-throughput in vivo chemical screens. Such systems can offer 
chemical throughput and detection sensitivity to rival in vitro screens whilst also 
providing highly informative data on target tissues and potential adverse effects 
giving a more reliable and efficient tool for chemical risk assessment. Other 
novel automated systems are now being developed to scan and analyse 
responses in transgenic zebrafish larvae in medium throughput systems202 and 
new technology such as the VAST™ system shows potential for further 
improvement upon the work presented here.  
A further major benefit of transgenic fish and their application in such screens is 
that they could lead to a significant replacement and reduction in animals for 
chemical testing (in line with the 3Rs principle),195 as they allow for better 
effects targeting and analysis across multiple organ systems in individual 
organisms in real time. Use of transgenic embryos rather than adult fish could 
also substantially reduce the numbers of fish in chemical testing.  
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As shown in the Generation of Transgenic Zebrafish Models chapter (3), it has 
to be recognized that substantial validation of these transgenic models is 
required before their application in these screening systems. Results from 
Chapter 5 highlight that life stage dependent effects may occur for specific 
chemicals and thus responses in embryos may not always be representative of 
responses in later life stages. In the short term, this will demand use of more 
intact animals for the validation process. Furthermore, to date there has been 
little attempt to compare directly responses in transgenic animals with wild type 
lines, embryos or otherwise, and this warrants further study. As an example, 
although a wide array of target tissues for oestrogens are identified in this work, 
the models express only one type of transgenic ERE and surrounding 
sequence, which will not be effective for all oestrogenic signalling systems. 
Confidence that transgenic fish are truly representative of the more standard 
lines of fish currently used in chemical testing will be required before they are 
taken up widely in standardised chemical testing. Indeed it could be argued that 
a standardised validation process needs to be established for transgenic lines 
before they are accepted into standardised regulatory guideline tests for 
chemicals.  
Sequential Exposures and Temporal Tissue Response 
Oestrogenic chemicals are commonly found as mixtures in the environment and 
there is increasing evidence to suggest EDCs can have interactive (e.g. 
additive) effects. Potency analysis for EDCs, however, typically involves single-
chemical exposures and with little, or no, consideration given for animal 
exposure history. Unlike combined chemical mixture exposure, the application 
of sequential exposure is a much simpler approach to assessing chemical 
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interactions in living organisms but is one that is currently significantly 
underutilised in EDC mixture analysis.  
In Chapter 5 (p171-172), the ERE-Kaede-Casper model was applied to assess 
the effects of sequential exposures and identified an increased sensitivity of 
response to oestrogenic chemicals after an initial (0-48 hpf) exposure to an 
environmentally relevant concentration of EE2. The driving factors behind this 
sensitisation effect were unclear. No significant change in ER expression was 
identified by qPCR analysis but this may have been related to issues of timing 
or sensitivity. The sensitisation effect also appeared to be reduced after longer 
periods of incubation in embryo water. Nevertheless, these results highlight the 
importance of chemical mixture assessment (sequential or combined) to better 
predict potential oestrogenic chemical effects in wildlife and human populations.  
The application of the ERE-GFP-Casper in Chapter 4 (p120-121) had 
previously highlighted different target tissue affinities characteristic of the 
individual chemicals. However, it was suspected that the sensitivity of tissues is 
also likely to be dependent on the stage of growth and development of the 
zebrafish. As demonstrated using the ERE-Kaede-Casper line in Chapter 5 
(p170), photoconversion of fluorescence responses at particular time-points 
offers the possibility to identify windows of sensitivity for specific tissues in 
response to oestrogenic chemicals. As an example, non-photoconvertion of 
ERE-Kaede-Casper larvae imaged at 5 dpf after exposure suggested that EE2 
had consistently induced high levels of kaede expression in a wide range of 
tissues during the 5-day exposure. This result mirrored those that were seen 
using the ERE-GFP-Casper model in Chapter 4. However, photoconversion at 3 
dpf and 4 dpf stages (during the exposure) revealed that sensitivity of the 
individual tissues varied significantly during the 5-day period. These results on 
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temporal tissue sensitivity to EE2 give us a better understanding of the highly 
dynamic roles that oestrogen may play during the early stages of life in 
developing organisms such as the zebrafish. This work also suggests that the 
risk of tissue-specific adverse effects caused by exposure to these chemicals 
may be strongly linked to the stage of development of an organism.  
Finally, the ERE-Kaede-Casper model was used to study tissue responses to 
oestrogen in individual tissues at 24-hour periods after an initial 0-2 dpf 
exposure to EE2. The results in Chapter 5 (p178) show that fluorescence 
induction continued after the EE2 exposure for periods that varied depending 
on the exposure dose. The driving factors behind the dynamics of response are 
not clear from this study but could likely involve accumulation, metabolism and 
excretion of the chemical within these tissues. Zebrafish have been applied 
successfully as in vivo toxicokinetic models for assessing uptake, metabolism 
and excretion of oestrogenic chemicals.57 Models such as the ERE-Kaede-
Casper may offer useful non-destructive tools for toxicodynamics assessment 
as proposed below. 
 
Final Thoughts and Future Prospects 
1) Oestrogen Exposures 
Additive effects previously seen using EDC mixtures and the sensitisation effect 
identified using the ERE-Kaede-Casper model in sequential exposures have 
highlighted the need for further study of complex oestroen exposures. These 
models provide the opportunity for others to investigate the effects of many 
aspects of oestrogen exposure. The effects of multiple compounds in mixture 
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(combined or sequential), windows of exposure and concentrations offer a 
complexity that previously was not readily examinable.  
   
2) Toxicodynamics 
The ERE-Kaede-Casper could provide a valuable model for supporting 
toxicokinetic studies. The ability to photoconvert kaede fluorescence could 
potentially be applied to assess for both the presence and persistence of the 
exposure chemical in the target tissues. In many (most) cases where the parent 
compound only is oestrogen active the ERE-Kaede-Casper could potentially 
offer an effective system to non-destructively study the toxicodynamics of 
oestrogenic chemicals in zebrafish. 
 
3) High-throughput, high-content in vivo screening system 
The screening system presented in this thesis is currently limited in its capacity 
to analyse chemicals at high-throughput levels achieved via in vitro assays. The 
sensitivity of the overall system is also limited by measurement of whole-body 
fluorescence response rather than tissue-specific response quantification. Both 
of these issues can be improved upon significantly in the near future via the use 
of more modern automated dosing and imaging systems such as VAST™ to 
achieve higher throughput of chemicals (and their mixtures) and improved 
automated tissue-specific quantification using current image analysis programs. 
Using dynamic models such as the ERE-Kaede-Casper, such a system could 
additionally undertake the proposed sequential exposure and toxicodynamics 
assessments. In doing so, this system would act as a multifaceted screening 
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tool for improved predictions of potency and adverse effects of oestrogenic 
chemicals in wildlife and human populations.    
 
4) Effect mechanisms and signalling pathways 
Transgenic fish systems such as the models presented in this work also offer 
the potential for studying detailed effect mechanisms and signalling pathways. 
As an example, application of morpholinos/CRISPRs could be applied in 
combination with chemical exposures to ablate specific receptors and to identify 
roles of receptor subtypes in mediating the toxicant response. The transgenic 
models published to date are also relatively simple and combining different 
reporter systems in the same animals (and using different fluorescent markers) 
in the future should allow for multiple toxicological responses (linked to multiple 
signalling pathways) in the same animal.  
 
 
 
  
 200 
Chapter 7 
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Chapter 7 
Appendix 
The appendix in this thesis contains:  
 
“Transgenic Fish Systems and their Application in Ecotoxicology” 
Lee, O; Green, JM; Tyler, CR, Critical Reviews in Toxicology, 2015 
This is a critical review of techniques and methods used to generate transgenic 
zebrafish and medaka models for ecotoxicology assessments and includes a 
comparative analysis of the models themselves. This paper is included in its 
original format.  
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7.1 Transgenic Fish Systems and their 
Application in Ecotoxicology 
Okhyun Lee, Jon M. Green, Charles R. Tyler* 
Critical Reviews in Toxicology, 2015 
Crit Rev Toxicol. 2015 Feb;45(2):124-41. doi: 10.3109/10408444.2014.965805. Epub 2014 Nov 14. 
 
University of Exeter, Biosciences, College of Life & Environmental Sciences,  
Exeter EX4 4QD, United Kingdom 
 
Abstract 
The use of transgenics in fish is a relatively recent development for advancing 
understanding of genetic mechanisms, developmental processes, aquaculture, 
and in pharmaceutical discovery. Transgenic fish have also been applied in 
ecotoxicology where they have the potential to provide more advanced and 
integrated systems for assessing health impacts of chemicals. The zebrafish 
(Danio rerio) is the most popular fish for transgenic models, for reasons 
including their high fecundity, transparency of their embryos, rapid 
organogenesis and availability of extensive genetic resources. The most 
commonly used technique for producing transgenic zebrafish is via 
microinjection of transgenes into fertilized eggs. Transposon and meganuclease 
have become the most reliable methods for insertion of the genetic construct in 
the production of stable transgenic fish lines. The Gal4-UAS system, where 
GAL4 is placed under the control of a desired promoter and UAS is fused with a 
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fluorescent marker, has greatly enhanced model development for studies in 
ecotoxicology. Transgenic fish have been developed to study for the effects of 
heavy metal toxicity (via heat-shock protein genes), oxidative stress (via an 
electrophile responsive element), for various organic chemicals acting through 
the aryl hydrocarbon receptor, thyroid and glucocorticoid response pathways, 
and estrogenicity. These models vary in their sensitivity with only very few able 
to detect responses for environmentally relevant exposures. Nevertheless, the 
potential of these systems for analyses of chemical effects in real time and 
across multiple targets in intact organisms is considerable. Here we illustrate 
the techniques used for generating transgenic zebrafish and assess progress in 
the development and application of transgenic fish (principally zebrafish) for 
studies in environmental toxicology. We further provide a viewpoint on future 
development opportunities.   
  
Introduction 
Since the early 1980, transgenic animals – those that carry foreign DNA derived 
from an exogenous source and deliberately inserted into their genome - have 
been created in a variety of animals including mammals, birds, amphibians, fish 
and invertebrates (Donovan, Kerr, and Wall, 2005; Fan and Watanabe, 2003; 
Hamra et al., 2002; Hong et al., 2009; Hrytsenko, Pohajdak, and Wright, 2010; 
Huss, Poynter, and Lansford, 2008; Mozdziak and Petitte, 2004; Sinzelle et al., 
2006; Tsai, Lai, and Yang, 1997; Wang et al., 1995).  Transgenic technology 
has been used in biological and medical research to find cures for cancers, 
diabetes, Huntington’s disease and cardiovascular diseases and has 
contributed significantly to agriculture including for improved milk production, 
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and both increased growth rate and disease resistance in farmed animals 
(Bader et al., 2000; Donovan, Kerr, and Wall, 2005; Fan and Watanabe, 2003; 
Hansson et al., 1999; Houdebine, 1995; Mozdziak and Petitte, 2004; Reventos 
and Munell, 1997; Thomas et al., 2001). Transgenic research applied to 
mammals was initiated in the 1980s and for fish somewhat after this in the late 
1990s. Subsequently, there has been a rapid increase in the use of transgenic 
animals in research, illustrated by the number of academic papers published, 
increasing from around 280 in 1988 to almost 16000 in 2012 (using the search 
term transgenic animal- PubMed, Figure 1a) and in fish from 8 in 1990 to 
around 250 in 2012 (using the search term fish + transgenic- PubMed, Figure 
1).  
Transgenic fish have been developed as model systems for understanding 
genetics mechanisms, developmental processes and for pharmaceutical 
discovery (target validation), safety assessment and bio-synthesis (Dunham, 
2009; Moro et al., 2012; Nguyen et al., 2012). They have also been created to 
study specific processes in fish including cold tolerance, and for enhancing both 
disease resistance and growth rate in aquaculture species (Devlin et al., 2004; 
Du et al., 1992; Dunham, 2009; Wang et al., 1995). Recently, transgenic fish 
have also been developed for studies in ecotoxicology to screen and test 
chemical where they can inform on tissue targets and effect mechanisms 
(Blechinger et al., 2002; Bogers et al., 2006; Gorelick and Halpern, 2011; Lee et 
al., 2012; Legler et al., 2000; Tong et al., 2009). Transgenic fish have been 
created in divergent species including the loach Misgurnus anguilIicaudtis, mud 
loach Misgurnus mizolepis, goldfish Carassius auratus, common carp Cyprinus 
carpio, rainbow trout Oncorhynchus mykiss, atlantic salmon Salmo salar, coho 
salmon Oncorhynchus kisutch, channel catfish Ictalurus punctatus, and nile 
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tilapia Oreochromis niloticus, zebrafish Danio rerio and medaka Oryzias latipes 
(Devlin et al., 2004; Dunham et al., 2002; Dunham et al., 2002; Kinoshita, 2004; 
Kobayashi et al., 2007; Lawson and Weinstein, 2002; Maclean, Penman, and 
Zhu, 1987; Nam et al., 2001; Saunders, Fletcher, and Hew, 1998; Uzbekova et 
al., 2000; Wang et al., 1995). 
Zebrafish and medaka have become the most popular model species for 
transgenic manipulations. Favorable features of these species for transgenic 
work include their ease of breeding in the laboratory, relatively low associated 
maintenance costs, high fecundity, transparency of the embryos and rapid 
organogenesis (attractive features for studying developmental processes) and 
the availability of sequenced genomes providing extensive genetic resources. 
Additionally, for the zebrafish, the chorion of the egg is relatively soft facilitating 
microinjection of DNA and genetic constructs. The availability of mutant lines for 
this species, such as casper (roy + nacre mutant zebrafish) that lack skin 
pigmentation also enable studies for observing effects in body tissues, for 
example tracing individual cancer cells as they spread through the body 
(Feitsma and Cuppen, 2008; White et al., 2008). The zebrafish has high 
genome (approximately 70%), structural and physiological similarities with 
humans (Blader and Strahle, 2000; Briggs, 2002).. High quality genomic 
resources are also available for the medaka (Matsumoto et al., 2009), 
which  has a large within species genetic diversity. The medaka has smaller 
genome compared with the zebrafish (about half the size) and human (one-third 
the size) (Naruse et al., 2004). 
The zebrafish has been used to advance understanding on formation of the 
embryonic axis, cell lineages, and formation of the central and peripheral 
nervous systems. It has also proven valuable for studies on human diseases, 
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notably carcinogenesis, wound healing, immunological diseases, behavioural 
abnormalities, infection and Parkinson’s disease (Blader and Strahle, 2000; 
Bretaud, Lee, and Guo, 2004; Burgess and Granato, 2008; Feitsma and 
Cuppen, 2008; Kelly, Erezyilmaz, and Moon, 1995; Kimmel and Warga, 1987; 
Lieschke and Currie, 2007; Martin and Feng, 2009). The zebrafish and medaka 
have both become popular model organisms for studies on molecular 
mechanisms of chemical toxicity and analysis of behavioural outcomes (Hill et 
al., 2005; Nagel, 2002; Puiseux – Dao and Edery, 2006). Transgenic zebrafish 
and medaka employing fluorescent markers are used not only to identify 
chemically induced target gene activation but also to quantify relative uptake 
and accumulation of chemicals in those tissues. An advantage of the medaka 
over the zebrafish for studies into the effects of chemicals on sex, is that it has 
an established XY/XX genetic sex determination mechanism, whereas the sex 
determining mechanism(s) in the zebrafish are not determined.   
In this review, we first present a critical overview on the methods for producing 
transgenic fish, the recent progress made in different gene transfer methods, 
and illustrate their utility and applications. In latter part of this review we detail 
progress in the development of transgenic zebrafish and medaka for studies in 
environmental toxicology. Finally, we set out some thoughts on future prospects 
for the use of these small transgenic fish in environmental toxicology.  
 Methods for producing transgenic fish 
Creating a transgenic fish first requires production of the gene of interest and 
then its introduction into the organism. The general method for generating the 
gene construct is shown in Figure 2. 
Production of the gene construct  
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Several methods are now used to produce transgenic fish, but all involve a 
transgenic construct with a promoter and a gene. The foreign gene for transfer 
(transgene) is constructed using recombinant DNA techniques. Traditionally the 
gene of interest was most commonly expressed using E. coli plasmid vectors 
that replicate at high levels in their host cells. To clone the DNA of interest the 
sequence is inserted into a cloning or expression vector through the use of 
restriction enzymes to create compatible ends and ligase to seal the integration. 
This approach to cloning however, is time-consuming and relatively inefficient, 
and it can be difficult to find suitable restriction enzymes in the target DNA. 
False positive clones (vector without insert) can be common using this method 
due also to universal nucleotide ligation (Liu, 2013). More efficient methods for 
cloning the DNA target of interest now include In-Fusion cloning (Clontech) and 
Gateway cloning (Life Technologies) which are also considerably faster too. In-
Fusion cloning can ligate a DNA fragment with 15 bases of homology at their 
linear ends and a linearized vector with the use of their proprietary In-Fusion 
enzyme, a poxvirus DNA polymerase with 3′–5′ exonuclease activity. The 
Gateway cloning system is a site-specific recombination method and uses a set 
of the components of the λ (lambda) system for in vitro transfer of DNA, the λ 
integrase protein (Int), the λ excisionase protein (Xis), the E.coli protein IHF and 
the att recombination sequences embedded in the DNA to be recombined 
(Marsischky and LaBaer, 2004). There are many other cloning systems 
available from commercial suppliers, but In-Fusion and Gateway cloning 
systems have become especially popular for  gene construct generation due to 
their ease of use, fewer number of cloning steps, and good reliability(Xiao et al., 
2010). 
Introduction of the gene construct into fish host: 
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Having produced the construct, this is then transferred into the cytoplasm of 
fertilized fish eggs at the one cell stage, often using microinjection or 
electroporation (see next section). The injected DNA undergoes replication and 
some cells in the embryos will subsequently carry the transgene. Some 
integration events occur subsequent to DNA replication giving rise to mosaic 
fish, however, which may, or may not, contain the transgene in the germline. 
Animals are then maintained to adulthood and confirmation that they carry the 
transgene is undertaken using polymerase chain reaction (PCR) or Southern 
blot analysis in an external tissue, such as fin (Horvat et al., 1993). Southern 
Blot is commonly used to determine transgene copy number and the number of 
integration sites in the transgenic founder. The identification of the integration 
sites and copy number is important for understanding the relationship between 
the integration site and the specific phenotype. 
 Founders containing the inherited transgene (F0) are identified by crossing 
founder (transgenic fish) and wild-type fish (non-transgenic fish) and assessing 
whether the transgene occurs in the F1 generation. The germ-line transmission 
rate from the F0 generation to the F1 generation is variable because F0 are 
mosaic (variable cell expression) and the transgene is unevenly integrated in 
their gonadal tissues. Progeny derived from the F0 fish are crossed with wild-
type fish, and the resulting heterozygous offspring are crossed with each other 
to create a homozygous fish (i.e both alleles are present in the same fish) (see 
Figure 2).  
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Gene transfer methods: 
Microinjection  
Transgenes can be introduced into the fertilized eggs, via microinjection or 
electroporation, or via the use of primordial germ cells. Gene transfer by 
microinjection is the most popular method. In mammals, the gene is injected 
into the pronuclei of the embryo, but in fish the pronuclei cannot be seen after 
fertilization and some fish eggs are opaque (Chen and Powers, 1990; Palmiter 
et al., 1982). Consequently, in fish linearized DNA is microinjected into the 
cytoplasm of fertilized eggs. This approach in fish has been shown to induce 
high, albeit variable (35% to 80%), rates of mortality and relatively low 
integration rates (2-17%) (Hayat et al., 1991). Differences in success rates 
between the studies in fish probably include differences in the timing of the 
injections (embryo stage). The amount of DNA injected depends on the egg 
size of the fish species, but often includes up to 106 copies (Culp, Nusslein-
Volhard, and Hopkins, 1991; Stuart, McMurray, and Westerfield, 1988). 
Amplification of the injected DNA occurs in the embryo between the initiation of 
gastrulation and onset of somitogenesis (Stuart, McMurray, and Westerfield, 
1988). Introducing DNA into the egg of fish species that produce eggs with a 
hard outer surface (chorion) is difficult and more likely induces significant 
damage. Embryos in some fish species also develop very rapidly, passing 
through the first cell stage in a very short time interval and making it extremely 
difficult to microinject a large compliment of eggs. 
   Electroporation  
Electroporation  the application of short electrical pulses that result in an 
enhanced permeability of the cell membrane - is another method for introducing 
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the DNA insert into the host embryo(Cerda et al., 2006; Chen and Powers, 
1990; Dunham, 2003). In vivo electroporation has proved to be an efficient 
method for delivering expression plasmids to large numbers of cells in different 
regions of the developing nervous system in zebrafish embryos and adults and  
has also been used to study gain or loss of function in various tissues (Cerda et 
al., 2006; Kera, Agerwala, and Horne, 2010; Rao, Rambabu, and Rao, 2008; 
Teh C, Chong SW, and Korzh V, 2003).   
Voltage, buffer choice, quantity of DNA, and the manner in which the voltage is 
applied (bursts and frequency of the current) can all affect the efficiency of the 
electroporation. A major drawback of electroporation as a technique is the 
considerable variation in the uptake efficiency of the DNA into the embryo, 
making standardization(s) difficult (Powers et al., 1995). Electroporation, 
however, can be used to target specific tissues and this has been shown for 
embryonic neural tube, retinal, and somatic tissue (Tawk et al., 2002; Teh C, 
Chong SW, and Korzh V, 2003; Vergara and Canto-Soler, 2012). 
Primordial germ cells 
The use of primordial germ cells (PGCs) is the most recently used method for 
gene transfer. PGCs are the precursors of the germ cell lineage which are 
committed to differentiate into either spermatogonia or oogonia after gonadal 
sex differentiation (Yoshizaki et al., 2003). PGC-mediated gene transfer is used 
to deliver a foreign gene into the genome of cultured cells and the 
transformants are isolated by drug selection before they are introduced into 
individual fish (Takeuchi et al., 2002). Germ-line contribution can be performed 
by microinjection into the peritoneal cavity of hatched embryos with cultured 
PGC (Matsui, Zsebo, and Hogan, 1992). PCG-mediated gene transfer offers the 
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potential for producing transgenic fish of commercially valuable species that 
have a long generation time and produce low numbers of offspring. This 
method also allows for the generation of gene-targeted fish via homologous 
recombination. A method for the culture of PGCs obtained from zebrafish 
embryos has been established by Fan et al. (2008), but this method is limited 
because it is difficult to isolate PGCs in high quantities from early stage 
embryos. Furthermore, the information on the required in vitro culture conditions 
for enabling proliferation and survival of PGCs in fish is extremely limited.  
 
Transgenesis Vectors and Systems 
A number of different vectors have been used for the delivery and insertion of 
transgenes into the genome of zebrafish (and medaka) embryos. Commercially 
available E. coli plasmid constructs have most commonly been used due to 
their wide availability, ease of use and suitable size for carrying most transgene 
sequences. There are, however, other vectors that hold certain advantages 
over traditional E. coli plasmid constructs, which we now consider. 
BAC Clone and Fosmids 
Bacterial Artificial Chromosomes (BAC) have been used widely to study 
zebrafish gene function and regulation. BAC clones are able to hold large DNA 
insertions (up to 300kb) and therefore have the potential to carry a complete 
gene structure, including any endogenous promoters associated with cell-type 
specificity or temporal expression of the gene. Another benefit of BACs is their 
apparent resistance to positional effects in comparison with smaller plasmid 
vectors (Suster et al., 2011). Positional effects are a category of transgene 
silencing incurred by undesirable chromosomal location and flanking DNA., An 
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example of the application of BAC transgenesis is for a reporter system for 
oestrogen like substances in the medaka described in more detail below under 
Transgenic Fish in Ecotoxicology (Kurauchi et al., 2005). 
An alternative but similar technique to BAC recombination is the use of fosmids. 
Fosmids are single-copy plasmids that act as a vector for large DNA insertions. 
This system has been applied successfully for the production of a transgenic 
Cyp1a reporter zebrafish investigating dioxin target tissues (Kim et al., 2013), 
also described below in the section Transgenic Fish in Ecotoxicology. The large 
size of BAC clones and fosmids however, tend to suffer from low efficiency 
rates in producing transgenic lines. The use of Tol2 transposon assisted 
insertions (see Transposons section), however, in particular, an inverted Tol2 
cassette (iTol2 cassette) is improving success rates considerably (Suster et al., 
2011).  
Retroviruses 
The Moloney murine leukemia virus (MLV) is a viral vector that can be adapted 
(pseudotyped) to infect a range of different host cells, including zebrafish cells, 
for transgene delivery. Retroviral insertion has been used in the application of 
gene traps (GT), enhancer traps (ET) and protein traps (PT) in conjunction with 
typical transgenic reporter sequences (Trinh le and Fraser, 2013). These traps 
are an effective means for the identification of transcriptionally active genes and 
analysis of their function (reverse genetic screening). The MLV retrovirus has 
been used in a large scale enhancer detection screen to insert an enhancer 
trap vector into zebrafish (Ellingsen et al., 2005). This technique involves the 
insertion of a zebrafish promoter and reporter sequence (such as GFP) into the 
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genome via the MLV vector for the identification and characterization of 
regulatory gene activity during development.  
The pseudotyped MLV system has proven to be one of the most efficient 
transgene insertion techniques available and can result in successful germ line 
transmission of insertions to almost all F1 progeny, with an average of 10 
copies per cell (Chen et al., 2002; Wang et al., 2007). Due to the difficulties 
associated with producing high-titer viruses and limitations in cargo sizes, 
however, transposable elements are the more popular approach (Trinh le and 
Fraser, 2013). Nevertheless, the technique holds significant promise for use in 
reverse genetic screens in ecotoxicology and provides a strong alternative to 
genetic knockout technologies (Bedell, Westcot, and Ekker, 2011; Meng et al., 
2008).  
Transposons  
The frequency of germ line transmission for conventional DNA microinjection is 
very low and results in mosaic expression in F0. Furthermore, gene silencing 
can occur over generations using conventional DNA microinjection methods. In 
the light of these problems, transposons have become popular as methods for 
gene transmission. Transposons are sequences of DNA that are able to move 
directly from one site to another site within the chromosome or onto extra 
chromosomol DNA within the same cell. There are two types of transposons, 
autonomous and non-autonomous. An autonomous transposon encodes its 
own enzyme (transposase) and can excise and transpose. In contrast, a non-
autonomous transposon does not encode its own transposition proteins and 
requires transposase activity, which can be supplied as mRNA, in order to 
enable its relocation. Only non-autonomous transposons that requires artificially 
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provided transposase can be utilised to produce stage transgenics (Kawakami 
et al., 2004; Ryder and Russell, 2003). Use of transposons requires 
transposase introduction into early one cell stage eggs by microinjection 
together with transposase mRNA. Tol2 transposon and Sleeping Beauty (SB) 
are the main transposons used currently in creating transgenic zebrafish. Both 
these methods use enzymes to facilitate the integration of foreign DNA into the 
host genome. The Tol2 transposon system, derived from medaka and 
belonging to the hAT(hobo/Ac/Tam3) family of transposons, is now widely used 
in zebrafish, and in other vertebrates, due to its high efficiency for gene delivery 
and expression (Hamlet et al., 2006; Kawakami, 2005; Kawakami, Shima, and 
Kawakami, 2000; Sato et al., 2007). Using a Tol2 construct co-injected with 
transposase mRNA, germ line transmission frequency success rates can be as 
high as 50% (Kawakami et al., 2004). Furthermore the use of the Tol2 
transposon system tends to avoid gene silencing effects that can occur with 
linear plasmid injection (Kawakami, 2005). This transposon vector system is 
useful for the generation of a stable transgenic fish or analyses of activation of a 
promoter, an enhancer, or a gene of interest in transient expression assay 
(Asakawa and Kawakami, 2009; Asakawa et al., 2008; Lee et al., 2012; Lee, 
Tyler, and Kudoh, 2012). The Tol2 transposon is derived from the medaka so 
this system cannot not been used in the medaka due to an endogenous activity.  
Sleeping beauty is a reactivated transposon from the Tc1/mariner superfamily 
of transposable elements isolated from fish and is used regularly in the 
production of transgenic zebrafish models (Ivics et al., 1997; Miskey et al., 
2005). The transgenesis rate using sleeping beauty , however, tends to lower 
than that for Tol2 (at around 30% (Davidson et al., 2003; Thermes et al., 2002)), 
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and so the latter has become the most favoured transposon system (Balciunas 
et al., 2006).   
Meganucleases  
The traditional approach of microinjecting circular or linearized plasmid DNA 
into fertilized embryos can often result in concatemeric copies of transgenic 
DNA. This can lead to mosaicism or silencing in F0 generations, as well as 
reduced germ line integration (Culp, Nusslein-Volhard, and Hopkins, 1991; 
Stuart, McMurray, and Westerfield, 1988; Westerfield et al., 1992; Winkler, 
Vielkind, and Schartl, 1991). To improve the specificity and rate of stable 
transgenesis, transposase and meganuclease I-SceI can be co-injected with 
plasmid DNA (Grabher, Joly, and Wittbrodt, 2004; Kawakami, 2007; Rembold et 
al., 2006; Thermes et al., 2002). Meganuclease is used to mediate a single 
insertion at a low copy number whereas transposase is used to produce 
numerous single-copy insertions (Kawakami et al., 2004; Ogino, McConnell, 
and Grainger, 2006; Rembold et al., 2006; Thermes et al., 2002).  
Meganuclease I-SceI is an endonuclease that prevents concatamerization 
when co-injected with a plasmid containing I-SceI sites flanking the transgene 
(Jacquier and Dujon, 1985). It is thought that meganulcease I-SceI remains 
bound to the flanking recognition sites, which may be how concatamerization is 
prevented, but in general the mechanism of meganuclease’s success is still 
unclear (Soroldoni, Hogan, and Oates, 2009). For comparative studies on cis-
regulatory sequences in a fish genome, a consistent and unique locus of 
transgene insertion is extremely important. Having meganuclease sites 
artificially engineered into the genome gives high specificity of a single 
insertion, and is therefore particularly useful in these studies (Grabher and 
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Wittbrodt, 2008). However, Tol2 assisted insertion remains the most reliable 
and efficient systems in producing stable transgenic lines and hence remains a 
much more popular technique for mediating transgenesis.  
PhiC31 integrase-based targeting method  
Most established methods for transgenesis are not able to control copy number 
and integration sites leading to variable transgene expression caused by so-
called position effects (Kirchmaier et al., 2013). The position effects refer to 
varying transcription of a transgene inserted into different chromosomal regions. 
An exception to this is the recently developed PhiC31 integrase-based targeting 
method, developed in zebrafish and medaka, which enables pre-selection of 
successfully targeted integrations early on in the injected generation and 
provides highly reproducible patterns of transgene activity (Kirchmaier et al., 
2013; Roberts et al., 2014).  
Targeted Genome Editing 
An emerging area of genome modification for insertion of a transgene is 
targeted genome editing. The process involves engineering of customised 
nucleases to induce DNA sequence specific double strand breaks (DSBs) which 
are then exploited for sequence alterations. The three techniques gaining most 
attention currently are (Miller et al., 2010) clustered regularly interspaced short 
palindromic repeats (CRISPRs), transcription activator-like effector nucleases 
(TALENs) (Miller et al., 2010) and Zinc Finger Nucleases (ZFNs), each differing 
in the ease of construction methods, potential off-target activities and their 
theoretical target range. ZFNs have been the most widely used to date but the 
relative difficulty and high cost of their construction, has meant that CRISPRs 
and TALENs are now gaining the most attention.  
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CRISPRs 
The highly adaptive CRISPR–Cas (clustered regularly interspaced short 
palindromic repeats–CRISPR-associated proteins) immune system occurs in 
bacteria and archaea to provide protection against viruses, plasmid DNAs and 
other disruptive mobile genetic elements (MGEs). Once exposed to a new 
MGE, spacer sequences derived from the MGE are incorporated into the 
CRISPR loci, separating a series of repetitive DNA motifs. Transcription leads 
to small CRISPR RNAs that are displayed on Cas protein complexes to provide 
RNA-guided targeting and degradation of foreign DNA by Cas nucleases.  
Hwang et al. have shown that site-specific nucleotide deletions or substitutions 
in the zebrafish genome can be achieved using RNA-guided Cas9 nuclease 
(RGN) with germ line transmission of the mutations reaching up to 100% 
(Hwang et al., 2013). Auer and co-workers have since demonstrated the use of 
the CRISPR-Cas9 RGNs to mediate the loci-specific insertion (or ‘knock-in’) of 
DNA cassettes (Auer et al., 2014). Using previously established transgenic 
zebrafish lines, Auer et al. (2014) were able to target GFP reporter sequences 
and knock-in a KalTA4 sequence (an alternate version of Gal4, (Distel, 
Wullimann, and Koster, 2009)) resulting in the expression of KalTA4 in formally 
GFP positive cells. The accuracy and efficiency of the CRISPR-Cas9 targeting 
system has made RGNs a promising tool as an alternative to the use of 
morpholinos for gene silencing as well as for creating transgenic zebrafish 
reporter lines. CRISPR RGNs are also relatively easy to construct (Joung and 
Sander, 2013). 
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TALENs 
TALENs comprise a non-specific FokI nuclease fused to a customisable DNA-
binding domain composed of highly conserved repeats derived from TALEs; 
proteins which are secreted by Zanthomonas spp. bacteria to alter gene 
transcription in host plant cells (Boch and Bonas, 2010; Miller et al., 2010). 
Huang and co-wrokers  first demonstrated heritable mutations in zebrafish 
target genes could be achieved using TALENs, having successfully introduced 
indel mutations in tnikb and dip2a genes (expressed in blood cells and 
vasculature of zebrafish embryos) (Huang et al., 2011). Use of TALENs has 
also been extended to the knock-in of genes via homologous recombination 
(Hwang, Peterson, and Yeh, 2014; Zu et al., 2013). Although slightly more 
complex to construct than CRISPRs, TALENs has a broader targeting range 
with almost no restrictions in target sequence (Reyon et al., 2012).  
 
The GAL4-UAS Transgene Expression System  
Various manipulated systems have been introduced to improve efficiency, 
sensitivity, tissue specificity and ease of generation transgenic fish, as 
described above. A system that has greatly enhanced transgenic models in 
zebrafish (and Xenopus), and is now being employed for studies in 
ecotoxicology, is the GAL4/UAS system (Hartley, Nutt, and Amaya, 2002; 
Scheer and Campos-Ortega J. A., 1999). This is comprised of a two-part 
expression system using a yeast (Saccharomyces cerevisiae) transcription 
activator protein GAL4 and its target sequence UAS (Upstream Activated 
Sequence) (Duffy, 2002; Hartley, Nutt, and Amaya, 2002). The GAL4 gene 
encodes a protein of 881 amino acid and in the yeast is a regulator of the 
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galactose-inducible genes (Johnston and Hopper, 1982; Scott et al., 2007). The 
UAS element is analogous to an enhancer element defined in multicellular 
eukaryotes, which is essential for the transcriptional activation of Gal4-regulated 
genes (Brand and Perrimon, 1993; Duffy, 2002).  
The GAL4-UAS system was first introduced into Drosophila by Brand and 
Perrimon (1993) (Brand and Perrimon, 1993) to analyse the function of 
developmental genes (Brand and Dormand, 1995; Brand, Manoukian, and 
Perrimon, 1994). GAL4/UAS introduced spatial and temporal control of 
transgene expression using two transgenic lines, one activator line and one 
effector line, that were combined (Brand and Perrimon, 1993; Fischer et al., 
1988). In an activator line the gene for the yeast transcriptional activator GAL4 
is placed under the control of a desired promoter whereas the effector lines 
contain DNA-binding motif of GAL4-UAS linked the gene of interest (Scheer and 
Campos-Ortega J. A., 1999). UAS is fused to an effector gene which is silent if 
the GAL4 activator is absent. GAL4 can be expressed in many different 
patterns through placement under the control of various ‘Drosophila 
melanogaster’ tissue-specific promoter sequences (Kramer and Staveley, 
2003). Many GAL4 lines have been developed and widely used for ectopic 
expression (the expression of a gene in an abnormal place in an organism) for 
genes of interest. When the GAL4 activator line and UAS effector line are 
crossed, the offspring express a GAL4-dependent transgene in a tissues-
specific manner (Distel, Wullimann, and Koster, 2009).  
The GAL4-UAS system was first applied in zebrafish by Scheer and Campos-
Ortega (1999) and has been used since in the generation of various transgenic 
zebrafish models including for studies into cell type-specific ablation and in the 
mapping of neuronal circuits and neuronal activity (Asakawa et al., 2008; 
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Davison et al., 2007; Distel, Wullimann, and Koster, 2009; Scott et al., 2007). 
GAL4FF is an engineered transcriptional activator consisting of the DNA-
binding domain from GAL4 fused to a duplicated portion of the VP16 
transcriptional activation domain.   GAL4FF is reported to be less toxic to 
zebrafish embryos (Asakawa et al., 2008) and a GAL4FF-UAS system (Figure 
5) has been successfully applied for chemicals effects studies in ecotoxicology 
(Lee et al., 2012). 
A drawback in the generation of transgenic lines using the UAS systems is that 
these sequences can be prone to CpG methylation and thus silencing, 
especially with high UAS copy number (Goll et al., 2009; Subedi et al., 2013). 
Attempts have been made to solve this problem by modifying the UAS to 
mitigate for silencing (Akitake et al., 2011). Recently, alternative bipartite 
reporter systems have developed in the zebrafish that are not prone to 
transcriptional silencing, including the Q transcriptional regulatory system and 
tryptophan repressor (Subedi et al., 2013; Suli et al., 2014). The Q 
transcriptional regulatory system, derived from genes in Neurospora crassa, is 
similar to GAL4/UAS system. The transcriptional activator QF binds to the 
QUAS upstream regulatory sequence and induces the expression of target 
genes. Transcriptional silencing of Q system does not occur because the QF 
binding site does not carry essential CpG dinucleotide sequences that are 
subject to DNA methylation (Subedi et al., 2013).  
Recently, the Escherichia coil (E. coli) tryptophan repressor was used in stable 
zebrafish transgenic lines and the tryptophan repressor system showed no 
transcriptional silencing in subsequent generations of zebrafish (Suli et al., 
2014). A regulatory protein called a repressor can bind to the operator site of 
the tryptophan operon and becomes active only when it is associated with 
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tryptophan. The binding of tryptophan to the tryptophan repressor protein 
causes a change in conformation in the repressor. 
 
Seeing the Response - Reporter Genes  
Reporter genes are used to quantify expression of the transgene and can also 
be used to rapidly determine success of gene transfer techniques and the 
tissue location of their expression in the host organism (Alam and Cook, 1990). 
Most reporter genes are placed downstream of the promoter of the inserted 
transgene. Common reporter genes used in transgenic research include E.coli 
β-galactosidase (lacZ), chloramphenicol acetyltransferase (CAT), neomycin 
phosphotransferase (NPT), luciferase (Luc), green fluorescent protein (GFP), 
Kaede, YFP, DsRed and mCherry (Ando et al., 2002; Culp, Nusslein-Volhard, 
and Hopkins, 1991; Dunham et al., 1999; Leclerc et al., 2000; Nagai et al., 
2002; Razak et al., 1999; Uzbekova et al., 2003). The most common reporter 
genes used in transgenic fish research to date are GFP and Luc (Figure 3). 
Luciferase (Luc), originates from Photinus pyralis (firefly) and encodes the 
enzyme luciferase, and causes the cell that expresses it to catalyse luciferins 
and produce light (Contag and Bachmann, 2002). Furthermore, there is a high 
signal intensity associated with the luciferase molecule which allows for rapid 
measurements. It is also suitable as a reporter gene for the quantitative 
measurement of gene expression. The luciferase assay is widely used in 
pharmaceutical research (drug screening) for high-throughput analysis of gene 
transcription in living cells because the procedure is simple and requires only a 
small volume of test material. Luciferase as a method however, requires a 
costly substrate and is not stable (luciferase half-life varies from 1.5 to 3 hours 
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depending on the host cell and the gene construct) (Goodman and Gao, 1999). 
Furthermore, the image integration time is long to compensate for the low signal 
intensity (Vooijs et al., 2002; Xiong et al., 1999). Recently, several research 
groups have shown that luciferase can be detected in live zebrafish embryos, 
larvae and adults (Chen et al., 2013; Weger et al., 2012). 
GFP is a fluorescent protein isolated from bioluminescent jellyfish Aequorea 
victoria, and can be visualized by microscopy. It can be seen directly in living 
cells and intact organisms and responses can be measured in real time. 
Furthermore, when used in conjunction with zebrafish mutant lines that lack skin 
pigmentation, GFP can be detected in fish for all life stages. Advantages of GFP 
over luciferase include superior brightness, innate fluorescence and relatively 
high photostability. GFP was first used in zebrafish in 1996 (Amsterdam et al., 
1996) and has since been used widely in the study of gene expression patterns, 
analysis of tissue-specific promoters/enhancers, tissue/organ development, cell 
migration and mutagenesis screening (Driever et al., 1996; Gong, Ju, and Wan, 
2001; Haffter et al., 1996; Udvadia and Linney, 2003). GFP has also been 
applied in the development of biosensor transgenic zebrafish to monitor 
chemicals such as heavy metals and oestrogens (Blechinger et al., 2002; Chen 
et al., 2010; Gorelick and Halpern, 2011; Lee et al., 2012; Tong et al., 2009). 
RFP (red fluorescent protein) has the advantage over GFP in  that there is less 
background interference. DsRed, red fluorescent protein from Discosoma sp., 
can be used together with other GFP variants for multicolor imaging (Dietrich 
and Maiss, 2002). mCherry is the best general-purpose red monomer due to its 
superior photostability (Shaner, Steinbach, and Tsien, 2005).  
Kaede is another fluorescent protein applied as a reporter in transgenic 
animals. The encoding gene for this protein was isolated from the stony coral 
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Trachyphylia geoffroyi (Ando et al., 2002). The kaede protein is capable of 
irreversible photoconversion from green to red fluorescence under UV or violet 
light illumination (Figure 3). This lends itself, for example, to studies on 
assessing how stimulation of a gene response subsequently affects its 
response for a subsequent stimulation of that gene as the events can be 
separated by the different colour patterning in the organism (Ando et al., 2002). 
Kaede is also a useful tool for sequentially tracking selectively labeled cells in 
fish embryos (Sato, Takahoko, and Okamoto, 2006). 
Recently, a system has been developed to manipulate further the production of 
incorporated fluorescent proteins, called kaloop. It involves autoactivation (self-
perpetuation) of the fluorescence, and this is being applied as a powerful tool 
for spatiotemporal genetic fate mapping of specific cells types in zebrafish 
(Distel, Wullimann, and Koster, 2009).  
 
Transgenic Fish and Ecotoxicology 
Transgenic zebrafish have considerable potential for use in aquatic 
ecotoxicology as biosensors and as more effective models for identifying 
molecular mechanisms that underlie signalling pathways, and for understanding 
the physiological and pathological impacts of chemical exposure (Blechinger et 
al., 2002; Bogers et al., 2006; Gorelick and Halpern, 2011; Lee et al., 2012; 
Legler et al., 2000). Biosensor fish work on the premise that specific genes, 
often enzymes or receptors, are inducible by certain chemicals/pollutants. 
Exposure of the fish to the pollutant of concern, or a natural water containing 
that pollutant, induces the activation of an inducible promoter that in turn 
triggers expression of the reporter (e.g. GFP) (Figure 4). Transgenic fish 
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developed to study contaminant and other environmental stressors include for 
cadmium and copper toxicity via induction of heat-shock protein gene, oxidative 
stress - through the induction of an electrophile responsive element (EpRE), for 
various organic chemicals acting interacting with the aryl hydrocarbon receptor-
mediated toxicity (measured via cyp1a1), thyroid and glucocorticoid response 
pathways, and estrogenicity (vitellogenin, choriogenins, oestrogen receptor 
responsive elements) generally employing either luciferase or GFP as reporter 
genes (Almeida et al., 2010; Blechinger et al., 2007; Blechinger et al., 2002; 
Bogers et al., 2006; Chen et al., 2010; Gorelick and Halpern, 2011; Ji et al., 
2012; Kurauchi, Hirata, and Kinoshita, 2008; Kurauchi et al., 2005; Kusik, 
Carvan, and Udvadia, 2008; Lee et al., 2012; Legler et al., 2000; Legler et al., 
2002; Mattingly, McLachlan, and Toscano, 2001; Petersen et al., 2013; Salam 
et al., 2008; Tong et al., 2009; Zeng et al., 2005) (See Table 1 for a summary of 
the different transgenic fish lines developed).  
   Heat-shock protein  
Transgenic biosensor fish have been developed that employ the heat shock 
protein (hsp) promoters, for 70 (hsp 70) and 27 (hsp 27), that are readily 
induced by various environmental stressors including increased temperature 
and heavy metals. In a transgenic zebrafish created using eGFP (enhanced 
green fluorescent protein) as the reporter under the control of the hsp 70 gene 
promoter, exposure to cadmium (Cd, for 96 hours) found a response at 
exposure concentrations as low as 0.2 µM (22.5 µg/L) (Blechinger et al., 2002). 
This is a more sensitive response system than for Cd induction of hsp 70 
expression in cultured cells (0.5~50 µM , 0.06~5.6 mg/L)) (Ait-Aissa et al., 2000; 
Braeckman et al., 1999). In the hsp 70-eGFP transgenic zebrafish cadmium 
treatment induced GFP expression in tissues in a dose-dependent manner with 
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a tissue sensitivity order of gill> skin> olfactory organ> digestive tract> liver> 
pronephros. Subsequent studies identified responses in olfactory sensory 
neurons (OSNs) for a brief (3 h) 5 µM Cd (562.1 µg/L) exposure and responses 
in the lateral line neuromasts after 24 h for a 0.2 µM Cd (22.5 µg/L) exposure 
(Blechinger et al., 2007). In addition, cell death in the olfactory placode was 
observed following a 3 h 125 µM Cd (14.1 mg/L) exposure. 
Transgenic zebrafish developed with GFP driven by the regulatory region of hsp 
27 (also known as HspB1- one of the most widely expressed and distributed 
small heat shock proteins) have also been shown to be responsive to Cd 
exposure with GFP expression occurring in heart, skin and muscle (Wu et al., 
2008) after a 24 h heat shock treatment. This model (hsp 27-GFP transgenic 
zebrafish), however, was far less sensitive to Cd compared with the hsp 70-
eGFP transgenic zebrafish (Blechinger et al., 2002), with GFP expression 
detected in embryos only at high Cd exposure 320 µM Cd (36 mg/L), but not for 
exposures between 1.35~135 µM (0.2~15.2 mg/L)).  
Cyp1a1 promoter 
The promoter of the cyp1a1 gene has been used to drive a GFP reporter gene 
for measuring exposure to organic chemicals in both transgenic zebrafish and 
medaka (Hung et al., 2012; Kim et al., 2013; Ng and Gong, 2013). Cyp1a1 is a 
cytochrome P450 enzyme involved in the oxidative metabolism of various 
organic substances including, polycyclic aromatic hydrocarbon (PAHs) and 
polychlorinated biphenyls (PCBs). Cyp1a1 also acts as a marker of the 
activation of the aryl hydrocarbon receptor (AhR), a ligand-activated 
transcription factor known to mediate the toxic effects of several classes of 
environmental contaminants including polychlorinated biphenyls (PCBs), 
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polycyclic or halogenated aromatic hydrocarbons (PAHs) and dioxins (e.g. 
2,3,7,8-Tetrachlorodibenzo-p-dioxin, TCDD) (Mattingly, McLachlan, and 
Toscano, 2001).  
Transgenic Cyp1a-GFP medaka embryos (72 hpf) exposed to TCDD (for 24 h) 
showed GFP expression in kidney, liver and gut at an exposure concentration 
of only 0.005 nM (1.6 ng/L) (Ng and Gong, 2013). Other responding tissues at a 
higher TCDD exposure concentration (0.5 nM (161 ng/L)) included olfactory 
pits, caudal fin, gills, neuromast cells. This transgenic medaka was also shown 
to be highly responsive to other PAHs including, 3-methylcholanthrene (3-MC) 
and benzo[a]pyrene (BaP) with expression in the liver and kidney. A similar 
transgenic Cyp1a-GFP zebrafish was shown to be responsive to PCBs in liver 
and intestine at exposure concentrations down to 0.04 µg/ml (40 µg/L)(Hung et 
al., 2012). In the most recently developed transgenic cyp1a reporter zebrafish, 
incorporating eGFP, responses to TCDD were detected in brain vessel, heart, 
gut, retinal bipolar cells, otic vesicle, lateral line, cloaca and pectoral fin bud 
down to 1 nM TCDD (322 ng/L) (Kim et al., 2013). The transgenic cyp1a-eGFP 
zebrafish embryos was also responsive to the AhR agonists benzo[a]pyrene 
(B[a]P), 3-methylcholanthrene (3-MC) and β-naphthoflavone (β-NF) at exposure 
concentrations of 1 µM (268.4 µg/L) and 10 µM (2.7 mg/L), respectively. 
 
 
 
   Electrophile responsive element 
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Transgenic zebrafish models developed for studying oxidative stress, where 
chemical modification of DNA, proteins and lipids can alter their biological 
functions, have incorporated an electrophile-responsive element (EpRE), with 
luciferase and GFP as reporters (Kusik, Carvan, and Udvadia, 2008). In the first 
zebrafish model developed of this kind EpRE-LUC-GFP, a Luc-GFP protein 
fusion protein was used (Kusik, Carvan, and Udvadia, 2008). This combination 
of GFP and luciferase allowed for both visualizing the location of the tissue 
responses (GFP) and quantifying transgene expression (via luciferase) in the 
same fish. In the transient assay for this model (embryos injected at the one cell 
stage with a plasmid pEpRE-LUC-GFP), GFP expression was observed in the 
skin for exposure to 0.1 µM  (27.2 µg/L) mercuric chloride (HgCl2) and in many 
other cells, including neurons, muscle and the notochord, for exposure to 0.3 
µM (81.45 µg/L) HgCl2. In the stable transgenic EpRE-LUC-GFP zebrafish line 
that was created there was a HgCl2 concentration dependent induction of 
luciferase activity in embryos (LOEC 0.2 µM (54.3 µg/L)) but no GFP 
expression, the reason for which was unclear. In a similar EpRE transgenic 
zebrafish developed with luciferase only as a reporter embryos were not found 
to be especially responsive when challenged with copper sulphate limiting their 
use for environmental studies. There are other responsive elements activated 
directly or indirectly by oxidative stress such the Nrf2 (nuclear factor E2-
related factor 2) -antioxidant response element (ARE) and metal response 
elements (MREs) (Chu et al., 1999; Nguyen, Nioi, and Pickett, 2009), but these 
have not yet been applied in transgenic fish models.  
 
   Endocrine Disrupting Chemicals  
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There is increasing concern about the impacts of chemicals in the environment 
that have ability to disrupt the endocrine system which can result in adverse 
effects on developmental, reproduction, neurological and/or immune function in 
both humans and wildlife (Chia et al., 2010; Goodhead and Tyler, 2009; Li et 
al., 2011). These chemicals have been referred to as endocrine disrupting 
chemicals (EDCs) and they are derived from both natural and anthropogenic 
sources. Transgenic zebrafish models have been developed for studying the 
structure or function of thyroid, corticosteroid, androgen and oestrogen systems. 
    A single zebrafish transgenic model has been developed for studying thyroid 
hormone function by Ji et al., 2012. They generated a transgenic zebrafish with 
eGFP driven by the TSHβ (glycoprotein hormone - thyrotropin) β) promoter. 
Exposure to thyroid hormones, thyroxine (T4) and tri-iodothyronine (T3) 
decreased GFP expression in the pituitary gland (20 nM, 13 µg/L) for T3, 90 nM 
(69.8 µg/L) for T4) for a 3 day exposure. Exposure to goitrogens (3.96 mM, 
548.9 mg/L) KClO4 and 1.3 mM (221.3 mg/L) PTuracil) for 3 days induced 
activation of TSHβ expression and enhanced GFP expression in the pituitary 
gland. This transgenic TSHβ-eGFP zebrafish could usefully be applied for 
studies on pituitary TSHβmRNA expression and thyroid function, but not as an 
effective biosensor for assessing the effects of thyroid disrupting chemicals due 
to the high levels of GFP expression resulting from endogenous TSHβ.  
   Transgenic zebrafish lines have been developed for measuring responses to 
glucocorticoids. Glucocorticoids are important modulators of energy metabolism 
and a number of studies have showed that some EDCs might be able to 
stimulate glucocorticoid signaling through effects on the glucocorticoid receptor 
(GR) or by disturbing glucocorticoid synthesis or function (Atanasov et al., 2005; 
Sargis et al., 2010). The first transgenic zebrafish model developed for 
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glucocorticoid receptors contained four glucocorticoid response elements (GRE) 
upstream of TATA minimal promoter and luciferase as the reporter (Weger et 
al., 2012). The GRE-LUC transgenic zebrafish larvae were shown to respond in 
a concentration -dependent manner to dexamethasone (DEX) treatment (2.5-10 
µM (1~3.9 mg/L)) and glucocorticoid signaling was blocked by exposure to the 
GR antagonist, mifepristone (Weger et al., 2012). Exposure of these transgenic 
zebrafish larvae to tributyltin (TBT), an antifoulant used to prevented growth of 
marine organisms, inhibited ligand binding to GR and blocked GR activation. 
The metabolite of TBT, dibutyltin (DBT) is known to be responsible for this GR 
interaction. GC signaling in GRE-LUC larvae was inhibited with environmentally 
relevant exposure concentrations for TBT (20 nM). Very recently, two further 
GRE transgenic zebrafish lines have developed by  different research groups 
(Benato et al., 2014; Krug et al., 2014). One of these models (Krug et al., 2014) 
contains six glucocorticoid response elements and a short half-life green 
fluorescent protein (6ΧGRE:d4EGFP). For acute and chronic exogenous 
glucocorticoid treatment strong GFP was observed in a variety of tissues, 
including the brain after exposure to 10 μM (3.6 mg/L) hydrocortisone and 10 
μM (5mg/L) fluticasone propionate (Krug et al., 2014). This model was also 
shown to be applicable for studies into the stress response with elevated 
cortisol. In the GRE model developed by Benato et al (2014) nine GRE tandem 
repeats were included to drive eGFP expression (Benato et al., 2014). In 
untreated transgenic zebrafish there was ubiquitous expression of eGFP in the 
head, posterior trunk and tail bud at 14 hpf and subsequently in the head and 
caudal trunk around the yolk sac and its extension at 24 hpf. GFP intensity was 
then reduced in the head and tail regions at 72 hpf and become more localized 
in internal organs at 6 dpf. Exposure of 48 hpf embryos to DEX induced a 
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concentration related responses with a LOEC of 100 nM (39.3 µg/L). At an 
exposure of 10 µM (3.9 mg/L) DEX eGFP signal was enhanced in pectoral fins, 
dermal mesenchymal-like cell, muscle fibers, pituitary, pineal gland and blood 
vessels and blood cells. Reporter activity in this transgenic line was decreased 
by GR knockdown and RU486 treatment. GFP expression was also observed in 
several organs in untreated (natural expression) adult males and females. After 
10 µM (3.9 mg/L) DEX treatment for 24 h, GFP signal was increased in the 
brain, liver, intestinal muscosa, kidney, splanchnocranium, spinal cord, eye and 
skin in the both male and female in this transgenic line. This model therefore 
looks to have good utility for studies into GC functions in both early and adult 
life.   Various transgenic fish lines have been developed with an oestrogen 
responsible promoter derived from the vitellogenin (vtg) or choriogenin genes. 
Vitellogenin (vtg) is an egg yolk precursor protein, normally synthesized in the 
liver of females, but also inducible in males in response to oestrogen exposure, 
and is the most widely used biomarker for exposure to oestrogenic chemicals in 
aquatic ecotoxicology. Choriogenins are egg envelope proteins that are 
similarly synthesized in the liver of maturing female fish in response to 
estrogens. Both vitellogenin and choriogenin respond to oestrogens in low ng/L 
exposure regimes and at sub-nanogramme exposure concentrations for the 
synthetic oestrogen ethinylestradiol (Thomas-Jones et al., 2003). 
Some of the first transgenic models employing promoters for the vitellogenin 
and choriogenin genes with GFP reporters were developed in medaka. These 
models however, were not sufficiently sensitive for detecting exposure to 
oestrogens for environmentally relevant exposures. Examples of this include for 
a vitellogenin1 (vtg1) gene promoter Zeng et al., 2005 that required 500 ng E2/L 
(17β-estradiol), 50 ng EE2/L (17α-ethinylestradiol) or 1 mg BPA/L (bisphenol A) 
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exposures to induce detectable levels of GFP. Similarly, a transgenic medaka 
developed with gene regulatory elements of choriogenin H detected responses 
in the liver for exposure concentrations of 0.63 nM for E2(171 ng E2/L), 0.34 nM 
for EE2 (100 ng EE2/L) and 14.8 nM for estrone (E1, 4 µg E1/L) after a 24h 
exposure (Kurauchi, Hirata, and Kinoshita, 2008). Kinoshita et al., 2010 applied 
this model to detect levels of estrogen-like substances in waters in Thailand and 
Malaysia, but its use in this regard would be for sites extremely heavily polluted 
with oestrogen only. A further transgenic medaka incorporating a choriogenin H 
gene promoter and a red fluorescent protein reporter (RFP) gene was similarly 
shown to have a relatively low detection sensitivity for estrogens, with 
responses to 1 µg E1/L, 200 ng E2/L, 1 µg DES/L and 10 mg BPA/L, for 7 day 
exposures (Cho, Kim, and Nam, 2013). Although not sufficiently sensitive to 
detect oestrogens that occur for most environments, the species of medaka 
used was euryhaline allowing for comparative effects analysis on chemicals in 
aqueous environments of differing salinity. The most sensitive transgenic 
medaka produced using the choriogenin L gene with a GFP reporter was 
responsive to 25 ng E2/L (for a 6 day exposure) (Salam et al., 2008).. A single 
GFP transgenic zebrafish line has been developed with an estrogen-inducible 
promoter for a vitellogein gene (vtg1) (Chen et al., 2010) that was reported to 
detect GFP in the liver at  0.1 µg E2/L, 1 µg estriol /L, 1 mg BPA/L, and 10 mg 
nonylphenol (NP)/L. The lack of appropriate controls in this work however 
makes it difficult to provide a robust evaluation of this model.  
The transgenic medaka and zebrafish lines developed incorporating vitellogenin 
and choriogenin genes in the reporter systems reported on above vary in their 
responsiveness to oestrogen and generally they are limited in the use for 
environmental monitoring as they lack the required sensitivity. Responses in all 
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of these transgenic medaka and zebrafish for vtg and choriogenin genes are 
also restricted to the liver, the site of vitellogenin and choriogenin synthesis. 
They do nevertheless, provide systems for screening chemicals for oestrogenic 
activity in vivo in real time and can be applied to inform on cumulative 
responses to estrogens. 
Of a slightly different nature, but nevertheless relevant for informing on the 
feminizing effects of oestrogens in fish, transgenic medaka containing the 
regulatory promoter of the 42Sp50 gene driving GFP or RFP have been 
developed for detecting testis ova, a condition induced in response to oestrogen 
exposure in males. 42Sp50 is abundantly expressed in oocytes (Kinoshita et 
al., 2009). In these studies induction of testis ova occurred for a 2 week 
exposure to 830 ng estradiol-benzoate/L. Although this model was not 
sufficiently sensitive for detecting effects of oestrogens on germ cell 
development for environmentally relevant exposures it has utility for studying 
the mechanisms controlling oogenesis and germ cell differentiation.  
There have been a number of transgenic lines developed in zebrafish for 
detecting oestrogens using oestrogen response elements (ERE), which binds 
the oestrogen receptor–ligand complex activating oestrogen responsive genes. 
The first of these transgenic biosensor zebrafish developed by Legler et al. 
(2000) incorporated 3×EREs inserted upstream of TATA minimal promoter and 
luciferase as the reporter (Legler et al., 2000). Juveniles of this zebrafish 
transgenic model were responsive to E2 at concentrations down to 0.1 nM (27.2 
ng/L) (for a 96 h exposure) and the testis was the most responsive target tissue. 
This transgenic zebrafish, was subsequently applied to show antiestrogenic 
effects of the polycyclic musks (such as 6-acetyl-1,1,2,4,4,7- 
hexamethyltetraline (AHTN) and 1,2,4,6,7,8-hexahydro- 4,6,6,7,8,8-
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hexamethylcyclopenta-ç-2-benzopyran (HHCB)), commonly used in the 
fragrance industry) (Schreurs et al., 2004). Limitations of this transgenic model 
include that measurement of the reporter luciferase required termination of the 
fish and identifying the specific responding tissues required their individual 
dissection and analysis. Work using this transgenic model did however, show 
that the main target tissues (the liver and gonad) were responsive down to 
exposures of EE2 (3 or 10 ng/L) and demonstrated also that responses to 
oestrogenic EDCs differed for different developmental stages (Bogers et al., 
2006). 
Two subsequent transgenic zebrafish models developed incorporated EREs 
with GFP. In 2011, Gorelick and Halpern (2011) reported on a transgenic 
zebrafish containing five tandem consensus EREs upstream of a mouse c-fos 
minimal promoter and the GFP gene. The transgenic zebrafish embryos were 
exposed to a range of oestrogenic chemicals including E2, DES 
(diethylstilbestrol), BPA, EE2 and NP, with responses see in the heart, brain, 
liver, aorta and ventral fin for exposure to E2 (with a LOEC of 100 µg/L), liver 
and heart for exposure to EE2 (with a detection down to 10 ng/L). No GFP 
expression was detected in embryos exposed to NP. Use of this transgenic 
model indicated that different oestrogenic compounds induced tissue specific 
differences in their activity. A drawback of this model was the relatively low 
sensitivity- very high exposure concentrations of oestrogens (1-100 µg E2/L) 
were employed to induce these responses. However, in their more recent work 
with this model, they were able to observe tissue-specific GFP expression for 
exposure to wastewater effluents  (Gorelick et al., 2014).  
The most recently developed ERE transgenic zebrafish developed by Lee et al. 
(2012) is currently the most sensitive transgenic zebrafish system developed for 
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detecting environmental estrogens. This model includes a 3×tandem ERE and a 
Tol2 mediated GAL4FF-UAS system. The zebrafish embryos and larvae had 
response sensitivities to the EDCs tested of 1 ng EE2/L, 5 ng E2/L, 100 µg 
BPA/L and 1 µg NP/L. Responses in this model were detected in a wide variety 
of tissues including the liver, heart, skeletal muscle (somite and cranial), ear/eye 
ganglions, brain, otic vesicle, lens and neuromasts (Figure 5). Skeletal muscle 
cells, cranial muscle cells, heart cells and neuromast cells were especially 
responsive to estrogen. There were tissue-specific expression patterns for the 
different environmental oestrogens indicating differences in tissues toxicities 
(Lee et al., 2012).  
Life stage differences in responses to oestrogens and differences in health 
effects for different developmental stages, most likely relate to the expression 
patterns of the different oestrogen receptor (esr) subtypes. However, it is not yet 
known how the oestrogenic response pattern observed (via GFP expression) 
relates to the expression of ERs, although this could now be studied in this 
model using morpholino knockdown or CRISPR of the different oestrogen 
receptor sub-types in organisms and in real time. 
 Transgenic zebrafish have also been developed to examine the effects of 
oestrogenic chemical exposure on development of the brain using the promoter 
of a cyp19 gene. Cytochrome P450 aromatase (cyp19) is enzyme complex that 
catalyses the synthesis of estrogens, thereby controlling many different 
physiological processes of oestrogens and is mainly expressed in the gonad 
(cyp19ala) and brain (cyp19a1b) (Chiang et al., 2001). These are oestrogen 
sensitive target genes. Tong et al. (2009) generated a transgenic zebrafish line 
that expresses GFP under the control of the brain aromatase cyp19a1b 
promoter. In this line GFP expression occurred in the radial glial cells in 
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response to oestrogen and was associated with endogenous aromatase B 
expression (Tong et al., 2009). Exposure of embryos to a variety of different 
oestrogenic chemical classes including natural and synthetic steroids, 
alkylphenolic compounds and phyto- and myco-estrogens (for 5 days) induced 
strong GFP expression in the region between the anterior telecephalon and 
caudal hypothalmus and most of these responses were concentration 
dependent (Brion et al., 2012). The effective concentrations (EC50) for inducing 
these responses were 0.013 nM (3.9 ng/L) EE2, 0.01 nM (2.7 ng/L) DES, 0.48 
nM (130.8 ng/L) E2, 3303 nM (0.8 mg/L) BPA, 2501 nM (0.7 mg/L) genistein. 
This zebrafish line provides a very useful model for studies into the roles of 
natural estrogens, and effects of environmental estrogens, on brain 
development and function. Models using the cyp19a1a gene promoter are likely 
to be forthcoming in the very near future for studies into the effects of 
oestrogens on gonadal development.   
 
Benefits, Limitations and Future Application of Transgenic Fish in 
Ecotoxicology 
Transgenic fish systems provide the advantages of both in vitro and in vivo 
systems for testing chemicals. As embryos/larvae they offer as reasonably rapid 
screening systems with high sensitivity (for some models) and good 
repeatability. They can also be relatively cheap to use, once the models have 
been established, and especially so when compared with similar mammalian 
models. Equally however, there are reasonably high costs, most notably in 
skilled time, to develop fish transgenic models and then in maintaining the lines. 
Transgenic fish allow for effective toxicokinetic studies for assessing uptake, 
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distribution and accumulation of chemical ligands/activators in the tissues of live 
fish and this can be combined with biological effects analyses in a targeted 
manner. The ability to visualize tissues responsive to chemicals for exposures 
during early life offers the possibility also to track subsequent effects in those 
specific tissues in later life. Furthermore, transgenic fish could be usefully 
applied to study how different chemicals (single chemicals or chemical 
mixtures) interact within the body to affect different body tissues to assess the 
effects of sequential exposures, and investigate effects of real world mixtures 
(e.g. effluent discharges) on developmental processes and health. The 
availability of fluorescent markers such as kaede offer exciting opportunities to 
help identify responses and effects for sequential exposures to the same, or to 
different chemicals. Transgenic fish systems also offer the potential for studying 
detailed effect mechanisms and signaling pathways. As an example application 
of morpholinos/CRISPRs could be applied in combination with chemical 
exposures to ablate specific receptors and to identify roles of receptor subtypes 
in mediating the toxicant response. The transgenic models published to date 
are relatively simple and combining different reporter systems in the same 
animals (and using different fluorescent markers) in the future should allow for 
multiple toxicological responses in the same animal. As an example 
incorporating both the ERE and cyp19 gene promoters that are linked with 
different fluorescent proteins in the same transgenic fish will more fully inform 
on the roles and effects of oestrogens and oestrogen mimicking chemicals in 
fish. Novel automated systems are now being developed to scan and analyze 
responses in transgenic zebrafish larvae in medium throughput systems (Chang 
et al., 2012) and this will enhance further small fish transgenic for chemicals 
screening and testing. A further major benefit of transgenic fish systems is they 
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could lead to a significant replacement and reduction in animal in chemical 
testing, as they allow for better effects targeting and analysis across multiple 
organ systems in individual organisms in real time. Use of transgenic embryos 
rather than adult fish could also reduce substantially the numbers of fish in 
chemical testing. Equally however, it has to be recognized that substantial 
validation of these transgenic models is required before this is possible. Life 
stage dependent effects may occur for specific chemicals and thus responses in 
embryos may not always be representative of responses in later life stages. 
This in turn will, in the short term, demand use of more intact animals for the 
validation process. Furthermore, to date there has been little attempt to 
compare directly responses in transgenic animals with wild type lines, embryos 
of otherwise, and this warrants further study. Confidence that transgenic fish are 
truly representative of the more standard lines of fish currently used in chemical 
testing will be required before they are taken up widely in standardized 
chemical testing. Indeed, it could be argued that a standardized validation 
process needs to be established for transgenic lines before they are accepted 
into standardized regulatory guideline tests for chemicals.  
  Although transgenic fish have been developed and applied successfully for 
detecting responses to a range of chemicals, there are also a number of 
inherent difficulties/limitations of the models. Most of these, however, should be 
relatively easy to resolve, in the near future with scientific endeavor and the 
appropriate resources to do so. It is clear from the transgenic fish models 
reported upon in the previous section that considerable differences occur in 
their sensitivity and efficiency. Some of these differences  in transgene 
expression may be due to differences in the test chemicals/ chemical 
formulations used from different manufactures in the different laboratories 
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(rarely are details given in this regard). This however is unlikely to result in the 
orders of magnitude differences seen in sensitivity between some experimental 
models for the same promoter. More likely, these differences are due to 
differences in the targeting vector, the number of responsive sequences used, 
promoters adopted, and/or reporter gene and the site of integration.  
Differences in the exposure duration and fish life stages exposed may also 
account for some of the differences in sensitivity reported. It is difficult to 
reconcile these differences for recommending an ‘optimized approach’ and in 
fact it is unlikely that one approach will be optimal for all genes of interest. 
Nevertheless, there are some general features that will help in creating both a 
stable and responsive transgenic fish. From the published information Tol2 
transposon and I-SceI meganuclease-mediated transgenesis protocols, appear 
to be the more reliable (and stable) systems for creating transgenic biosensor 
fish as they have been successfully applied to a wide range of molecular 
sequences and both are suited to microinjection methods. The insertion of 
multiple response elements, rather than a single element, also appears to result 
a more sensitive transgenic model. An area of research that could provide 
fruitful dividends is into the efficacies of the different types (i.e. natural vs 
synthetic) and the nature of promoter sequences.  
Pigmentation in skin has been a major limitation for using juvenile and adult 
transgenic fish. Embryos and early life stages of zebrafish, and many other fish 
species, lack significant skin pigmentation and induction of GFP and other 
fluorescent markers is easily observed even in relative deeply seated tissues. In 
juveniles and adults, however, this is not the case and animals have to be 
dissected to view responses in internal organs. A way to circumvent this 
problem is to develop the transgenic systems in skin pigment free lines (e.g. 
 239 
casper, as one example for zebrafish). It is also the case that for models 
developed for understanding chemicals interacting with endogenous hormone 
receptors the endogenous hormones will affect which life stages and possibly 
which sex can be usefully applied. As an example for studies into the effects of 
environmental estrogens, sexually maturing females will contain varying (but 
significant) levels of endogenous circulating estrogen, making any chemical 
effects analyses extremely difficult, and in adults such studies may only be 
practicable with males.  
It should be recognized that to produce and maintain stable transgenic fish lines 
is a considerable undertaking and careful planning is required to ensure 
valuable lines can be maintained and secured for future studies. Separate lines 
of transgenic zebrafish should be bred and subsequent generations tested on a 
regular basis through routine screening of their responses to ensure 
consistency and also to avoid potential problems associated with inbreeding, 
such as a reduction of reproductive fitness. Consistency in responses of specific 
transgenic lines is crucial for any standardized chemical testing. Thus the 
development and maintenance of transgenic fish lines is not a trivial exercise 
and more easily undertaken in large, well funded laboratories. This being the 
case, transgenic lines created should be made available, on request, to other 
research laboratories to maximize their utility and model uptake and 
independent validation.  
In conclusion, transgenic fish (principally zebrafish) have been applied widely in 
studies in developmental biology and medicine, and provided systems for 
exploring many biological questions. Recent developments show that 
transgenic zebrafish offer promise as biosensors in ecotoxicology, but to date 
only a few models have been developed that have both the required specificity 
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and sensitivity for application to understand environmental health effects. Most 
of the fish models developed, however, have good utility for investigating effect 
mechanisms of chemicals and in a highly integrative manner. Transgenic fish 
line may prove particularly beneficial in elucidating of adverse outcome 
pathways. With the technology established for the creation of stable and 
sensitive transgenic fish for studying chemical effects and in real time there are 
exciting possibilities for ecotoxicologists.  
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Figure and table legends: 
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Summary of the different transgenic zebrafish and transgenic 
medaka lines developed for ecotoxicology. The table includes the 
transgene sequences and insertion techniques used to generate the individual 
transgenic lines as well as the chemicals used in exposures.  
 
 
Figure 1. Number of publications between the years 1967-2013 that include 
"transgenic animals’ (1a) or transgenic (TG) fish/transgenic zebrafish as 
analyzed using PubMed. A search for ‘transgenic (TG) zebrafish in 
ecotoxicology’ returned only12 publications in the last 15 years. 
 
 
Figure 2. Procedure for generating transgenic fish. Once the construct is made 
by either restriction enzyme/ligase cloning (a), In-Fusion cloning (Clontech) (b), 
or Gateway cloning (Life Technologies) (c), the plasmid is microinjected into 
one cell stage embryos and the embryos are the subsequently raised to 
adulthood. The presence of the transgene is confirmed by polymerase chain 
reaction (PCR) and/or Southern blotting on genomic DNA isolated from fin 
tissue. Single founder (F0) fish are mated with single wild-type (non-transgenic) 
fish and their offspring are mated with each other to confirm germ-line 
integration and to establish a homozygous transgenic line. 
 
Figure 3. Principles of how reporter genes (luciferase (Luc) (A), green 
fluorescent protein (GFP) (B) and kaede (C) enable visualizing target gene 
Table 1.  
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expression. The reporter genes (Luc, GFP and Kaede) are expressed when 
DNA is transcribed into messenger RNA (mRNA) and then translated into a 
reporter protein. In a reporter gene assay using luciferase, a luminescence 
signal is generated by the reaction of luciferase’s substrate, luciferin (A). GFP 
expressing cells are detected by fluorescence microscopy (B). Kaede protein, 
when exposed to UV or violet light, is capable of irreversible photo-conversion 
from a green to a red fluorescent form (C). 
 
. 
Figure 4. Schematic of a biosensor transgenic zebrafish system for detecting 
exposure to aquatic pollutants. The transgenic zebrafish containing DNA 
elements responsive to a toxicant is placed in the exposure water and as the 
contaminants enter  and reach the body tissues, activation of the response 
elements occurs that induces the production of GFP in that target tissue.  
 
 
Figure 5. Mechanism of amplification of the oestrogenic signal in a GAL4FF-
UAS transgenic zebrafish. Within the transgenic fish, oestrogen responsive 
elements (EREs) respond to the oestrogenic signal to drive the first reporter, 
Gal4ff. Gal4ff binds to UAS in the 2nd transgene to drive the 2nd reporter, a 
green fluorescent protein (GFP). This two step reporter system amplifies the 
signal and enhances the sensitivity of the biosensor.  
    Induction of GFP in 3×ERE:GAL4FF/UAS:GFP transgenic zebrafish  
exposed to estrogen. Four day old larvae exposed to clean water alone (control: 
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A) or 17β-estradiol (100 ng E2/L: B). GFP expression is observed in the cranial 
muscle (cm), heart (h), lens (le), liver (li), neuromast (n) and somite muscle (sm) 
by confocal microscopy (Zeiss) with a ×10 objective lens.   
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Figure 2. Procedure for generating transgenic fish 
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Figure 3. Principles of how reporter genes (luciferase (Luc) (A), green 
fluorescent protein (GFP) (B) and kaede (C) enable visualizing target 
gene expression.  
 
 
A 
B 
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Figure 4. Schematic of a biosensor transgenic zebrafish system for 
detecting exposure to aquatic pollutants.  
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Figure 5. Mechanism of amplification of the oestrogenic signal in a 
GAL4FF–UAS transgenic zebrafish.  
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